(George Ware) Reviews of Environmental Contaminati (BookFi)
(George Ware) Reviews of Environmental Contaminati (BookFi)
(George Ware) Reviews of Environmental Contaminati (BookFi)
Environmental Contamination
and Toxicology
VOLUME 193
Reviews of
Environmental Contamination
and Toxicology
Editor
David M. Whitacre
Editorial Board
Lilia A. Albert, Xalapa, Veracruz, Mexico · Charles P. Gerba, Tucson, Arizona, USA
John Giesy, Saskatoon, Saskatchewan, Canada · O. Hutzinger, Bayreuth, Germany
James B. Knaak, Getzville, New York, USA
James T. Stevens, Winston-Salem, North Carolina, USA
Ronald S. Tjeerdema, Davis, California, USA · Pim de Voogt, Amsterdam, The Netherlands
George W. Ware, Tucson, Arizona, USA
Founding Editor
Francis A. Gunther
VOLUME 193
Coordinating Board of Editors
University of Florida
700 Experiment Station Road
Lake Alfred, Florida 33850, USA
(863) 956-1151; FAX (941) 956-4631
E-mail: [email protected]
Springer
New York: 233 Spring Street, New York, NY 10013, USA
Heidelberg: Postfach 10 52 80, 69042 Heidelberg, Germany
springer.com
Foreword
v
vi Foreword
discoveries in the fi
fields of air, soil, water, and food contamination and
pollution as well as methodology and other disciplines concerned
with the introduction, presence, and effects of toxicants in the total
environment.
Archives of Environmental Contamination and Toxicology (Vol. 1 in 1973)
for important complete articles emphasizing and describing original
experimental or theoretical research work pertaining to the scientific fi
aspects of chemical contaminants in the environment.
Manuscripts for Reviews and the Archives are in identical formats and
are peer reviewed by scientists in the fifield for adequacy and value; manu-
scripts for the Bulletin are also reviewed, but are published by photo-offset
from camera-ready copy to provide the latest results with minimum delay.
The individual editors of these three publications comprise the joint Coor-
dinating Board of Editors with referral within the Board of manuscripts
submitted to one publication but deemed by major emphasis or length more
suitable for one of the others.
vii
viii Preface
Summerfield,
fi North Carolina D.M.W.
Table of Contents
Foreword ..................................................................................................... v
Preface ......................................................................................................... vii
xi
Rev Environ Contam Toxicol 193:1–29 © Springer 2008
Contents
I. Introduction ............................................................................................................ 1
II. Chlorinated Hydrocarbons as Key Environmental Pollutants........................ 4
III. Implementing Remediation Technologies for Organochlorine-
Contaminated Sites................................................................................................ 8
A. Soil.................................................................................................................... 11
B. Groundwater ................................................................................................... 13
IV. Definitions
fi of An Integrated Approach ........................................................... 16
A. Soil Washing ................................................................................................... 17
B. Wastewater Treatment .................................................................................. 17
C. Characterization of Waste Streams ............................................................. 19
D Windrow Composting .................................................................................... 20
V. Discussion ............................................................................................................. 20
Summary ............................................................................................................... 21
Acknowledgments ............................................................................................... 22
References ............................................................................................................ 22
I. Introduction
Despite its importance in human life, until recently the relationship between
soils and human health has been undervalued, especially in least developed
countries. Currently, a holistic approach has been incorporated to identify
best practices in soil science, defi
fining it as “the task of all people concerned
with the soil to direct their interest, not just towards the physical, chemical,
and biological aspects, but also to those environmental, economic, social,
legal, and technical aspects that affect soil use” (Abrahams 2002; Fent
2003). Considering this defi finition, the European Union (EU) as well as
most developed countries have recognized organochlorine-contaminated
1
2 A. Bezama et al.
sites as potential threats to the human health, threats that take different
forms, such as their inflfluence on water (e.g., drinking water resources), soil,
and air as well as their interrelationships, which can directly affect human
health (EC 2002; EP 2002; Bezama et al. 2004). Moreover, economic expan-
sion and industrial growth are linked with growing lack of “greenfields”
fi (a
term that defi fines all areas without previous history of development): the
supply of new building sites is limited and must contend with other compet-
ing uses, such as housing, recreation, nature, traffic, fi or agriculture (De
Sousa 2001; Tedd et al. 2001). Thus, cleaning and reusing contaminated
sites can be a meaningful alternative to address this issue, because most
contaminated sites are located in metropolitan centres and are, therefore,
prime candidates for urban development (Lorber et al. 2004).
The identification
fi of sites that pose a potential risk to human health and
ecosystems, the verifi fication of their actual pollution level, and assessment
of the involved risks are the first steps when managing a contaminated land
(Bezama et al. 2007a). Occurrence and distribution of soil problems in
Europe are infl fluenced by the diversity, distribution, and specifi fic vulner-
ability of soils across the continent, coupled with physical aspects such as
geology, relief, and climate (EEA 1999). About 550,000 sites across the EU
have been identifi fied as defi finitively or potentially contaminated, and the
best estimate is that 1.3 million contaminated areas will be registered,
although there is still a lack of information about the type and size of these
contaminated areas. An estimated overview of the contaminated sites situ-
ation in Europe can be observed in Fig. 1 (Bezama 2006).
Organochlorine compounds represent an important fraction of the pol-
lutants present in the identifiedfi contaminated sites in Europe, especially
considering those originating from industrial and agricultural activities,
which together are approximately 75% of the identifi fied potentially con-
taminated sites (EEA 1999, 2003). For example, from the approximately
70,000 sites suspected to be contaminated in Austria, 33,549 have been
registered as potentially industrial contaminated sites. Of these registered
sites, 163 have already been investigated, evaluated, and classified.
fi The data
show that ∼32% of the registered contaminated sites were contaminated
with organochlorine compounds, whereas in 2002 these were found as main
pollutants in ∼29% of the 163 evaluated sites (FEA 2002).
As in most South American countries, the magnitude of the Chilean
contaminated site problem has yet to be established. To date, two studies
have been conducted for the identifi fication and preliminary risk assessment
of sites under suspicion of contamination, considering the associated human
health and environmental risks (Fundación Chile 2004; Bezama et al.
2007a). The latter work is a case study in an industrial Region in South
Central Chile that is the second most important nationally in social and
economic terms. This preliminary investigation, based on historical data-
bases of industrial activities and without a more accurate identificationfi
process due to limited funding, identified fi nearly 510 sites as suspect of
Remediation of Contaminated Sites 3
contamination in the fifirst stage, from which approximately 10% were evalu-
ated as dangerous to human health. As expected, a large number of these
sites have an industrial origin. According to Seguel (2002), the total amount
of industrial wastes generated in this Chilean Region amounts to about
350,000 t/yr. Most of the generated waste corresponds to the forestry sector
(including sawmills, pulp and paper, cardboard, chipboards, and other com-
panies, comprising ∼21% of the regional waste generation) and to the iron
and steel industry (17%). Considering these industrial activities, it is possi-
ble that chlorinated compounds are pollutants in this Region’s contami-
nated sites.
The objective of this study is to define
fi the technical considerations to
be used when dealing with chlorinated-compound-contaminated sites,
especially focusing on sites contaminated with chlorinated hydrocarbons
(CHCs), chlorophenols (CPs), and polychlorinated biphenyls (PCBs), con-
sidering their occurrence in a developing economy such as Chile. These
defifinitions are then followed by the determination of an integral site reme-
diation technology that is based on the European experience but which
could be easily transferable to the reality of developing countries in South
America, specifically
fi considering the Chilean case.
4 A. Bezama et al.
Cl Cl Cl Cl Cl
Cl Cl
Cl Cl Cl
Cl Cl O H Cl O H
Cl Cl Cl Cl Cl
Cl C l Cl
Cl O H OCH 3 Cl OCH 3
Cl Cl Cl Cl Cl
Cl Cl Cl
Cl Cl Cl Cl Cl
Cl Cl Cl
between 1929 and 1939. One of the most important characteristics of the
PCBs is the wide variability in their physicochemical properties (vapor
pressure, water solubility, and partition coefficients)
fi as a consequence of
their great number of congeners (209), varying from very low molecular
weight/high volatility compounds (such as monochlorobiphenyl) to not very
volatile/high molecular weight compounds (such as decachlorobiphenyl),
which determines their behavior and mobility in different environmental
compartments (Table 1). Such characteristics have resulted in international
standards to regulate use of these compounds in all their life-cycle stages
and in all their applications, e.g., recently in the European food industry
(EC 2006).
Total PCB global production has been estimated to reach 1.3 million ts
(Breivik et al. 2002). In Chile, as in other developing countries, PCBs have
been used for more than 30 yr in many different industrial applications
(Barra et al. 2004), principally as dielectric fl
fluid, whose use was prohibited
in 1982, in new transformers and condensers. However, their use in old
devices and later storage may present a high environmental risk. In July
6
C12H3Cl7
C12H2Cl8 Octa 12 194–205 429.8 7.1 66.0 0.0006 0.0002–0.0003 11
C12HCl9 Nona 3 206–208 464.2 7.2–8.16 68.7 — 0.00018–0.00012 3
C12Cl10 Deca 1 209 498.6 8.26 71.1 0.00003 1 × 10−6–1 × 10−7 1
a
Refers to the number of isomers identified
fi in commercial mixtures.
Source: Guitart et al. (1995); de Voogd et al. (1990); Ritter et al. (2005).
Remediation of Contaminated Sites 7
I 699 22 721
II 62,014 156,408 218,442
III 10,767 56,267 67,034
IV 7,745 681 8,426
V 12,132 250 12,382
R.M. 77,235 5,005 82,240
VI 44,944 742 45,686
VII 173 173 173
VIII 80,645 20,378 101,023
IX 450 0 450
X 60 0 60
XI 0 0 0
XII 30,314 2,616 32,930
Total 327,005 242,542 569,547
North 4 25.3
North Center 3 37.2
South Center 3 12.4
South 3 15.3
South End 3 198.5
Water
solubility* Specific
fi Boiling point °C Vapor pressure
Contaminant Kow (mg/L) gravity (760 mmHg) pK Ka (mmHg)
PCP properties are of special importance for Chile because the intensive
forestry activity in the South Central region results in a large number of
sawmills and wood-related enterprises, where the Potentially Contami-
nated Sites are highly probable from PCP use, especially in those compa-
nies operating before 1999, when the Chilean government banned PCP use.
Until that date, more than 500 t PCP was imported and used for wood
impregnation, where sodium salt is the most common form used.
In Table 4, it can be observed that nonionic PCP has low solubility and
very low vapor pressure, which means, looking at its Kow value, that PCP
has a great affinity
fi for organic matter and will probably remain adsorbed
onto the organic part of the soil in the unsaturated zone. It is possible to
assume that nonionic PCP has a low Henry’s law constant, so that it will be
very difficult
fi to find PCP in the vapor phase. Regarding nonionic TCP, this
compound would be preferentially found in the vapor phase of the vadose
zone because of its high vapor pressure, moderated water solubility (Table
4), and high Henry’s law constant. The Kow for TCP is small, and TCP can
be assumed to adsorb lightly on organic matter of the soil. Finally, it is
possible to assume that nonionic CP would be preferentially dissolved in
the aqueous phase of the vadose zone because of its high solubility value,
low vapor pressure (see Table 3), and moderated Henry’s law constant. The
Kow value for CP is also small, and it is possible that this pollutant could
lightly adsorb onto soil organic matter. For the unsaturated zone, the situ-
ation would be as described in Fig. 3a, assuming as well an unsaturated zone
pH smaller than pKa and that all compounds are present in their nonionic
form.
All these considerations correspond to the pollutants in their original
form, not dissociated, although they may change depending on the pH of
the water and soil system, affecting each compound’s dissociation capacity
in dependence with its pKa value. These dissociated species may present
different behaviors in the surrounding environment and will have different
Remediation of Contaminated Sites 11
(a) (b)
Soil pore
p
Soil pore
p
Gaseous TCP Gaseous
nonionic TCP
Water pore
Water pore
Dissolved
Dissolved TCP
anionic TCP
solubilities, Henry’s law constants, and vapor pressures. Thus, soil and
water pH would become an important factor when choosing or designing
a remediation process. If we consider that pH controls the presence of the
dissociated species in a soil–water environment, the dissociation curve for
each pollutant and its dependence with pH needs to be known. Taking as
example a pH value of 7 in the soil/water system, PCP would be preferen-
tially in the anionic form and its solubility will increase from 1.4 × 101
(nonionic PCP) to 104 mg/L (anionic PC-phenolate). In contrast, the situa-
tion for TCP and CP should be quite different, because at pH 7 TCP would
be present at about 50% in the anionic form and 50% in the nonionic form
and CP should be mainly present in the nonionic form in the aqueous phase.
Therefore, there might be only small quantities of nonionic TCP and CP
that remain adsorbed onto the soil pores (Fig. 3b).
A. Soil
A widely used remediation practice for soils polluted with hydrocarbons is
bioremediation. In recent years, bioremediation has been increasingly
selected to treat organochlorine compounds, because it is more publicly
acceptable as it relies on natural processes to treat contaminants (EPA
2000; GeoSyntec Consultants 2005). Bioremediation utilizes microorgan-
isms to degrade organic contaminants in soil, sludge, and solids, either
excavated or in situ. Microorganisms break down contaminants by using
them as a food source or cometabolizing them with a food source. Aerobic
processes require an oxygen source, and the end products typically are
carbon dioxide and water, although metabolites can also be found as inter-
mediates (Zink and Lorber 1995). In ex situ processes, optimal aerobic
12 A. Bezama et al.
B. Groundwater
Since the late 1970s, the on-site “pump and treat” process has been used
for groundwater remediation. Groundwater is pumped, treated normally in
afifilter/adsorbent system, and returned to the groundwater layer (Voudrias
2001). Sand filters,
fi granular activated carbon adsorbents, biofi filters, and
advanced oxidation processes have commonly been used as treatment
systems. The main disadvantages of this technology are related to its high
operational costs and the use of water as the carrier fluid. Still, the tendency
is toward increased use of in situ groundwater remediation.
In situ bioremediation has potential to remove contaminants present in
the groundwater plume, but it is limited by low ambient temperatures from
the aquifers. Mineralization processes from the contaminants could be seri-
ously affected by this factor, and biological on site treatment of contami-
nated groundwater could even require heating (Valo et al. 1990). There has
been very little experience with in situ biological treatment of contaminated
groundwater, as ex situ systems are more controllable, predictable, and less
complex than in situ treatments (Hamby 1996).
Activated carbon, minerals, waste-derived adsorbents, and zero-valent
metals are the adsorbent materials most used, with an interesting applica-
tion as a reactive wall for contaminant compound adsorption. Activated
carbon is mainly used in drinking and wastewater treatment facilities as
well as in groundwater remediation, and it can adsorb a wide range of
organic and inorganic pollutants present in water systems (USEPA 1998).
Its amphoteric character governs adsorption onto activated carbon. In fact,
in response to pH changes, the carbon surface develops coexisting electric
charges of opposite sign, whose prevalence depends on the solution’s chem-
istry. Therefore, attractive or repulsive electrostatic interactions between
the adsorbate and the adsorbent must be taken into consideration (Radovic
et al. 2000).
Activated carbon can adsorb heavy metals such as Cr(III), Cr(VI), Mo,
Co, Ni, Cu, Zn, Cd, Hg, Pb, U, Au, and As as well as phosphates (Radovic
et al. 2000), phenols (Streat et al. 1995), substituted phenols and benzenes
(Mollah and Robinson 1996; Aksu and Yener 2001), dyes (Walker and
Weatherley 1999), natural organic matter (NOM) (Radovic et al. 2000),
14 A. Bezama et al.
coal, straw, and tires were tested successfully for the removal of phenol and
p-chlorophenol from contaminated water (Streat et al. 1995).
Bagasse fly ash, a sugar industry waste, has been recently investigated
for the removal of some specific fi toxic and carcinogenic compounds such as
pesticides based on a chlorobiphenyl structure (Gupta and Ali 2001). This
same residue is also capable of removing Cd and Ni from wastewater
streams (Gupta et al. 2003).
Low-cost adsorbents obtained from organic residues have also been
developed to remove hexavalent chromium, which is often found in waste-
water discharges from electroplating, metal finishing, and chrome prepara-
tion, and is considered to be highly toxic with a potential carcinogenic
effect. At acidic pH, sawdust, sugar cane bagasse, sugar beet pulp, and corn
cob, which are naturally occurring cellulosic waste materials, are able to
adsorb Cr(VI) present in contaminated water (Sharma and Foster 1994).
Moreover, Cu and Cd ions have been found to adsorb successfully onto
bone char (Ko et al. 2000), whereas Al, Ca, Cd, Cu, Fe, Mg, Ni, Pb, and
Zn ions (especially Pb) were efficiently
fi removed from an acidic leachate
by cocoa shells and, to a lesser degree, by cedar bark (Meunier et al.
2002).
With respect to colored effl fluents, these wastewaters are not only aes-
thetically displeasing, but they also impede light penetration, thus upsetting
biological processes within a stream. Additionally, many dyes are toxic to
some organisms and may cause direct destruction of aquatic communities,
requiring some form of advanced treatment. Adsorption of acid and basic
dyes present in aqueous solutions onto low-cost adsorbents such as bagasse
pith, peat, corn cob, bean waste, and sugar-industry mud (Magdy and
Daifullah 1998), as well as onto low-cost sewage sludge-based activated
carbon (Rozada et al. 2003), have produced very successful results.
Zero-valent metals are one of the most promising adsorbent materials,
with an interesting application for pollutant adsorption in in situ ground-
water remediation, and are partially displacing on-site groundwater treat-
ment processes like “pump and treat.” In this process, the groundwater is
pumped, treated normally in a filter/adsorbent system, and returned to the
ground, although the tendency is toward increased use of in situ remedia-
tion (Zorzi and Hammer 1998). Fe0, Al0, Zn0, Ni0, Cu0, Pd0/C, and their
combinations have been successfully tested for organochloride removal
from groundwater. Moreover, it has been demonstrated that zero-valent
iron is capable of producing reductive dechlorination of a great spectra of
chlorinated organic compounds (Table 5).
Some unknown Fe0-treatable CHCs have recently been carefully studied.
Particularly, PCB reductive dechlorination may also occur in the presence
of zero-valent iron while extracting PCBs from soil and sediments with
subcritical water (Yak et al. 1999). From the chlorophenol group, the elec-
trochemical dechlorination of 4-chlorophenol to phenol was determined to
occur rapidly on palladized carbon cloth or palladized graphite electrodes
16 A. Bezama et al.
IV. Definitions
fi of an Integrated Approach
On May 19, 2005, Chile ratifified the Stockholm Convention to prevent the
damage caused by persistent organic pollutants (POPs) on the environ-
ment, including human health. With this ratifification, Chile agreed to apply
all the necessary measures to eliminate or restrict intentionally generated
POPs as well as to appropriately eliminate the existent unused POPs,
to minimize unintentional POP generation, and to establish a National
Stockholm Convention Implementation Plan. Within this framework, Chile
adopted as one of its priority lines the remediation of POP-contaminated
environmental liabilities.
Remediation of Contaminated Sites 17
A. Soil Washing
First, contaminated soil should be sieved. The large size soil fraction, which
is normally less contaminated, should be immediately disposed. The con-
taminated soil fraction should be washed under optimal temperature, pH,
and tensoactive concentration. With these optimized values, the final pol-
lutant distribution in the different soil-size fractions should be determined.
It is expected that the pollutants should concentrate in the fine
fi soil fraction
<63 μm (Reinert et al. 1999), which will be characterized and treated further
in a windrow composting system. As guide values for the chlorinated organ-
ics concentration in cleaned soil, it is possible to use the Austrian Norm for
soil remediation S2088-2 (OeN 2000), where limit values and prevention
values are established (Table 6). For possible soil landfilling
fi after the clean-
ing process, the Austrian Landfi fill Policy (List 2001) should be applied, dif-
ferentiating between four landfillfi types, and each one has limit values for
pollutants in the soil (Table 7).
B. Wastewater Treatment
The wastewater stream from the soil washing process will be contaminated
with CHCs. This stream should be cleaned by adding fl flocculating com-
pounds through a press filter
fi and a further activated carbon adsorption
process. The filtration process will treat the suspended compounds, while
the activated carbon system should adsorb the dissolved pollutants. The
cleaned wastewater should be returned to the washing system as process
water, following an integrated process concept. The Austrian Water Law
will be used for fi
first-limit wastewater values. The emission limit values will
follow the indication for emission into open canalization (Table 8).
18 A. Bezama et al.
Fig. 4. Overview of the proposed integral concept for the remediation of organo-
chlorine compound-contaminated soils.
Table 6. Limit and prevention values for polyaromatic
hydrocarbons (PAH) and PCB presence in soil.
PAH 1 50
PCB 0.2 1
Total content
PAH 0.5 2 t.b.d. 100
Hydrocarbons 20 100 5,000 20,000
TOC (as C) 20,000 30,000 30,000 50,000
POX (as Cl) — — — 1,000
Elute
Hydrocarbons 5 50 100 —
TOC (as C) 200 500 500 t.b.d.
EOX (as Cl) 0.3 3 t.b.d. 30
Surfactants 1 5 20 t.b.d.
(as TBS)
t.b.d., to be determined if relevant; TOC, total organic carbon; POX, purgeable organic
halogens; EOX, extractable organic halogens.
a
Types of sanitary landfills
fi defi fined according to FEA (2001); Jacobsen and Kristoffersen
(2002).
PAH 2
PCB 0.2
Hydrocarbons 200
D. Windrow Composting
Biological degradation of the organochlorine compounds should be per-
formed in a windrow composting system. The fractions to be handled are
the biodegradable, still-contaminated fine fraction from the soil washing
process, the spent activated carbon, and the waste fraction from the waste-
water treatment’s fi filtration process. To optimize the relationship between
the nutrients (i.e., carbon, phosphorus, and nitrogen) in the biological
process, structural material and appropriate substrates (i.e., amendments)
should be added. As a final product, a stabilized material is obtained that
should at least comply with the limit values presented in Table 8 for its
further landfilling.
fi To search for additional uses, a complete characteriza-
tion of the stabilized material shall be determined. For land applicability
uses, the compost limit values are regulated by the Austrian Compost
Policy as summarized in Table 9 (BLFUW 2001).
V. Discussion
Contaminated sites are becoming more important throughout the world, as
their containment and/or remediation can be coupled with a reasonable
further redevelopment of these sites, which is foreseen as one of the most
important future environmental tasks. In the future, research on contami-
nated site remediation must focus on the application of combinations of
already existing technologies in such a way as to appropriately degrade the
most abundant pollutants in an economically and environmentally sound
way. Particularly, organochlorine compounds represent an important frac-
tion of the pollutants found at the identified
fi contaminated sites in Europe,
especially considering those originating from industrial and agricultural
activities, being present in approximately 75% of the identified
fi potentially
contaminated sites. Therefore, the sites contaminated with such pollutants
Remediation of Contaminated Sites 21
Summary
Chlorinated hydrocarbons represent an important aspect of the contami-
nated sites identifi
fied worldwide, especially when considering those origi-
nated from industrial or agricultural activities, which represent approximately
75% of the potentially contaminated sites identifi fied in developed European
countries.
Chlorinated hydrocarbons, such as trichloroethylene, perchloroethylene,
dichloromethane, 1,1,1-trichloroethane, or chloroform, are used extensively
in many industries (e.g., in metal degreasing, dry cleaning, paint industries,
organic synthesis, etc.), and their common use can make them into a sig-
nificant
fi pollution source in the atmosphere, soils, and aquifers. Another
important group of organochlorine compounds are polychlorinated
biphenyls (PCBs). Among the characteristics of the PCBs, one of the most
important is a wide variability in their physicochemical properties (vapor
pressure, water solubility, and partition coefficients)
fi because of their
great number of congeners (varying from very slight compounds, such as
22 A. Bezama et al.
Acknowledgments
This work was partially supported by FONDECYT N° 1050647 (R. Barra),
and by The Research Directorate of the University of Concepción.
References
Abrahams PW (2002) Soils: their implications to human health. Sci Total Environ
291:1–32.
Remediation of Contaminated Sites 23
Schmitz HJ, Andel P (1997) Bodenbehandlungsanlagen: Die Jagd nach dem Boden
wird härter. Terra Tech 5:17–31.
Seguel P (2002) Catastro de residuos industriales de la VIII Región (Register of
industrial waste in the VIII Region). Bachelor of Engineering thesis. Universi-
dad del Desarrollo, Concepción, Chile.
Semer R, Reddy KR (1996) Evaluation of soil washing process to remove mixed
contaminants from a sandy loam. J Hazard Mater, 45(1):45–57.
Shiu WY, Ma KC, Varhanickova D, Mackay D (1994) Chlorophenols and alkyl-
phenols: a review and correlation of environmentally relevant properties and
fate in an evaluative environment. Chemosphere 29(6):1155–1224.
Sharma DC, Forster CF (1994) A preliminary examination into the adsorption
of hexavalent chromium using low-cost adsorbents. Bioresour Technol 47:
257–264.
Sheets RG, Bergquist BA (1999) Laboratory treatability testing of soils contami-
nated with lead and PCBs using particle-size separation and soil washing.
J Hazard Mater 66:137–150.
Stehmeier LG, Francis M, Jack TR, Diegor E, Winsor L, Abrajano TA (1999) Field
and in vitro evidence for in-situ bioremediation using compound-specific fi 13C/12C
ratio monitoring. Org Geochem 30:821–833.
Stiber NA, Small MJ, Fischbecl PS (1998) The relationship between historic indus-
trial site use and environmental contamination. J Air Waste Manag Assoc
48:809–818.
Stoops G, Cheverry C (1992) New Challenges for Soil Research in Developing
Countries: A Holistic Approach. Proceedings of the Workshops, funded by the
European Community, Life Sciences and Technologies for Developing Coun-
tries (STD 3 Programme), Rennes, France.
Streat M, Patrick JW, Camporro-Perez MJ (1995) Sorption of phenol and para-
chlorophenol from water using conventional and novel activated carbons. Water
Res 29(2):467–472.
Sturchio NC, Clausen JL, Heraty LJ, Huang L, Holt BD, Abrajano TA (1998)
Chlorine isotope investigation of natural attenuation of trichloroethebe in an
aerobic aquifer. Environ Sci Technol 32:3037–3042.
Tanabe S, Iwata H, Tatsukawa R (1994) Global contamination by persistent organo-
chlorines and their ecotoxicological impact on marine mammals. Sci Total
Environ 154:163–177.
Tedd P, Charles JA, Driscoll R (2001) Sustainable brownfieldfi re-development—risk
management. Eng Geol 60:333–339.
Tokunaga S, Hakuta T (2002) Acid washing and stabilization of an artificial
fi arsenic-
contaminated soil. Chemosphere 46:31–38.
UNEP (2002) PCB Transformers and Capacitors, from Management to Reclassifi- fi
cation and Disposal. Geneva, Switzerland.
Urum K, Pekdemir T, Ross D, Grigson S (2005) Crude oil contaminated soil
washing in air sparging assisted stirred tank reactor using biosurfactants Chemo-
sphere 60(3):334–343.
USEPA (1998) Permeable reactive barrier technologies for contaminant remedia-
tion. EPA/600/R-98/125. EPA, Washington, DC.
Valo R, Häggblom MM, Salkinoja-Salonen M (1990) Bioremediation of chlorophe-
nol containing simulated groundwater by immobilized bacteria. Water Res 24:
253–258.
Remediation of Contaminated Sites 29
Contents
I. Introduction .......................................................................................................... 31
II. Chemistry .............................................................................................................. 31
A. Physicochemical Properties .......................................................................... 31
B. Synthesis .......................................................................................................... 36
C. Mode of Toxic Action ................................................................................... 36
III. Methods of Analysis ............................................................................................ 38
IV. Environmental Fate and Occurrence................................................................ 39
V. Photodegradation................................................................................................. 40
VI. Metabolism in Microorganisms, Plants, and Animals .................................... 43
Summary ............................................................................................................... 48
References ............................................................................................................ 48
I. Introduction
The triazolopyrimidine sulfonamide (TSA) herbicides were registered in
the United States in 1993. Their mode of action is by inhibition of aceto-
lactate synthase (ALS), an enzyme common to plants and microorganisms
but not found in animals. ALS inhibitors include other herbicide families
such as the sulfonylureas, imidazolinones, and pyrimidinyl thiobenzoates.
In the 1970s, sulfonylureas were the first
fi ALS inhibitors to be introduced
to the market. Their discovery was greeted as a great achievement because
of their ability to suppress weeds at extremely low application rates com-
pared to previously used herbicides and with low toxicity risk to humans
and wildlife. By 1991, the market value of ALS inhibitors had reached $1.3
billion (U.S.). However, some of the problems associated with their use
include the induction of resistance in weed species to both ALS-inhibiting
and alternative herbicides. ALS inhibitors have also been found to damage
31
32 T.W. Jabusch and R.S. Tjeerdema
nontarget plants at residual levels that are below the detection limits of
standard analytical methods (Saari et al. 1994; Whitcomb 1999).
TSA herbicides were first developed in the late 1980s by Dow Agro
Sciences and are now widely applied for postemergence control of broad-
leaf weeds in food and forage crops (Table 1), commonly in rotation and/or
mixtures with different mode of action herbicides. Flumetsulam was the
first to be introduced to the U.S. market in 1993 to control weeds in corn
fi
and soybean fields.
fi It was followed by cloransulam-methyl and diclosulam,
which were developed for use with soybeans and peanuts for broadleaf
weed control. Although neither metosulam nor fl florasulam are registered
in the United States, they have been introduced in other countries for weed
control with maize (Kleschick and Gerwick 1989; Ware and Whitacre 2004;
PAN 2006). Penoxsulam, the newest addition, was registered in the U.S. in
2004 for the control of annual grasses, sedges, and broadleaf weeds in rice
culture (USEPA 2004a). At this writing, the new analogue pyroxsulam is
pending U.S. registration for control of annual grasses and broadleaf weeds
with winter wheat (USEPA 2006).
II. Chemistry
A. Physicochemical Properties
Triazolopyrimidine sulfonamides are among the newer structural types of
herbicides that have made important impacts upon the industry over the
past 10–15 yr; they represent an increasingly science-based approach to pest
control. They are selective ALS inhibitors, generally exhibit a broad activ-
ity spectrum with good crop selectivity and typically high herbicidal activity
at low application rates of 10–50 g active ingredient (a.i.)/ha (Kleschick
et al. 1992; Baskaran et al. 1996), and include seven compounds: flumet- fl
sulam, metosulam, cloransulam-methyl, diclosulam, florasulam,fl penox-
sulam, and pyroxsulam (Fig. 1). Their physicochemical properties are
summarized in Table 1.
Triazolopyrimidine sulfonamides exhibit acidic dissociation constants
(pKKas); thus, their water solubilities are highly pH dependent (see Table 1).
For example, the water solubility of penoxsulam ranges from 0.006 g/L at
pH 5 to 1.46 g/L at pH 9 (Roberts et al. 2003). Generally, these compounds
tend to be highly water soluble at basic and neutral pHs, and their solubility
decreases at lower pHs. Octanol–water partitioning and soil sorption coef-
ficients, as well as hydrolytic rates, for these compounds are also pH depen-
fi
dent. Log octanol–water partition coeffi ficients (log Kow) are low and indicate
that these agents do not signifi ficantly partition into lipids or other organic
solvent phases. The reported soil sorption coefficientsfi (Kds) for flumet-
fl
sulam (5–182) and penoxsulam (0.2–5.1) indicate moderate to high mobility
in soils (Kleschick et al. 1992; Jabusch and Tjeerdema 2005). Chemical
degradation by hydrolysis is also pH dependent; the hydrolytic half-life (t1/2)
Table 1. Physical, chemical, and toxicological properties of the TSA herbicides.
Cloransulam-
Property Flumetsulam Metosulam Diclosculam Florasulam methyl Penoxsulam Pyroxsulam
Chemical N-(2,6-
N N-(2,6-Dichloro-3- N-(2,6-
N N N
N-(2,6- Methyl 3-chloro- 2-(2,2- N-(5,7-
N
name Diflfluorophenyl)- methylphenyl)- Dichlorophenyl)- Diflfluorophenyl)- 2-(5-ethoxy-7- Difl fluoroethoxy)- Dimethoxy-[1,2,4]
5-methyl-[1,2,4] 5,7-dimethoxy- 5-ethoxy-7- 8-fl
fluoro-5- fluoro-[1,2,4] N
N-(5,8-dimethoxy- triazolo[1,5-a]
triazolo[1,5-a] [1,2,4]triazolo fl
fluoro-[1,2,4] methoxy-[1,2,4] triazolo[1,5-c] [1,2,4]triazolo[1,5-c] pyrimidin-2-yl)-2-
pyrimidine-2- [1,5-a] triazolo [1,5-c] triazolo[1,5-c] pyrimidine-2- pyrimidin-2-yl)-6- methoxy-4-
sulfonamide pyrimidine- pyrimidine-2- pyrimidine-2- sulfonamido) (triflfluoromethyl) (trifluoromethyl)
fl
2-sulfonamide sulfonamide sulfonamide benzoate benzenesulfonamide pyridine-3-
sulfonamide
Trade Accent gold Strongarm® Firstrate®, Gf-881®, Granite®,
name(s) herbicide®, Frontrow®, Grasp®
Broadstrike®, Gangster®,
Frontrow®, Gauntlet®,
Hornet®, Naf- Riverdale
280, Naf-281, 565®
Python®,
Scorpion®
Application Corn, soybean, Cereals Soybean, peanut Cereals, pasture Soybean Rice Wheat, hay, straw
Chemistry and Fate of Herbicides
barley, wheat
Application 10–80 g a.i./ha 30–70 g a.i./ha Maximum global Canada 5 g a.i./ha 17.5–44 g a.i./ha 40 g a.i./ha
rate use rate: 52 g Europe 7.5 g a.i./ha
a.i./ha
CAS 98967-40-9 139528-85-1 145701-21-9 145701-23-1 147150-25-4 219714-96-2 422556-08-9
number
Chemical C12H9F2N5O2S C14H13Cl2N5O4S C13H10Cl2FN5O3S C12H8F3N5O3S C15H13ClFN5O5S C16H14F5N5O5S C14H13F3N6O5S
formula
Molecular 325.3 418.3 406.1 359.3 429.8 483.4 434.4
weight
33
34
Table 1. (cont.)
Cloransulam-
Property Flumetsulam Metosulam Diclosculam Florasulam methyl Penoxsulam Pyroxsulam
t1/2 (d)
Hydrolysis NA NA 1007 at pH 5 NA >365 at pH 5 NA NA
t1/2 (d) 241 at pH 7 118–231 at pH 7
1.9 at pH 9 3 at pH 9
Sources: Kleschick et al. 1992; Wolt et al. 1992; Frear et al. 1993; Baskaran et al. 1996; USEPA 1997; Parnell and Hall 1998; Jackson et al. 2000; Krieger et al. 2000a; Baron 2001; van
Weesenbeeck et al. 2001; Zabik et al. 2001; Rouchaud et al. 2002b; Roberts et al. 2003; USEPA 2004b; Borges et al. 2005b; Jabusch and Tjeerdema 2005; Cambridge Soft Corporation
2006; Jabusch and Tjeerdema 2006a; PAN 2006; Wood 2006.
Chemistry and Fate of Herbicides 35
O O
N
N O
A. S NH
F B. N N
N S NH Cl
N O N
O N O
F
Cl
F
O Cl
C. D. N O
O
N N N S NH F
S NH Cl N N N
O
F N O F
O
O
F N O O
S NH O N N N
N N N NH O
E. F. N F
O S F
Cl O
O O F
O
F
F
F
H OF F
O N N
G. S
N
N O
N O N
O
B. Synthesis
Flumetsulam, the first marketed TSA herbicide, is derived from the
reaction of 5-methyl-[1,2,4]triazolopyrimidine-2-sulfonyl chloride with
2,6-difl
fluoroaniline in pyrimidine. The sulfonyl chloride is prepared from
2-(benzothio)-5-methyl-[1,2,4]triazolo[1,5-α]pyrimidine by reaction with
chlorine in aqueous acid (Fig. 2; Kleschick et al. 1992). At near-neutral pHs,
the sulfonamide bridge of triazolopyrimidine sulfonamide molecules is
thought to be deprotonated, rendering the compound highly water soluble
(Renew and Huang 2004). At lower pHs, the ratio of the anionic to the
neutral species shifts toward the latter, and solubility as well as soil mobility
slightly decrease (Wauchope et al. 2002).
F
N O N O
N N
S Cl + H2N S NH F
N N N
N O N O
5-Methyl[1,2,4]triazolo F Pyridine F
[1,5-a]pyrimidine- 2,6-Difluoroaniline
Flumetsulam
2-sulfonyl chloride
N-(2,6-Difluorophenyl)-5-methyl-
[1,2,4]triazolo-
Cl2 AcOH-H2O [1,5-a]pyrimidine-2-sulfonamide
-5°C to 3°C
N N
S
N N
2-(Benzylthio)-5-methyl-
[1,2,4]triazolo[1,5-a]pyrimidine
Because of the low use rates of TSA herbicides, ultratrace residue meth-
odologies are required for their detection in environmental samples or to
enforce tolerance levels in food crops (Maycock et al. 1995; Shackelford et
al. 1996; Whitcomb 1999). Analytical methods with high sensitivity levels
for the detection of TSA herbicides in environmental matrices include
liquid chromatography with ultraviolet detection (LC-UV), thermospray
liquid chromatography with mass spectrometry (TSP-LC-MS), capillary gas
chromatography with mass spectrometry (GC-MS), LC tandem MS (LC-
MS/MS), capillary electrophoresis with UV detection (CE-UV), coelectro-
osmotic CE-UV, and direct enzyme-linked immunosorbent assay (ELISA).
All these methods are to varying degrees associated with some inherent
difficulties
fi but are able to detect one or several TSA herbicides in the ppb
range after varying extraction, cleanup, and preconcentration procedures
(Maycock et al. 1995; Baskaran et al. 1996; Shackelford et al. 1996; Krynitsky
1997; Parnell and Hall 1998; Krieger et al. 2000b; Laganà et al. 2000; Borges
et al. 2005a–c).
LC-MS and CE were successfully employed for ultratrace analysis of
TSA herbicides in environmental matrices in multiresidue determinations
at the ppb range. CE is a high-efficiency
fi separation method for pesticide
analysis in complex environmental matrices, but its low detection sensitiv-
ity, which is normally in the ppm range, needs to be overcome; this can be
achieved by sample preconcentration with a method called sample stacking.
Krynitsky (1997) analyzed fl flumetsulam along with 12 sulfonylurea herbi-
cides in runoff water by CE and LC/MS and achieved a limit of quantitation
(LOQ) of 0.02 ppb with a sample preparation method that included acidi-
fication, extraction by reversed-phase SPE, and extract cleanup with a
fi
tandem sample stacking system consisting of a strong anion-exchange SPE
cartridge stacked on an alumina cartridge. For the determination of fi five
TSA herbicides (diclosulam, cloransulam-methyl, fl flumetsulam, metosulam,
and flflorasulam) in soy milk, Borges et al. (2005c) developed a methodology
combining SPE and CE-MS with sample stacking in normal stacking mode
(NSM) and achieved limits of detection (LODs) down to 74 ppb. The same
authors achieved LODs between 0.1 and 0.24 ppb for analysis of the
same suite of TSA herbicides (diclosulam, cloransulam-methyl, flumet- fl
sulam, metosulam, and florasulam) in water samples with a methodology
that employed CE-UV, SPE using C18 cartridges, and on-line preconcentra-
tion by sample stacking with matrix removal (SWMR; Borges et al. 2005b).
The separation electrolyte was 24 mM formic acid and 16 mM ammonium
carbonate at pH 6.4; recovery ranged between 55% and 110%. For the
detection of TSA herbicides in soils, the authors combined a methodology
using SPE (using C18 cartridges), on-line fi field-enhanced sample injection
(FESI), and coelectroosmotic CE-UV and achieved LODs between 18 and
34 ppb (Borges et al. 2005a).
Chemistry and Fate of Herbicides 39
three Mississippi soils of varying texture and organic content were primarily
limited to the upper 8 cm of soil 84 d after treatment (Murphy and Shaw
1997). During the cropping period, fl flumetsulam residues were detectable
but low (near the GC-MS method detection limit of 0.3 ppb) in the 8–15 cm
surface layer and were never detected in the 15–20 cm layer. The results
indicate that fl
flumetsulam strongly adsorbed to soil and that leaching is not
a signifificant dissipation route (Rouchaud et al. 2002a). The reported soil
t1/2 of fl
flumetsulam ranges from 30 to 60 d at pH 6–7 (2%–4% organic
carbon; Gerwick and Kleschick 1991).
A runoff study combined with PRZM modeling revealed that less than
6% of diclosulam applied to peanut fi fields would be lost from severe rain-
fall, assuming worst case management practices. Of the total diclosulam
runoff, 97% was transported off the field by water, with <3% associated
with the sediment (van Weesenbeeck et al. 2001). Soil aging effects,
resulting in increased adsorption, can contribute to the limited mobility
of diclosulam (Yoder et al. 2000; Zabik et al. 2001), cloransulam-methyl
(van Weesenbeeck et al. 1997), and florasulam in soils (Krieger et al.
2000a). The leaching potential of cloransulam-methyl to groundwater was
modeled using conservative inputs for soil, weather, and application rate.
The maximum predicted concentration in groundwater for the most vul-
nerable soil was 2.7 μg/L (ppb), which is more than two orders below
the U.S. EPA-defi fined health level of 1,000 ppb (USEPA 1997; van
Weesenbeeck and Havens 1999). The same study also suggests no signifi- fi
cant risk for nontarget terrestrial plants, based on comparisons of esti-
mated environmental concentration (EEC) and EC25 distributions obtained
from conservative Tier 2 phytotoxicity studies (van Weesenbeeck and
Havens 1999).
So far, few monitoring studies have attempted to determine ambient
TSA herbicide concentrations. In 1998, a monitoring study was conducted
to determine the occurrence of ALS inhibitors in rivers, reservoirs, and
groundwater in the midwestern U.S. Flumetsulam, the only TSA herbicide
measured, was detected in 83% of samples collected from 75 surface water
(63%) and 25 groundwater sites (12%), at a median concentration of
0.01 ppb and a maximum of 0.035 ppb. These concentrations are not likely
to be toxic to nontarget aquatic plants or of concern for human consump-
tion, but do add to the overall burden of pesticides carried by midwestern
rivers (Battaglin et al. 2000).
V. Photodegradation
Photolytic processes are considered important contributors to the degrada-
tion of TSA herbicides, both on soil and, particularly, in water (USEPA
1997; van Weesenbeeck et al. 1997; Krieger et al. 2000c; Zabik et al. 2001;
USEPA 2004b; Jabusch and Tjeerdema 2006b). Photodegradation studies
Chemistry and Fate of Herbicides 41
F
N O
S NH F
N N N
O
O F
florasulam
F F F
N O N O O
N
S OH S NH2 S NH F
N N N N N N N N N
O O O
O O OH F
F OH
O O N O
N
S NH2 S NH F
N N N N N
O O
H
F
OH
5-OH-ASTP DFP-ASTCA
OH
O N O
S NH2
N N
O
H
ASTCA
Fig. 3. Suggested photodegradation pathways for fl
florasulam in water (adapted
from Krieger et al. 2000c).
Chemistry and Fate of Herbicides 43
O O O
N N 1 N
N
NH O N N N NH2
NH2 N N N
N S F F
O N
O F O OH
O
2-amino-TP 5-OH-2-amino-TP
F
F 2
penoxsulam
O
3
N N N
NH
O
N S
O
O OH
F F
F F TPSA
F F
O O
S NH S NH
O O N
N F O
F O N N
NH NH
F F
O HO
O O
BSTCA
BSTCA-methyl
F
F
F F
F O
F
O S NH
2
S NH ? O
O
O N
O N F
NH
F
F
F BST (sulfonamide)
A. F O
N O
F N O
S NH O
N N N S NH O
O N N N
Cl O O
O Cl HO
OH
cloransulam-methyl 5-OH-cloransulam-methyl
F N O O F O O
N
S NH O S NH OH
N N N N N N
O O
O Cl Cl
OH
cloransulam 5-OH-cloransulam
B. F
F
N O OH
N O
S NH F O
N N N S NH F O N
O N N N S NH F
F O N N
O F O
OH H
F
florasulam 5-OH-florasulam
(minor route)
OH
O
HN N N O
S NH F O
N S NH2
O N N
F O
H
C. ASTCA
O Cl (minor route)
O
N N N
S NH Cl
O
F N O HN N
S NH2
diclosulam N O
TSA
Cl
F O Cl
F N O N
S NH Cl F N O
S NH2
N N N N N N S NH Cl
O O N N N
OH Cl O
O
OH Cl
ASTP
5-OH-diclosulam 8-Cl-diclosulam
O
O
N N N
NH O 2 NN N
NH2
N S F F N
O O
O F
O (Minor product)
2-amino-TP
F
F
Penoxsulam
1
O
N
NH O
HN N N F
S F
O
O F
O
F HN N
O
F
N NH
HO
5-OH-penoxsulam O S O
F
O F
F
F F
BSTCA
HN N
O
N NH
O
O S O
F
O F
F
F F
BSTCA-methyl HN N
N NH
F O S O
F
H2N
O O F
F O S F F
F F
O
F
F
BST
Sulfonamide
Fig. 6. Suggested anaerobic metabolism of penoxsulam in fl
flooded rice field soils.
(Adapted from Jabusch and Tjeerdema 2006a.)
Chemistry and Fate of Herbicides 47
N O
N
S NH
F
N N O
F
flumetsulam
N O N O
N N
S NH F S NH F
N HO
N O N N O
F F
OH
OH
F
N N O
HO
S NH F
N N
O
N O
N HO OH N O
S NH F N
S NH F
N N O HO O
N N O
F O
HO OH F
HO
O OH
O
OH
F OH
N N HN H
HO OH
HO
SH F
N N
O O OH
O
OH
recovered radioactivity appearing in the urine and feces. Only one metabo-
lite, cloransulam, was identified,
fi amounting to 9.5% of total radioactive
residue in the liver (Lewer et al. 2000). Cloransulam is the corresponding
acid formed by ester hydrolysis of cloransulam-methyl (see Fig. 6A).
48 T.W. Jabusch and R.S. Tjeerdema
Summary
The TSA herbicides are generally applied to agricultural fi fields at low rates.
Possessing low mammalian toxicity, they pose little risk to either humans
or wildlife. Plants demonstrate a wide range in sensitivity to these com-
pounds. For example, the observed toxicity of fl flumetsulam to five different
aquatic plant species varied by more than 10,000 fold (Peterson et al. 1994),
beginning in the ppb range. Application of the TSA herbicides may pose a
potential risk to both aquatic and terrestrial plants at the manufacturer-
proposed rates, including the risk of injuring rotational crops by residues
of previous applications. There has been little ambient monitoring for the
TSA herbicides, but a study of selected low use rate herbicides in Midwest
U.S. waters found that observed fl flumetsulam concentrations were not
likely to be toxic to nontarget aquatic plants (Battaglin et al. 2000). Most
TSA herbicides possess low mobility but moderate persistence in soils, with
persistence increasing at lower temperatures. Environmental half-lives
range from less than a day to several months. Penoxsulam, which is desig-
nated for use with rice, is highly mobile but not very persistent in both water
and soils. Degradation of the TSA herbicides in the environment occurs by
a combination of processes (photodegradation, microbial degradation, and
hydrolysis). A major issue concerning use of the TSA herbicides is the rapid
development of herbicide resistance in target species. There are major data
gaps concerning the ambient fate and distribution of these compounds, and
it is undetermined whether, and if so, to what extent, TSA herbicides have
indirect ecological effects by contributing to the overall burden of xeno-
biotic substances in the environment.
References
Barnes JW, Oliver LR (2004) Cloransulam absorption, translocation, and efficacy
fi
on common broadleaf weed species. Weed Sci 52:634–641.
Barnwell P, Cobb AH (1994) Graminicide antagonisms by broadleaf weed herbi-
cides. Weed Technol 18:763–772.
Baron J (2001) IR-4 New Products/Transitional Solution List—March, 2001.
Rutgers, The State University of New Jersey, North Brunswick, NJ.
Baskaran S, Lauren DR, Holland, PT (1996) High-performance liquid chromato-
graphic determination of flumetsulam, a newly developed sulfonamide in soil.
J Chromatogr A 746:25–30.
Battaglin WA, Furlong ET, Burkhardt MR, Peter, CJ (2000) Occurrence of sulfo-
nylurea, sulfonamide, imidazolinone, and other herbicides in rivers, reservoirs
and ground water in the Midwestern United States, 1998. Sci Total Environ 248:
123–133.
Bernasconi P, Woodworth AR, Rosen BA, Subramanian MV, Siehl DL (1995) A
naturally occurring point mutation confers broad range tolerance to herbicides
that target acetolactate synthase. J Biol Chem 270(29):17381–17285.
Borges JH, García-Montelongo FJ, Cifuentes A, Rodríguez-Delgado MÁ (2005a)
Analysis of triazolopyrimidine herbicides in soils using field-enhanced sample
Chemistry and Fate of Herbicides 49
Peterson HG, Boutin C, Martin PA, Freemark KE, Ruecker NJ, Moody MJ (1994)
Aquatic phyto-toxicity of 23 pesticides applied at expected environmental con-
centrations. Aquat Toxicol 28:275–292.
Renew JE, Huang C-H (2004) Simultaneous determination of fluoroquinolone,
fl
sulfonamide, and trimethoprim antibiotics in wastewater using tandem solid
phase extraction and liquid chromatography–electrospray mass spectrometry.
J Chromatogr A 1042:113–121.
Roberts DW, Knuteson JA, Jackson R (2003) The dissipation of penoxsulam in
flooded rice fields. In: Pesticides in Air, Plant, Soil & Water Systems: XII Sym-
posium Pesticide Chemistry, Piacenza, Italy, pp 349–357.
Rouchaud J, Neus O, Eelen H, Bulcke R (2002a) Dissipation and mobility of flu- fl
metsulam in the soil of corn crops. Meded Fac Landbouwwet Rijksuniv Gent
67(3):401–407.
Rouchaud J, Neus O, Eelen H, Bulcke R (2002b) Soil persistence and mobility in
corn fields of flumetsulam applied at low doses. Bull Environ Contam Toxicol
69:785–791.
Rubin B (1996) Herbicide-resistant weeds—the inevitable phenomenon: mecha-
nisms, distribution and significance.
fi Z Pfl flanzenkr Pfl flanzenschutz XV:17–32.
Saari LL, Cotterman JC, Thill DC (1994) Resistance to acetolactase-inhibiting
herbicides. In: Powles SB, Holtum JAM (eds) Plants: Biology and Biochemistry.
Lewis, Boca Raton, FL, pp 88–139.
Schmitzer PR, Eilers RJ, Cséke C (1993) Lack of cross-resistance of imazaquin-
resistant Xanthium strumarium acetolactase synthase to flumetsulam
fl and chlo-
rimuron. Plant Physiol 103:281–283.
Shackelford DD, Duebelbeis DO, Snell BE (1996) Determination of residues of
cloransulam-methyl in soybeans and soybean forage, hay, and processed com-
modities by capillary gas chromatography with mass spectrometric detection.
J Agric Food Chem 44:3570–3575.
Shaner DL, Singh BK (1997) Acetohydroxyacid synthase inhibitors. In: Roe RM,
Burton JD, Kuhr RJ (eds) Herbicide Activity: Toxicology, Biochemistry and
Molecular Biology. IOS Press, Amsterdam, pp 69–110.
Shaw DR, Murphy GP (1997) Field persistence of bioavailable flumetsulam.
fl Weed
Sci 45(4):568–572.
Sibony M, Rubin B (2003) Molecular basis for multiple resistance to acetolactate
synthase-inhibiting herbicides and atrazine in Amaranthus blithoides (prostrate
pigweed). Planta (Berl) 216:1022–1027.
Sprague CL, Stoller EW, Wax LM (1997) Response of an acetolactase synthase
(ALS)-resistant biotype of Amaranthus rudis to selected ALS inhibiting and
alternative herbicides. Weed Res 37:93–101.
Subramanian MV, Loney V, Pao L (1989) Mechanism of action of 1,2,4-triazolo[1,5-
a]pyrimidine sulfonamide herbicides. In: Copping LG, Dalziel J, Dodge AD
(eds) Prospects for Amino Acid Biosynthesis Inhibitors in Crop Protection
and Pharmaceutical Chemistry. Society of Chemical Industry, Farnham, UK,
pp 97–100.
Tjeerdema RS, Hill J, Fisher A, TenBrook P, Gunasekara A, Jabusch TW (2005)
Project No. RP-5: The Environmental Fate of Pesticides Important to Rice
Culture. Report to the California Rice Research Board. Department of Envi-
ronmental Toxicology, College of Agricultural and Environmental Sciences,
University of California, Davis, CA.
52 T.W. Jabusch and R.S. Tjeerdema
Contents
I. Introduction ..................................................................................................... 54
II. Nature of Carbamate Insecticides ................................................................ 56
A. Discovery ................................................................................................... 57
B. Carbamates and Their Toxicity .............................................................. 60
III. QSAR Models for Predicting Biological Parameters Used in
PBPK/PD Models ............................................................................................ 62
A. Human Oral Bioavailability .................................................................... 63
B. Toxicity Models ......................................................................................... 64
C. Liver Microsomal P450 and CYP Hydroxylation Models .................. 66
D. Tissue:Blood Partition Coefficients fi ........................................................ 66
IV. Experimentally Derived Biological Parameters Used in
PBPK/PD Models ............................................................................................ 68
A. Gastrointestinal Absorption .................................................................... 68
B. Skin Absorption ........................................................................................ 68
C. Tissue Partition Coeffi ficients/Distribution ............................................. 71
D. Glucuronidation and Transcellular Transport ...................................... 82
E. Metabolic Enzymes, P450s, and CaEs ................................................... 83
F. Models for In Vivo Metabolism of Carbamates ................................... 87
G. Response: In Vivo AntiChE Activity .................................................... 94
V. Target Enzymes, the ChEs and CaEs .......................................................... 98
A. Structure, Multiple Forms, and Distribution ........................................ 98
B. AChE, BChE, and CaE Substrate Selectivities ................................. 102
53
54 J.B. Knaak et al.
I. Introduction
Our interest in providing parameters for the development of quantitative
structure physiologically based pharmacokinetic/pharmacodynamic
(QSPBPK/PD) models for assessing health risks to carbamates (USEPA
2005) comes from earlier work with organophosphorus (OP) insecticides
(Knaak et al. 2004). Parameters specific fi to each carbamate are needed in
the construction of PBPK/PD models along with their metabolic pathways.
Parameters may be obtained by (1) development of QSAR models, (2)
collecting pharmacokinetic data, and (3) determining pharmacokinetic
parameters by fitting to experimental data. The biological parameters are
given in Table 1 (Blancato et al. 2000).
The quantitative structure-activity relationship (QSAR) model approach
requires (1) knowledge of the numerical values of the parameters of related
chemicals and (2) specification
fi of an equation for conducting the multiple
regression analysis (Fouchecourt et al. 2001). TOPKAT (Accelrys Software
Inc., San Diego, CA) is an excellent example of QSAR model development.
The program consists of several toxicity QSAR models; one provides infor-
mation on the acute oral toxicity of OP and carbamate insecticides. QSAR
models predicting Vmax and Km values for human liver microsomes (HLMs)
and CYP3A4 catalyzed hydroxylation reactions involving drug-based aro-
matic and alicyclic rings and aliphatic groups were recently developed by
Enslein et al. (2007). Liu et al. (2005) developed a QSAR model for pre-
dicting tissue/blood partition coeffi ficients, and Poulin and Theil (2002a)
Parameters for Carbamate Models 55
A. Discovery
Physostigmine
The fifirst known carbamate, physostigmine or eserine (CAS no. 57-47-6),
was discovered in extracts of the calabar bean. The alkaloid was found to
be miotic. Robertson (1863) suggested the drug for use in ophthalmology.
“Alkaloids are compounds of nitrogen, capable of uniting with acids, like
ammonia, and forming with them definitefi combinations, which are true
salts” (de Coninck 1886). The work of Stedman and Barger (1925) led to
the elucidation of the structure of physostigmine as the methylcarbamate
of a substituted indole derivative. Physostigmine appears to be the only
natural product within the N N-methylcarbamate group and is unstable in
water. The corresponding dimethylcarbamate (neostigmine, CAS no. 59-
99-4) was prepared by Aeschlimann and Reinert (1931) and was found to
be more stable and an effective miotic agent. Stemple and Aeschlimann
(1956) reviewed the properties of these compounds. Somani and Khalique
(1986) studied the distribution and pharmacokinetics of physostigmine in
rats after intramuscular administration. The time course of BChE activity
and plasma concentration showed that the maximum enzymatic inhibition
(47%) occurred about the same time (7 min) as the peak plasma concentra-
tion (583 ng mL−1 at 5 min) with enzymatic activity recovering to 81% at 2 hr
and 100% within 24 hr.
Dimethylcarbamates
Gysin (1954), at the Geigy Corporation, studied the insecticidal properties
of the dimethylcarbamates of 5,5-dimethyldihydroresorcinol (Dimetan,
CAS no. 122-15-6) and 1-iso-propyl-3-methyl pyrazole (Isolan, CAS no.
119-38-0). These two compounds, along with dimetilan (1-(dimethylcar-
bamoyl)-5-methyl-3-pyrazolyl dimethylcarbamate, CAS no. 644-64-4),
underwent considerable evaluation as commercial insecticides. All these
carbamates are potent anticholinesterase (antiChE) agents having I50 values
for AChE in fruit flies of 5–6 × 10−7 M for Dimetan to 7–10 × 10−8 M for
Isolan. The rate of hydrolysis of p-nitrophenyl methylcarbamate
(kb = 5.4 × 105 M−1 min−1) is about 107 times greater than that of the corre-
sponding dimethylcarbamate (kb = 3.4 × 10−2 M−1 min−1). The dimethylcar-
bamates are more stable than the methyl carbamates; however, as antiChEs
and insect toxicants, the methylcarbamates are far superior (Metcalf and
Fukuto 1962).
Phenylmethylcarbamates
Metcalf and March (1950) were among the first
fi to synthesize and study the
activity of simple phenyl methylcarbamates. Substitution in the ortho or
meta position with an alkyl group or halogen on the phenyl ring increased
insecticidal activity. Maximum activity was found with m-tert-butylphenyl
methylcarbamate. The mammalian/insect toxicity ratios ranged from >100
58 J.B. Knaak et al.
for butacarb (CAS no. 2655-19-8) to around 0.2 for aldicarb (CAS no. 116-
06-3). Increasing the chain length of N
N-alkyl groups exponentially increased
the recovery half-lives of inhibited insect AChE and decreased their inhibi-
tory potential when going from N N-methyl to N
N-ethyl groups (Yu et al.
1972a). The activity of alkoxyphenyl carbamates is governed by the same
set of rules that apply to the alkylphenyl carbamates. AntiChE and toxicity
for insects increase progressively with the size of the phenyl substituent,
with maximum activity at the isopropyl and sec-butyl groups. The ortho
positions are preferred over those of the meta positions. Goldblum et al.
(1981) developed a QSAR for a set of 269 phenyl N-methylcarbamates
N
inhibiting flfly head AChE (pI50 values). The data were taken from the
extensive studies of Metcalf and Fukuto (1962), Metcalf and Fukuto (1965a),
Metcalf and Fukuto (1965b), Metcalf and Fukuto (1967), and Metcalf et al.
(1965), which followed the earlier work of Metcalf and March (1950).
N-acylated carbamates
Fraser et al. (1968) substituted various acyl groups for the proton on the
N-methylcarbamates, producing N
N N-acyl carbamates that retained high
insecticidal activity and substantially reduced mammalian toxicity. Metabo-
lism is believed to involve deacylation to the parent carbamate with a cor-
responding increase in antiChE activity (Fahmy et al. 1966). In general, the
N-acyl derivatives are generally quite biologically unstable, although Sulli-
N
van et al. (1967) acetylated carbaryl as a means of increasing its stability
during gas chromatography. Acetylation is believed to aid penetration to
the site of action in the insect, where hydrolysis to the N-methylcarbamate
N
releases the parent carbamate. No information was available concerning
the metabolism of N-acyl-
N N-methylcarbamates in mammals. A reduction
N
in toxicity may well be related to aromatic ring hydroxylation or hydrolysis
of the carbamate over that of the acyl group.
Oxime carbamates
The structure–activity relationships of the N
N-methylcarbamoyl oximes were
reviewed by Felton (1968), Fukuto et al. (1969), and Payne et al. (1966).
The structural rigidity associated with the C=N bond is a unique feature
of the oxime carbamates. These carbamates form pairs of syn (Z isomer)
and anti (E isomer) isomers in which the oximino oxygen is either cis or
trans to the aldehyde H. The syn isomer of methomyl has 100 times the
antiChE activity and is 10 times more toxic to the housefl fly than the anti
isomer. Aldicarb is believed to exist as the syn isomer (Weiden 1968), and
it appears that this cis confi
figuration allows greater access of the carbonyl
carbon to the esteratic site and the methylthio group to the anionic site.
Methomyl is applied as a foliar spray, whereas the more toxic and environ-
mentally stable oxime carbamate, aldicarb, is applied to soil as a plant
systemic.
60 J.B. Knaak et al.
N
N-Methyl Tables (in
carbamate Molecular Appendices
Common name class weight CAS no. A and B)
a
Table 5. Bioavailability Classification.
fi
Rating 1 2 3 4
Bioavailability (%) ≤20 20–49 50–79 >80
a
Bioavailability Classification
fi System (Yoshida and Topliss 2000).
formulation of a new descriptor, Δ log D (i.e., log DpH 6.5 − log DpH 7.4). The
addition of 15 structural descriptors relating to well-known metabolic trans-
formations yielded a satisfactory QSAR equation, S(X) = Σwisi with Si, the
descriptor values, and Wi, the weighting factors. The optimum value for
log DpH 6.5 is −0.3, and a progressive negative impact on bioavailability
occurs when values move away from this level. A log DpH 6.5 value of 3.0
results in a reduction of the bioavailability score by 0.5 and a value of 5.0
by 1.3. This approach allowed the authors to obtain a correct classification
fi
rate of 71% for the training set and 60% for the 40 compounds included in
the validation set. Pintore et al. (2003a) obtained the data set from Yoshida
and Topliss (2000) and added 235 molecules. A large set of molecular
descriptors was examined, and the most relevant parameters were selected
using a procedure called genetic algorithm concepts and a stepwise tech-
nique (GA/SW). The aim of the project was to apply adaptive fuzzy parti-
tioning (AFP) to two bioavailability data sets. The AFP model improved
the power prediction about 10%–15% on the training and validation set
molecules. Pintore et al. (2003a) did not strongly support the use of the
physicochemical descriptors Δ log D and log P as they used topological and
electrotopological descriptors instead. Neither article discussed the nature
of the drug formulations used in the human bioavailability studies.
Carbamates are considered to be readily absorbed when dissolved in
corn oil, PEG 400, propylene glycol, or other relatively nontoxic solvents.
No information on the rate of absorption of these carbamates was found
in the literature. Model optimization procedures were used in a carbofuran
PBPK/PD models to simulate oral absorption (Zhang et al. 2006).
B. Toxicity Models
Venkatapathy et al. (2004) assessed the oral rat chronic lowest observed
adverse effect level (LOAEL) model in TOPKAT (Enslein et al. 1998).
The percentages of accurate predictions for nondatabase chemicals did not
compare well with predictions for chemicals in TOPKAT’s database. The
National Center for Environmental Assessment (NCEA), EPA, Cincinnati,
OH, used TOPKAT to screen/rank chemicals on the basis of their
hazard potential. The modules that are used with the greatest frequency by
NCEA are the rat chronic LOAEL, oral rat lethal dose (LD50), rodent
Parameters for Carbamate Models 65
included in the training sets. The model takes into consideration the volume
of the tissue composition (lipid, protein, and water), and the form(s) of the
compound (cationic, anionic and neutral) at pH 7.4. The present research
only included neutral and cationic forms. The QSAR equation took the
following form:
Rate of ingestion
In the case of a rate ingestion using the Exposure Related Dose Estimating
Model (ERDEM) (USEPA 2004), a dose (concentration in dosing liquid,
mg mL−1 or μmol mL−1) is administered at a uniform fl flow rate (mL min−1)
over a period of time (min) to give a dose in (mg or μmol) in the stomach.
The dose (mg), as it arrives in the stomach, is then absorbed as indicated
for a bolus dose. Total dose (mg) is calculated as follows: mg mL−1 × mL min−
1
× min. In practice, if the time of administration is rapid, the dose acts like
a single bolus dose.
B. Skin Absorption
History
Illnesses associated with the use of ChE-inhibiting pesticides (i.e., OP com-
pounds and N N-methylcarbamates) have generated considerable field
research into the relationship between ChE inhibition and residues in air,
on treated indoor surfaces, and on crop leaf surfaces (Honeycutt and Day
2001; Honeycutt et al. 1985; Siewierski 1984; Wang et al. 1989). This work
was accompanied by the development of information pertaining to the
science of percutaneous absorption (Bronaugh and Maibach 1985; Scott
et al. 1990) and the linking of field
fi exposures to percutaneous absorption
and ChE inhibition (Knaak et al. 1989, 2002; Nigg and Knaak 2000; USEPA
1992). The information in these studies was used to develop code within
ERDEM to predict the effects of dermal exposure to ChE-inhibiting pes-
ticides on ChE activity in exposed individuals. Knaak et al. (2002) described
the relationship between skin permeability, Kp (cm hr−1), and partition coef-
ficients of skin:air, skin:vehicle, and skin:blood. In the case of skin:air, a
fi
Kp-vapor value (cm hr−1) takes into consideration the partitioning of vapor
between air and skin, leading to a concentration in the skin and a percu-
taneous absorption rate (μg hr−1 cm−2). The permeability constants for
Parameters for Carbamate Models 69
where Assal = the amount of pesticide in the sample saline after filtration,
fi
Css = the concentration of pesticide in the sample saline after fifiltration,
Vss = the volume of saline in the test vial,
Arsal = the amount of pesticide in the reference saline,
Vj = the volume of tissue, and
Cj = the concentration of pesticide in tissue j.
The tissue : saline and tissue : blood PCts are calculated using Eq. 10.
Pj = Cj(V
Vj)/Assal (10)
Fig. 1. Schematic of the system used to filter samples containing chemical equili-
brated between tissue and saline. (Redrawn from Jepson et al. 1994 by permission
of Oxford University Press.)
Parameters for Carbamate Models 73
In the two experimental partition coeffi ficient studies (Jepson et al. 1994;
Knaak et al. 1995) involving OPs, the fat: blood PCs were significantly fi
below those estimated by the Poulen and Theil (2000) method. An increase
in the amount of fat (0.32 to 1.0 g) used by Jepson et al. (1994) in their
parathion (log P, 3.84) studies had a positive effect on this PC over the value
obtained by Knaak et al. (1995) for isofenphos (log P, 4.12). The differences
between experimental PC values and those obtained using mechanistic
models needs to be carefully examined before a recommendation can be
made regarding the use of in vitro over mechanistic values.
The relationship between log Po:w and log Dvo:w for adipose tissue : plasma
and adipose tissue : blood is shown in Figs. 2 and 3. Data from Parham
et al. (1997) for polychlorinated biphenyls (PCBs) are included in the adi-
pose : plasma fifigure, and data from Jepson et al. (1994) are included in the
adipose : blood figure. Tissue : blood PCts are routinely used in PBPK
models. The use of log Dvo:w reduces the partition coeffi ficients by approxi-
mately a factor of 10; however, this factor is not greatly reduced for che-
micals with log Po:w greater than 3. All the PCBs had log Po:w partition
coefficients
fi greater than 4.0; this is also the case with most of the OPs, but
not with the carbamates.
The log Dvo:w model appears unbiased when log P = 0 to 2 and biased
when log P > 3. The experimental parathion log P values of Jepson et al.
(1994) for parathion are shown along with values predicted by the model.
Selection of log Po:w and log Do:w Values for Use in Mechanistic Models
The key to using the mechanistic approach is the selection of a log P/log D
model that adequately predicts values for the 10 carbamates and their
metabolites (ionized and nonionized species). Log P models include Clog P
(Leo 1993), KLog P (Klopman et al. 1994), HLog P (Viswanadhan et al.
2000), ALog P (Wildman and Crippen 1999), XLog P (Wang et al. 2000),
ACDLog P (Petrauskas and Kolovanov 2000), SMILELOG (Convard
et al. 1994), CHEMICALC (Suzuki and Kudo 1990), and LOGKOW
(Meylan and Howard 2000). Hansch et al. (2002) currently have a database
containing almost 30,000 experimentally measured octanol/water log P and
log D values for constructing QSAR equations. The importance of log P
values cannot be overestimated, as Hansch et al. (2002) lists 4614 QSARs
with log P terms in a list of 8500 QSAR equations.
ACD Log D Sol Suite, Version 9.0 (Advanced Chemistry Development,
Toronto, Ontario, Canada) was selected for predicting pKa, log P, log D,
and water solubility (WS) values. The program is commercially available
and is used by the American Chemical Society to predict chemical and
physical properties of chemicals listed in SciFinder (American Chemical
Society, Washington, DC). Version 9.0 predicts log D at any pH and pro-
vides a printout of log D values in units of 0.1 pH.
As part of the selection process, the WS for each of the carbamates and
their metabolites were individually plotted against log DpH7.4 values to
determine whether a linear, but inverse, relationship existed based on the
knowledge that metabolism significantly
fi increases the water solubility of
administered pesticides, drugs, and other chemicals. Water solubility was
calculated using the equation of Meylan and Howard (1994a,b) where
Log S(mol/L) = 0.796 − 0.854 log Ko:w − 0.00728MW + corrections (20)
ACD log D values were used in the equation in place of log Ko:w to calculate
water solubilities. This procedure yielded linear plots with r 2 values greater
Parameters for Carbamate Models 77
Fig. 4. Water solubility (g L−1, Eq. 20) of aldicarb and metabolites as a function of
ACD log DpH7.4. Aldicarb and metabolites are identifi fied in Table 14 (Appendix A).
Outer bounds represent the 95% confidence
fi interval.
than 0.9 for all 10 carbamates and their metabolites. Figures 4 and 5 show
the plots for aldicarb and carbaryl. Water solubilities >10,000 (g L−1) were
calculated by the Meylan and Howard (1994a,b) equation for conjugated
carbamate metabolites but were not provided by the ACD log D suite.
These results were not obtained using log Ko:w values (Discovery Studio
Accord for Excel; Accelrys, San Diego, CA) for carbamate metabolites
because log Ko:w alone did not adequately predict values for water-soluble
ionized metabolites.
78 J.B. Knaak et al.
Fig. 5. Water solubility (g L−1, Eq. 20) of carbaryl and metabolites as a function of
ACD Log DpH7.4. Carbaryl and metabolites are identifi fied in Table 15 (Appendix
A). Outer bounds represent the 95% confidencefi interval.
Partition Coeffi
ficients for Carbamates and Metabolites
On the basis of the foregoing findings
fi involving water solubility for aldicarb
acid, log DpH7.4 (−2.56), determined by the ACD Log D Suite was used
in conjunction with an Excel spreadsheet (Table 6) to calculate log Dvo:w
(−4.20) from log DpH7.4 (−2.56) (Eq. 13) with log D*o:w = log Dvo:w (−4.20)
(Eq. 15, no pK Ka correction factor required) to obtain the adipose tis-
sue : blood partition coeffi
ficients for aldicarb acid (see Table 14, Appendix
A) using Eq 22. In the case of nonadipose tissue, Eq. 21 was used. When
log P (0.87) was used in Eq. 13, a value of −0.38 was obtained for log Dvo:w
Parameters for Carbamate Models 79
and a value of −4.10 with Eq. 15 for log D*o:w (pH, 7.4 and pKa, 3.68). The
results for log D*o:w compared favorably with the value obtained using
log DpH7.4.
In the case involving a glucuronide such as 4-OH carbaryl glucuronide,
log D*o:w (pH, 7.4 and pKa, 2.75) was −6.63 using log P (−0.57). When
log DpH7.4 (−4.28) was used the value for log D*o:w was −6.12. In the case of
a sulfate, such as 4-OH carbaryl sulfate, log D*o:w (pH, 7.4; pKa1, −4.58 and
pKa2, 11.64) was −6.17 using log P (1.57). When log DpH7.4 (−1.93) was used
the value was −3.50 for log D*o:w. The reason for the difference is related
to the manner in which ACD Log D Suite computes log DpH7.4 versus the
Henderson–Hasselbach equation (Eqs. 15 and 17) for a mono- or dipro-
tic acid. On the basis of the differences observed we decided to use
log DpH7.4 values for determining partition coefficients
fi for all carbamate
metabolites.
The tissue : plasma and tissue : blood partition coefficients
fi were deter-
mined using Eqs. 21 and 22 (see Table 6). Tissue : blood partition coeffi- fi
cients are depicted below.
[Do w or Po w (Vnlt . Vphlt
p )] [ (Vwt .7 Vpphlt )] fu b
PC t b nonadipose = ×
[Do w or Po w (Vnlb . Vphlp
p p )] [ (Vwb . Vpphlb )] fu
f t
(21)
[D*vo w or Dvo w (Vnlt . Vpht )] [ (Vwt .7Vpht
h )] fu b
PC t b adipose = × (22)
[D*vo w or Pvo w (Vnlb . Vphb
p )] [ (Vwb . Vpphb )] 1
Graphs of log DpH 7.4 vs. Adipose Tissue : Blood and Liver : Blood
Partition Coefficients
fi
The plots of log Do:w (pH 7.4) vs. PCt:b_liver and log D*o:w (pH 7.4) vs.
PCt:b_adipose for aldicarb and carbaryl are shown in Figs. 6 and 7.
In Figs. 6 and 7, the water-soluble metabolites, with log DpH7.4 < 0, all
have PCt:b_liver and PCt:b_adipose values ≤1.0 at the bottom of each plot, while
the parent carbamates and their neutral metabolites, with log DpH7.4 > 0,
have PCt:b values ranging from 1.0 to 40.0 extending up and on the right
side of each plot.
Table 6. Example Spreadsheet Used in Calculating Partition Coefficients
fi (Eqs. 21, and 22) for aldicarb acid in Table 14 (Appendix A).
80
Input parameters
Lipids
Neutral Phospho
Rat tissue Eq. no.b Tissue (Vt)c Water (Vw)c (Vnl)c (Vpl)c Ko:wd Numeratore Pt:bf Pt:pg Vt*Pt:ph
Adipose 22 0.0761 0.12 0.853 0.002 6E-05 0.1215 0.14 0.13 0.01
Adipose 21 0.0761 0.12 0.853 0.002 0.0028
J.B. Knaak et al.
Bone 21 0.041476 0.446 0.0273 0.0027 0.0028 0.4480 0.53 0.47 0.02
Brain 21 0.0057 0.788 0.0392 0.0533 0.0028 0.8255 0.98 0.86 0.00
Gut 21 0.027 0.749 0.0292 0.0138 0.0028 0.7588 0.90 0.79 0.02
Heart 21 0.0033 0.779 0.014 0.0118 0.0028 0.7873 0.94 0.82 0.00
Kidney 21 0.0073 0.771 0.0123 0.0284 0.0028 0.7909 0.94 0.82 0.01
Liver 21 0.0366 0.705 0.0138 0.0303 0.0028 0.7263 0.86 0.76 0.03
Lung 21 0.005 0.79 0.0219 0.014 0.0028 0.7999 0.95 0.83 0.00
Muscle 21 0.404 0.756 0.01 0.009 0.0028 0.7623 0.91 0.79 0.32
Skin 21 0.19 0.651 0.0239 0.018 0.0028 0.6637 0.79 0.69 0.13
Spleen 21 0.002 0.771 0.0077 0.0136 0.0028 0.7806 0.93 0.81 0.00
Plasma 21 0.0449 0.96 0.00147 0.00083 0.0028 0.9606 0.631i
Plasma 22 0.0449 0.96 0.00147 0.00083 6E-05 0.9606h
Whole blood 21 0.0816 0.84 0.0013 0.002 0.0028 0.8414g
Whole blood 22 0.0816 0.84 0.0013 0.002 6E-05 0.8414f
Erythrocytes 21 0.0367 NUj NU NU
Lipids
Neutral Phospho
Human tissue Eq. no.b Tissue (Vt)c Water (Vw)c (Vnl)c (Vpl)c Ko:wd Numeratore Pt:bk Pt:pl Vt*Pt:pm
Adipose 22 0.11957 0.18 0.79 0.002 6E-05 0.1814 0.22 0.19 0.02
Adipose 21 0.11957 0.18 0.79 0.002 0.0028
Bone 21 0.085629 0.439 0.074 0.0011 0.0028 0.4400 0.54 0.46 0.04
Brain 21 0.02 0.77 0.051 0.0565 0.0028 0.8097 0.99 0.86 0.02
Gut 21 0.0171 0.718 0.0487 0.0163 0.0028 0.7296 0.89 0.77 0.01
Heart 21 0.0047 0.758 0.0115 0.0166 0.0028 0.7697 0.94 0.81 0.00
Kidney 21 0.0044 0.783 0.0207 0.01622 0.0028 0.7944 0.97 0.84 0.00
Liver 21 0.026 0.751 0.0348 0.0252 0.0028 0.7688 0.94 0.81 0.02
Lung 21 0.0076 0.811 0.003 0.009 0.0028 0.8173 1.00 0.86 0.01
Muscle 21 0.4 0.76 0.0238 0.0072 0.0028 0.7651 0.93 0.81 0.32
Skin 21 0.0371 0.718 0.0284 0.0111 0.0028 0.7259 0.88 0.77 0.03
Spleen 21 0.0026 0.788 0.0201 0.0198 0.0028 0.8019 0.98 0.85 0.00
Plasma 21 0.0424 0.945 0.0035 0.00225 0.0028 0.9466 0.525i
Plasma 22 0.0424 0.945 0.0035 0.00225 6E-05 0.9466m
Whole blood 21 0.0771 0.82 0.0032 0.002 0.0028 0.8214l
Whole blood 22 0.0771 0.82 0.0032 0.002 6E-05 0.8214k
Erythrocytes 21 0.0347 NU NU NU
All tissue less plasma 0.956
Parameters for Carbamate Models
a
Values for monoprotic acids. Used in Eq. 15 to calculate D*vo:w.
b
Equation number used to calculate partition coeofficients:
fi Pt:b and Pt:pp.
c
Values used in Eqs. 21 and 22 as presented in Poulin and Thiel (2002a). Values for Eq 6 in Poulin and Thiel (2002a) are: E : P (erythrocyte:plasma in vivo) = 1, B : P
(blood : plasma in vitro) = 1, and Ht (hematocrit in blood) = 0.45.
d
Ko:w as calculated in Eq. 14 .
e
Numerator value from Eq. 21 or 22 depending on tissue.
f
Denominator value used in Eq. 21 or 22 for Pt:b in the rat.
g
Denominator value used in Eq. 21 or 22 for Pt:pp in the rat.
h
Denominator value used in Eq. 21 or 22 for Vt*Pt:p in the rat.
i
Volume distribution at steady state (Vdss; L kg−1).
j
NU, not used in Poulin and Thiel (2002a).
k
Denominator value used in Eq. 21 or 22 for Pt:b in the human.
l
Denominator value used in Eq. 21 or 22 for Pt:pp in the human.
m
81
specific
fi content of at least CYP3A4 was not constant in these microsomes.
The HLM and individual CYP Vmax and Km values for carbofuran are sum-
marized in Tables 34 and 35, respectively.
Pretreatment of rats with tetraisopropylpyrophosphoramide (iso-
OMPA) (CAS no. 513-00-8) 1 hr before carbofuran potentiated the toxicity
of this N
N-methylcarbamate insecticide threefold. CaE activity in a variety
of organs including brain, muscle, liver, and plasma was signifi ficantly
reduced, while acetylcholinesterase (AChE) activity was unchanged. Sig-
nificant
fi inhibition of AChE was observed after the combination of iso-
OMPA and carbofuran (Gupta and Dettbarn 1993).
Buronfosse et al. (1995) showed the sulfoxidation of methiocarb is cata-
lyzed by FMO and CYP with 50% being carried out by each enzyme system.
Stereoselective sulfoxidation occurs only for FMO with an enantiomeric
excess of 88% in favor of the (A)-enantiomer. Lung and kidney microsomes
have high flavin-containing monooxygenase levels. FMO is important rela-
tive to CYP in these tissues. Thioether-containing organophosphates are
effective substrates for the fl
flavin-containing monooxygenase in mouse liver
microsomes, with Km values between 3.5 and 36 nM. According to Tynes
and Hodgson (1985), thioether-containing carbamates are less effective
substrates in other animals having Km values near 280 nM (Tynes and
Hodgson 1985). The sulfoxidation of thioethers by HLMs was found to be
predominantly metabolized by P450 isozymes (85%–90%) compared with
FMO isoforms. The highest rates were obtained with CYP1A1, 1A2, 3A4,
2B6, 2C9*1, 2C19, 2D6*1, and FMO1 (Usmani et al. 2004b).
Very little if any work has been done on the in vitro metabolism of
oxamyl in humans. In vitro rat liver studies were carried out by Harvey and
Han (1978). NADPH fortified fi microsomal plus soluble rat liver fractions
failed to yield N-demethylated oxamyl oxime or oxamyl acid. The data
supports the N-demethylation of oxamyl as the pathway to des N-methyl
N
oxime or des NN-methyl oxamyl acid.
Aldicarb
The metabolic pathway is described in Table 24 (Appendix B). This carba-
mate pesticide is readily biotransformed by animals and humans (Andrawes
et al. 1967; Baron 1994; Knaak et al. 1966; Marshall and Dorough 1977,
88 J.B. Knaak et al.
1979; Tobia et al. 2004). Urinary metabolic products of aldicarb include the
more toxic aldicarb sulfoxide (∼35%), the less toxic sulfone (∼1.0%), oxime
sulfoxide (∼35.5%), oxime sulfone (∼2.0%), and neutrals or polar metabo-
lites (∼30.5%) as the major products (Knaak et al. 1966). The neutrals are
most likely nitrile sulfoxide and sulfone and alcohol sulfoxide and sulfone.
The structures of the metabolites are listed in Table 14 (see Appendix A).
Andrawes et al. (1967) reported that 80% of an oral dose to rats was elimi-
nated in urine and 4% in feces. Approximately 50% of the urinary metabo-
lites were water soluble and could not be extracted into organic solvents.
The hydrolysis products, aldicarb oxime, oxime sulfoxide and oxime sulfone,
have no significant
fi toxicity to animals or insects. The nitriles come from the
degradation of aldicarb, aldicarb sulfoxide and aldicarb sulfone and are the
primary stable products of aldicarb degradation (Cobb et al. 2001). Eigh-
teen analytical standards were prepared by Durden et al. (1970) for studies
involving the metabolism of aldicarb in plants and animals.
Carbaryl
The metabolic pathway is described in Table 25 (Appendix B). The princi-
pal metabolic pathways of carbaryl are ring hydroxylation and hydrolysis
(Dorough and Casida 1964; Knaak et al. 1965; Knaak and Sullivan 1967;
Knaak et al. 1968). As a result, numerous metabolites (aglycones) are
formed and subjected to conjugation with the formation and urinary
excretion of water-soluble sulfates and glucuronides (Cardona and
Dorough 1973; Knaak et al. 1967). Hydrolysis results in the formation of
1-naphthol, carbon dioxide, and methyl-amine. Hydroxylation produces
4-hydroxycarbaryl, 5-hydroxycarbaryl, N N-hydroxy-methylcarbaryl, 5,6-
dihydro-5,6-dihydroxycarbaryl, and 1,4-naphthalendiol (Leeling and
Casida 1966; Sullivan et al. 1972). The principal metabolites in humans
are the glucuronides of 1-naphthol and 4-hydroxycarbaryl and the sulfate
of 1-naphthol (Knaak et al. 1968). Chen and Dorough (1979) found no
evidence for the conjugation of naphthyl-14C-carbaryl with glutathione or
mercapturic acid in their studies. The hydrolytic pathway appears to be a
major pathway in humans with ring hydroxylation of either 1-naphthol or
carbaryl as secondary pathways (Knaak et al. 1968). Under normal expo-
sure conditions, the accumulation of carbaryl in animals is unlikely.
Enterohepatic cycling of carbaryl metabolites in rats has been reported
by Marshall and Dorough (1979) and Struble et al. (1983). According to
Marshall and Dorough (1979), 37.5% of an oral dose (0.01 mg kg−1 bw)
was excreted in bile after 3 hr, principally as glucuronides. The glucuronides
are absorbed, metabolized, and recycled, resulting in 1.4% of the dose
ultimately being eliminated in feces. Metabolites identified fi in bile were
5,6-dihydro-5,6-dihydroxycarbaryl glucuronide (12%–18% of biliary 14C),
and the conjugated isomer of hydroxymethylcarbaryl (2% of biliary 14C).
The percentage of biliary 14C decreased with higher dosages, with doses
Parameters for Carbamate Models 89
Carbofuran
The metabolic pathway for carbofuran is described in Table 26 (Appendix
B). The information on the pathway was extracted from Dorough (1968),
Ferguson et al. (1984), Fukuto (1972), Ivie and Dorough (1968), Knaak
et al. (1970), Knaak (1971), Marshall and Dorough (1979), Metcalf et al.
(1968), Roberts and Hutson (1999), and Usmani et al. (2004a).
The fate of ring-C14 and carbonyl-C14 carbofuran was studied by Knaak
et al. (1970) in the dairy cow with 83% and 12% of the dose, respectively,
being eliminated in urine. Less than 4% of the administered ring-labeled
carbofuran was eliminated in feces. The major metabolites were the sulfates
of carbofuran phenol (45.4%) and 3-keto-7-phenol (10.4%) and the gluc-
uronides of carbofuran phenol (14.4%), 3,7-diol (15.9%), and 3-hydroxy
carbofuran (4.2%). 3-Hydroxycarbofuran-carbonyl-C14 is hydrolyzed in the
cow to almost the same extent as carbonyl-C14-carbofuran.
Ivie and Dorough (1968) separated the urinary metabolites of ring-C14
carbofuran from the cow into organo extractables and water solubles, with
90%–97% of the label being present as water solubles. Carbofuran phenol
(34.36%) was the major hydrolysis product recovered in the water phase
of a 12-hr urine after acid hydrolysis along with 3-keto-7-phenol and the
3,7-diol. Small quantities of 3-OH carbofuran (9.14%) and 3-OH-N- N
hydroxymethyl carbofuran (2.16%) were also reported. Acid hydrolysis
failed to completely release the aglycones of carbofuran from their conju-
gates, leaving up to 57% in the water phase. The differences reported
between the two cow studies appear to result from (1) the administration
of carbofuran orally by bolling gun, (2) the administration via a rumen
fistula, and (3) the analytical procedures used to determine the urinary
fi
metabolites.
90 J.B. Knaak et al.
Formetanate
The metabolic pathway for formetanate is described in Table 27 (Appendix
B). Information on the pathway was taken from Sen-Gupta and Knowles
(1970), Fukuto (1972), and Roberts and Hutson (1999).
In rats treated with formetanate, 60%–80% of the urinary excretory
products were water-soluble conjugates. The major pathway was the forma-
tion of the formamino derivative, 3-formaminophenyl N-methylcarbamate,
N
followed by the enzymatic removal of the NN-methylcarbamoyl group to give
formaminophenol. Deformylation of formaminophenol (Ahmad and
Knowles 1971) resulted in 3-aminophenol whereas subsequent N-acetyla-
tion produced 3-acetamidophenol.
Major aglycones of sulfuric and glucuronic acids were 3-acetamidophe-
nol, 3-formaminophenol, and 3-aminophenol. Water-soluble carbamates
include 3-formaminophenyl-N-methylcarbamate
N and demethylformetanate.
Sen-Gupta and Knowles (1970) found 3-aminophenyl N-methylcarbamate
N
and formetanate phenol in plants but did not fi find them in rat urine. An
oral dose of 14C-formetanate was rapidly absorbed and excreted by rat, 85%
in urine and 8% in feces. After 72 hr, 2% of the 14C was still retained.
Methiocarb
The metabolic pathway of methiocarb is described in Table 28 (Appendix
B). The information was taken from Kuhr and Dorough (1976), Menzie
(1974), Oonnithan and Casida (1968), Roberts and Hutson (1999), Strother
(1972), and Van Hoof and Heyndrickx (1975).
When rat and human liver enzymes were incubated with [14C-carbonyl]-,
[ C-4-methyl]-, or [14C-N-methyl]
14
N methiocarb, about a dozen metabolites
Parameters for Carbamate Models 91
were observed. The major metabolite was methiocarb sulfoxide, with the
human liver producing slightly less than the rat (13% vs. 16%), according
to Strother (1972). Hydrolysis yielded the phenolic moiety of methiocarb,
oxidation of methiocarb sulfoxide yielded the sulfone, while hydroxylation
produced N N-hydroxymethyl methiocarb. Products were eliminated in free
and conjugated forms. Several metabolic products from human liver studies
were not observed in rat studies (Strother 1972). Rats given a single oral
dose of 5.0 mg methiocarb eliminated up to 2.3% of the dose in the urine
as unchanged methiocarb and 3.3% as its phenolic metabolites, mostly
within 48 hr of administration (Hayes and Laws 1991).
Methomyl
The metabolic pathway of methomyl is described in Table 29 (Appendix
B). Information on the metabolic pathway was taken from Harvey et al.
(1973), Huhtanen and Dorough (1976), and Reiser et al. (1997). In the
study by Harvey et al. (1973), radiolabeled methomyl (S-methyl [1-14C]
N-[(methylcarbamoyl)-oxy] thioacetimidate) administered orally to rats is
N
metabolized and rapidly eliminated within 24 hr in the ratio of one part
[14C]carbon dioxide, two parts [1-14C]acetonitrile, and one part urinary
metabolites. The identities of the urinary metabolites were not established
by Harvey et al. (1973); however the absence of methomyl, S-methyl
N-hydroxythioacetimidate, the S-oxide of methomyl, and the S,S-dioxide
N
of methomyl and conjugates was demonstrated. Methomyl can exist in two
geometric configurations
fi (Huhtanen and Dorough 1976), Z and E isomers.
In rats, carbonyl- or oximino-labeled syn-methomyl (Z isomer) was metab-
olized to carbon dioxide and acetonitrile at a 2 : 1 ratio. In contrast, the anti
isomer (E isomer) was metabolized predominantly to acetonitrile. It was
concluded on the basis of this and other evidence that a Beckman rear-
rangement of the syn- and anti oximes occurs before formation of carbon
dioxide and acetonitrile.
The methomyl PBPK/PD model developed in this review, but not pre-
sented, contains a lung compartment for removing 14C-carbon dioxide and
acetonitrile formed during the metabolism of methomyl in the liver. The Z
isomer of methomyl is partially converted to the E isomer during metabo-
lism. The Z isomer is metabolized to carbon dioxide, while the E isomer
goes to acetonitrile. AChE inhibition is believed to be largely caused by
the Z isomer, although the E isomer may also produce inhibition.
The acetonitrile formed by hydrolysis of methomyl is conjugated with
glutathione. The glutathione conjugate is hydrolyzed to form the glutam-
ylcysteine, cysteinylglycine, and the cysteine conjugates of acetonitrile. The
cysteine conjugate goes on to form an N N-sulfate–cysteine conjugate (Reiser
et al. 1997).
The main metabolites of methomyl are acetonitrile per se (5%–34% of
dose), respiratory carbon dioxide (19%–34% of dose), and unknown urinary
92 J.B. Knaak et al.
Oxamyl
The metabolic pathway for oxamyl is described in Table 30 (Appendix B).
This information was extracted from Chang and Knowles (1979) and Harvey
and Han (1978). Oxamyl is degraded by three pathways, hydrolysis to the
oxamyl oxime (oximino metabolite), des N N-methyl oxamyl, or enzymatic
conversion via oxamyl nitrile (DMFC) to oxamyl acid (N,
N N-dimethyloxamic
N
acid). The oxime and acid are both conjugated with glucuronic acid along
with des NN-oxamyl oxime and des N-oxamyl acid (N-methyloxamic acid)
from des N-methyl oxamyl before elimination in urine and feces (>70%)
(Harvey and Han 1978). No oxamyl or other organo-soluble metabolite was
detected in urine, feces, or tissues. 14C from oxamyl oxime is extensively
converted to 14CO2 or incorporated into amino acids accounting for most
(>50%) of the radioactivity retained in the tissues. Similar products were
found in the urine and feces of the mouse from intraperitoneally (IP)-
administered oxamyl-14C.
In the intact rat administered 14C-oxamyl (2.5–4.6 mg kg−1 bw), most of
the dose (68%–72%) was recovered in urine with lesser amounts in feces
after 72 hr. Conjugates of the oximino compound, the acid, and their mono-
methyl derivatives constituted >70% of the metabolites excreted in the
urine and feces. Less than 0.3% of the oxamyl was exhaled as carbon
dioxide (Harvey and Han 1978). Mice treated IP with 14C-oxamyl elimi-
nated 96.4% of the dose by 96 hr, 88.7% in urine and 7.7% in feces (Chang
and Knowles 1979).
Extensive degradation/metabolism of (1-14C) oxamyl was observed in
the goat. Radioactive thiocyanate was the major metabolite identified fi
in milk as well as in the methanol/water extracts for all tissue samples.
Oxamyl-derived residues in the urine derived from oxamyl nitrile have
been identified
fi as thiocyanate, des N N-oxamyl acid, oxamide, and des N-N
methyloxamide (Li et al. 1997). Thiocyanate is generated from cyanide
through the reaction with thiosulfate catalyzed by rhodanese (Solomonson
1981). The metabolic pathway in the ruminant (goat) appears to be signifi-fi
cantly different from the pathways determined in monogastric animals such
as the rat and mouse.
Pirimicarb
The metabolic pathway of this dimethylcarbamate is described in Table 31
(Appendix B). Information on the pathway was taken from Baron (1991).
Pirimicarb’s major urinary metabolites in the rat, dog, and cow are similar,
resulting from oxidative and hydrolytic mechanisms, and consisting pri-
marily of hydroxypyrimidines with modifi fications of the alkyl constituents
Parameters for Carbamate Models 93
Propoxur
The metabolic pathway for propoxur is described in Table 32 (Appendix
B). Information on the pathway was obtained from the in vitro work of
Oonnithan and Casida (1968) and the review of Knaak (1971). RLMs, in
the presence of NADPH, converted carbonyl-14C, N-methyl-
N 14
C, and ring-
14
C-propoxur to seven metabolites possessing the intact carbamate and
isopropoxy group, 2-isopropoxy-4-hydroxyphenyl methylcarbamate,
2-isopropoxy-5-hydroxyphenyl methylcarbamate, 2-isopropoxyphenyl
N-hydroxymethylcarbamate, and unidentifi
N fied products. The one metabo-
lite with the phenyl O−C (O)−N−C linkage was 2-hydroxyphenyl meth-
ylcarbamate, whereas the three phenols with the isopropoxy group (C−(C)
C−O) were 2-isopropoxyphenol, 2-isopropoxy-4-OH phenol, and 2-isopro-
poxy-5-OH phenol. In the presence of UDP-glucuronic acid, these products
would be conjugated with glucuronic acid. Sulfates appeared in the urine
94 J.B. Knaak et al.
of rats after the 2-wk daily oral administration of 30–50 mg kg−1 bw of pro-
poxur (Foss and Krechniak 1980; Krechniak and Foss 1982, 1983). At least
one of the unidentifi fied metabolites and 2-isopropoxy-5-hydroxyphenyl
methylcarbamate are more potent ChE inhibitors than propoxur (Oonni-
than and Casida 1968).
Propoxur is biotransformed in vivo by depropylation to 2-hydroxyphe-
nol-N-methyl-carbamate,
N and by hydrolysis to the phenol. Ring hydroxyl-
ation and isopropoxy hydroxylation followed by conjugation account for
the glucuronides detected in urine (ACGIH 1991). The in vivo fate of
individual 7.5 μmol kg−1 bw dosages (IP) of carbonyl-14C and N-methyl-14C
propoxur in the rat were studied by Krishna and Casida (1966). 14C-CO2
was recovered in exhaled air from the carbonyl-(31.2%) and methyl-
(21.7%) labeled propoxur after 48 hr, with the remaining percentage being
recovered in urine (>60%), feces (∼2%), and body tissues (∼2%–5%).
According to Hayes and Laws (1991), the relationship of urinary excre-
tion of 2-isopropoxyphenol to propoxur concentration was nearly linear
following inhalation exposure. This metabolite was found in the urine 3 d
after termination of exposure to 78 mg m−3, 2 d after exposure to 9 mg m−3,
and 24 hr after exposure to 0.4 mg m−3.
Thiodicarb
The metabolic pathway is described in Table 33 (Appendix B). Information
on the pathway was obtained from WHO/FAO (2000), and the metabolic
work on methomyl in Table 29 (Appendix B) (Harvey et al. 1973; Huhtanen
and Dorough 1976; Reiser et al. 1997).
Thiodicarb (acetamide-14C) is rapidly absorbed from the gastrointestinal
tracts of rats, metabolized to unstable intermediates (i.e., methomyl, metho-
myl oxime, etc.), and finally
fi to acetonitrile, CO2, and low molecular weight
metabolites. The initial step in the process involves hydrolysis to methomyl.
The nature of the isomer, either (E) or (Z), was not determined. In the rat,
an oral dose of 2.0 mg kg−1 bw thiodicarb (acetamide-14C) reached a peak in
plasma after 10 hr and was eliminated in urine (30%) and exhaled air
(40%). The urine contained water-soluble materials while the exhaled air
contained radiolabeled carbon dioxide and acetonitrile. The overall
NOAEL for erythrocytic and splenic effects was 3 mg kg−1 bw/d in a 79-wk
study (WHO/FAO 2000). Brain ChE depression (>60%) occurred at
5 mg kg−1 bw, with pin-point pupils and reduced body temperature.
conditions, significant
fi spontaneous reactivation occurs with carbaryl
(Nostrandt et al. 1993). Assay modififications that include (1) preincubation
of concentrated tissue with concentrated chromogen (i.e., DTNB), (2) dilu-
tion to fi
final reaction volume immediately before measurement, and (3)
measurement of ChE over a short period of time (5–10 min) gave results
comparable to a radiometric method. Signifi ficant spontaneous reactivation
may still occur with the modified
fi method if the assay is carried out for
>10 min (Nostrandt et al. 1993).
Aldicarb
The major metabolite of aldicarb, aldicarb sulfoxide, has been shown to
have 76 times greater antiChE activity than the parent compound (DHEW/
NCI 1979). Rats receiving an oral dose (0.33 mg kg−1 bw) of aldicarb
recovered from AChE inhibition 2 hr earlier than rats receiving aldicarb
sulfoxide (Knaak et al. 1966). AChE measurements were made using a
pH Stat. Cambon et al. (1979) studied the effect of aldicarb on the
activity of AChE in tissues from pregnant rats and fetuses. Dosages of
0.001, 0.01, and 0.10 mg kg−1 bw were administered to pregnant rats (oral
LD50 = 1 mg kg−1 bw; Kuhr and Dorough 1976) on day 18 of gestation. Tissue
samples taken from animals at the two highest dosages 1 and 5 hr post
administration showed a significant
fi decrease in AChE activity. The effect
persisted in maternal and fetal blood beyond 24 hr. The lowest dose did not
change AChE activity after 1 hr in maternal tissues except for the liver,
while the AChE activity in fetal blood, brain, and liver were signifificantly
inhibited. AChE determinations were made using the method of Ellman
et al. (1961).
Carbaryl
Short-term studies in animal species confirm
fi that carbaryl can cause toxicity
from ChE inhibition. Wide variations in the dosage required to induce
toxicity in either different species or in one species by different routes of
administration can in part be explained by differences in drug disposition.
Limited long-term exposure studies in rats and dogs have not demonstrated
unexpected adverse effects. However, long-term exposure in pigs results in
a progressive neuromyopathy that is associated with structural damage and
is not acutely reversible with atropine (Branch and Jacqz 1986a,b).
Motor activity and neuromotor function were examined in adult Sprague-
Dawley rats exposed to carbaryl, and behavioral effects were compared
with the time course of ChE inhibition. Rats received an IP injection of 0,
4, 8, 16, or 28 mg kg−1 bw carbaryl in corn oil 20 min before testing. Dosages
of 8, 16, and 28 mg kg−1 bw decreased rat maze activity whereas 16 and
28 mg kg−1 bw reduced open field activity. Maximum effects of carbaryl on
blood and brain ChE and motor activity were seen within 15 min. Maze
96 J.B. Knaak et al.
activity had returned to control levels within 30–60 min, whereas ChE levels
remained depressed for 240 min (Ruppert et al. 1983).
Carbofuran
Cambon et al. (1979) studied the effect of carbofuran on the activity of
AChE in tissues from pregnant rats and fetuses. Dosages of 0.05, 0.25,
and 2.50 mg kg−1 bw were administered to pregnant rats (oral LD50 =
11 mg kg−1 bw; Kuhr and Dorough 1976) on day 18 of gestation. The largest
dose, 2.5 mg kg−1 bw, resulted in signs of AChE inhibition within 5 min.
Eight of 32 rats treated at this level died within 30 min. AChE activity in
maternal brain was 27% of control activity whereas activity in fetal brain
was 80%. AChE activity was signifi ficantly reduced in maternal and fetal
tissues taken from surviving dams 1 hr after treatment at the high dose.
Activity was considered to be normal after 24 hr. AChE activity in tissues
taken from animals at the lower dosages (0.25 and 0.05 mg kg−1 bw) 1 hr after
administration was less than control values in certain tissues. Decreases
were observed in blood from dams and fetuses and maternal liver 1 hr after
the administration of 0.05 mg kg−1 bw. AChE determinations were made
using the method of Ellman et al. (1961).
Formetanate
Phenyl NN-methylcarbamates exert their insecticidal activity by inhibiting
enzyme ChE and do not require activation by metabolism before exhibiting
their enzyme-inhibiting properties (Parke 1968). Moser and MacPhail
(1987) studied the effects of ChE inhibition on operant behavior in rats. A
dose of 0.5 mg kg−1 bw formetanate produced a pronounced suppression of
response rates in trained rats.
Methiocarb
The antiChE insecticide, methiocarb, inhibits serine hydrolases by carba-
mylating a serine residue at the catalytic site. This insecticide is viewed as
a potential inhibitor of serine hydrolase-dependent immune functions,
including interleukin 2 (IL-2) signaling (Casale et al. 1993).
Methomyl
The inhibition of ChE by methomyl is quickly reversed in dogs given
10 mg kg−1 bw methomyl without atropine pretreatment. Signs of intoxica-
tion disappeared in 2 hr, and blood ChE levels returned to normal in less
than 4 hr (ACGIH 2001).
Oxamyl
For subchronic or prechronic exposure in female rats given oxamyl at
dietary levels of 100 ppm or higher for 29 d, AChE activity was decreased
Parameters for Carbamate Models 97
in the plasma from day 7 on and in the brain at sacrifice. fi There were no
clear effects on erythrocyte AChE levels. In males, AChE activity was
marginally depressed in plasma and erythrocytes. AChE activity was not
affected by oxamyl at 50 ppm (2.5 mg kg−1 bw d−1) (Hayes and Laws 1991).
According to Kennedy (1986), a 4.86 mg kg−1 bw single bolus dose of oxamyl
dropped blood ChE activity in the rat from 4.3 ± 1.0 to 2.6 ± 0.8 μmol sub-
strate hydrolyzed min−1 at 5 min after treatment. Activity fell to 1.8 ± 0.7 μmol
substrate hydrolyzed min−1 at 4 hr after treatment and returned to normal
(5.7 ± 0.8) 24 hr post dosing.
Pirimicarb
Cambon et al. (1979) studied the effect of pirimicarb on the activity of
AChE in tissues from pregnant rats and fetuses. Dosages of 2.0, 20,
and 50–150 mg kg−1 bw were administered to pregnant rats (oral LD50 =
145 mg kg−1 bw; Kuhr and Dorough 1976) on day 18 of gestation. All the
rats dosed with 50 mg kg−1 bw died soon after administration. AChE activity
in the maternal brain was 20% of control activity while activity in the fetal
brain was 65%. There was significant fi inhibition of AChE activity in all
tissues taken from animals at the mid-dose (20 mg kg−1 bw) 1 hr after admin-
istration. The effects were still apparent in blood and liver from dams and
fetuses after 5 hr. The lowest dose (2 mg kg−1 bw) produced a significant
fi
decrease in AChE activity in several tissues after 1 and 5 hr with no appar-
ent effect after 24 hr. AChE determinations were made using the method
of Ellman et al. (1961).
Propoxur
A nontoxic dose (5 mg kg−1 bw) of propoxur is potentiated by IP pretreat-
ment of rats with 1.0 mg kg−1 bw iso-OMPA (Gupta and Kadel 1990). CaE
activity was markedly reduced, indicating that propoxur toxicity is enhanced
by the inhibition of this hydrolase. Carbamylation of AChE produces an
accumulation of ACh and the picture of muscarinic and nicotinic poisoning.
Spontaneous hydrolysis of the carbamate–ChE complex occurs in vivo,
leading to the disappearance of clinical effects within 24 hr. Penetration
of the blood–brain barrier by the carbamates is insignificant;
fi for this
reason, few central nervous system (CNS) symptoms occur (Ellenhorn and
Barceloux 1988).
Thiodicarb
Thiodicarb is hydrolyzed to methomyl in animals and humans. The antiChE
properties of thiodicarb are related to the rate that methomyl is formed in
metabolizing tissues and made available to tissue ChEs. In a rat dose–
response study, a dermal dose of 33.3 mg kg−1 bw (322 μg cm−2, 25 cm2 treated
skin) resulted in 50% red cell ChE inhibition in 24 hr (Knaak and Wilson
98 J.B. Knaak et al.
1985). Carbaryl at dermal dose levels of 417 mg kg−1 bw (4,000 μg cm−2, 25 cm2
treated) produced no red cell ChE inhibition after 24 hr. An automated
Ellman procedure using a Technicon AutoAnalyzer II Continuous-Flow
Analytical system was used to analyze blood for AChE inhibition (Knaak
et al. 1978, 1980). No information is available concerning AChE reactiva-
tion using the automated Ellman procedure.
Fig. 8. Schematic representation of the binding sites of AChE based upon previous
kinetic, spectroscopic, and chemical modification
fi studies: ES, esteratic site; AS,
anionic substrate-binding site; ACS, active site-selective aromatic cation-binding
site; PAS, peripheral anionic binding site or sites. The hatched areas represent puta-
tive hydrophobic binding regions. The ACh molecule is shown spanning the este-
ratic and anionic sites of the catalytic center. Imidazole and hydroxyl side chains of
His and Ser are shown with the esteratic site. Within the anionic site, (COO-)n
represents six to nine putative negative charges. (Redrawn from Sussman JL et al.
1991 with permission from AAAS).
100 J.B. Knaak et al.
AChE
G1a G2a G4a A12b
Degradation Degradation Secreted by adrenal
product of product of G4 gland; peripheral nerve
G4 cells, found in plasma,
spinal flfluid
BChE
G1 G2 G4 A12
Degradation Degradation Human plasma BChE,
product of product of G4 95% of activity in
G4 plasma
Immobilized forms, asymmetrical
AChE
G1 G2 G4 A12
Torpedo californica
muscle of primitive
vertebrate
BChE
G1 G2 G4 A12
Muscle of
mammals and birds
Amphiphilic globular forms (membrane bound anchored to
phospholipids bilayers)
AChE
G1 G2 G4 A12
Erythrocyte, Mammalian brain, 20-
glycolipid anchor- kDa anchor containing
PIc, cleaved by fatty acids
protease
BChE
G1 G2 G4 A12
Heart of Torpedo Detergent-soluble form
marmorata and reported in mammalian
superior cervical brain
ganglion of rat
Genomic DNA analysis and genetic lineage studies from different species
suggest that all molecular forms of AChE in higher vertebrates are a
product of a single gene (Maulet et al. 1990; Randall et al. 1987; Rotundo
1988; Sikorav et al. 1987), while structural diversity (i.e., G1, G2, G4, A12) is
a product of posttranscriptional and translational events.
BChE
BChE is present in regions of the brain in positions not related to AChE,
such as capillary endothelial cells, in glial cells, and in neurons. Human
BChE is synthesized in the brain. Plasma BChE is a 24% carbohydrate
sialoglycoprotein synthesized in the liver (Khoury et al. 1987). In plasma,
the products of the BChE gene (BCHE) exist in multiple molecular forms.
Three main forms can be recognized by gel electrophoresis: they are des-
ignated in order of decreasing mobility as G1, G2, and G4. The G4 form
represents about 95% of the activity. The forms represent globular (G)
monomeric, dimeric, and tetrameric forms of the enzyme. G4 is a highly
stable enzyme (Masson and Goasdoue 1986). Earlier studies show that a
part of G4 can dissociate spontaneously into G1 and G2 (La Motta et al.
1965; Masson 1979).
Studies involving genomic blots and restriction maps indicate that there
is only one human BChE gene (Arpagaus et al. 1990; Lockridge and La Du
1991) located on the q arm of chromosome 3 (Sparkes et al. 1984; Zakut
et al. 1989). The enzyme shows a complex genetic and molecular polymor-
phism that appears to be mainly the result of posttranslational modifica- fi
tions of the gene products. Genomic blots provide strong evidence for one
gene in the monkey, dog, rat, mouse, guinea pig, cow, sheep, pig, rabbit,
and chicken. The complete amino acid sequence of the usual form of BChE
(Lockridge et al. 1987) was used to find the cDNA clone (McTiernan et al.
1987), while cDNA was used to find fi the gene (Arpagaus et al. 1990).
No genetic variants are known for human RBC AChE. About 10 genetic
variants are known for plasma BChE (Lockridge 1990). The human BChE
gene contains four exons. Exons 2, 3, and 4 contain sequences for the
globular, tetrameric BChE. Exon 2 encodes 83% of the mature protein,
from the N-terminal of the protein, Glu 1 to Gly 478. Exon 2 encodes the
active site serine, Ser 198, the putative anionic site component, Asp 70, the
potential active site histidine, His 438, seven of the total of nine carbo-
hydrate chains per subunit, and two disulfide fi loops, Cys 65–92 and Cys
252–263.
Five genetic variants of human BCHE have been mapped to exon 2.
Variants H, J, and K have 90%, 66%, and 33% lower activity, respectively.
Atypical is the dibucaine resistant variant, whereas Silent-1 has no activity.
The atypical variant has a reduced Km for all positively charged substrates
and inhibitors but a normal kcat. Atypical BChE has a glycine in position
70 in place of aspartic acid.
102 J.B. Knaak et al.
The J variant has been mapped to exon 3. Antibody assays indicate that
the amount of BChE protein is reduced. In the J variant, the charged amino
acid, Glu 497, is replaced by the hydrophobic residue valine.
The K variant has been mapped to exon 4. Antibody assays (Rubinstein
1978) indicate a reduced amount of serum protein. Glycine is substituted
for Ala at position 539. The K variant is the most common genetic variant,
occurring in homozygous form in 1.7% of the Caucasian population and in
heterozygous form in 22.6% of the population. The form is not associated
with any abnormal drug response.
CaE
CaEs are members of the α/β hydrolase family of enzymes, which contain
a catalytic triad consisting of a nucleophile (Ser-221), a base (His-467), and
an orientating acid (Glu-353) and are localized in the endoplasmic reticu-
lum of many tissues (Hosokawa et al. 1987, 1990; Satoh and Hosokawa
1998). Mammalian liver CaEs belong to a family of proteins encoded by
multiple genes. The isozymes were initially classified fi by their substrate
specificities
fi and pI (isoionic point). The isozymes are now classifi fied into
four main CES groups (carboxylesterase, EC 3.1.1.1) and several subgroups.
Two major human liver isozymes, hCE-1 and hCE-2, belong to classes
CES1 and CES2. By Northern blot, a single band of approximately 2.1
kilobases (kb) was seen for hCE-1 (Riddles et al. 1991), and three bands
of approximately 2, 3 and 4.2-kb were seen with hCE-2 (Schwer et al. 1997).
The intensities of the 2.1-kb band were liver >> heart > stomach > tes-
tis = kidney = spleen > colon > other tissues. In the case of hCE-2, the 2-kb
band was located in liver > colon > small intestine > heart, the 3-kb band in
liver > small intestine > colon > heart, and the 4.2-kb band in brain, testis,
and kidney only. Analysis of substrate structure versus effi ficiency for the
ester or carbamate substrates reveals that the two CaEs recognize different
structural features of the substrate (i.e., acid, alcohol, etc.). The catalytic
mechanism involves the formation of an acyl-enzyme on an active serine.
Knowledge of the substrate structure–activity relationships and the tissue
distribution of CE (CaE = CE) are critical for predicting the metabolism
and pharmacokinetics of pesticides in humans.
acids at each of these positions. Early work indicated that the main func-
tional difference between the AChE and BChE active sites is related to the
structure of the acyl pocket, where residues corresponding to Phe295 (288)
and Phe297 (290) are replaced by Leu and Val, respectively. BChE is more
reactive than AChE toward bulky substrates such as butyrylcholine (BCh)
(where kcat/Km = 22 × 108 vs. 0.3 × 108 M−1 min−1) or OP inhibitors such as
diisopropyl phosphofl fluoridate (DFP, CAS no. 55-91-4) (where ki = 1.0 × 105
vs. 1.66 × 10 M min−1) and paraoxon (CAS no. 311-45-5) (Kaplan et al.
7 −1
8.0. The reaction was started by the addition of 2–200 μL homogenate. CaE
activity was determined by titrating liberated acid with 0.01 N NaOH. The
enzyme activities (μmol min−1 g−1 tissue) in control rat tissues as determined
by Maxwell et al. (1987) are given in Table 8. BChE activity was determined
by subtracting AChE activity from total ChE activity.
Tissue μmol min−1 g−1 μmol hr−1 kg−1 μmol kg−1c μmol kg−1d μmol kg−1e μmol kg−1f Mean μmol kg−1 SDb μmol kg−1
Brain 7.34 4.40 × 105 3.76 × 10−2 2.86 × 10−2 4.89 × 10−2 5.65 × 10−2 4.29 × 10−2 1.23 × 10−2
Lung 0.38 2.28 × 104 1.95 × 10−3 1.48 × 10−3 2.53 × 10−3 2.92 × 10−3 2.22 × 10−3 6.36 × 10−4
Spleen 1.0 6.00 × 104 5.13 × 10−3 3.89 × 10−3 6.67 × 10−3 7.69 × 10−3 5.85 × 10−3 1.67 × 10−3
Muscle 1.29 7.74 × 104 6.62 × 10−3 5.02 × 10−3 8.60 × 10−3 9.92 × 10−3 7.54 × 10−3 2.16 × 10−3
Diaphragm 1.29 7.74 × 104 6.62 × 10−3 5.02 × 10−3 8.60 × 10−3 9.92 × 10−3 7.54 × 10−3 2.16 × 10−3
Intestine 0.71 4.26 × 104 3.64 × 10−3 2.76 × 10−3 4.73 × 10−3 5.46 × 10−3 4.15 × 10−3 1.19 × 10−3
Kidney 0.09 5.40 × 103 4.62 × 10−4 3.50 × 10−4 6.00 × 10−4 6.92 × 10−4 5.26 × 10−4 1.51 × 10−4
Heart 0.84 5.04 × 104 4.31 × 10−3 3.27 × 10−3 5.60 × 10−3 6.46 × 10−3 4.91 × 10−3 1.41 × 10−3
Liver 0.17 1.02 × 104 8.72 × 10−4 6.62 × 10−4 1.13 × 10−3 1.31 × 10−4 9.94 × 10−4 2.85 × 10−4
Plasma 0.22 1.32 × 104 1.13 × 10−3 8.57 × 10−4 1.47 × 10−3 1.69 × 10−3 1.29 × 10−3 3.68 × 10−4
Blood 1.32 × 104 1.128 × 10−3
a
Turnover rates (substrate hydrolyzed hr−1 active site−1) used for calculations.
Parameters for Carbamate Models
Enzyme activities (μmol min−1 g−1 tissue) for calculations of binding sites were taken from Table 8.
Esterase binding sites = (enzyme activity)/turnover rate.
b
Coeffi
ficient of variation = 28.64%.
c
Turnover: 1.17 × 107 hr−1; Wang and Murphy (1982).
d
Turnover: 1.54 × 107 hr−1; Torpedo, Selwood et al. (1993).
e
Turnover: 9.00 × 106 hr−1; Torpedo/recombinant, Radic et al. (1992).
f
Turnover: 7.80 × 106 hr−1; Mouse/wild type, Radic et al. (1992).
105
106 J.B. Knaak et al.
Tissue μmol min−1 g−1 μmol hr−1 kg−1 μmol kg−1 b μmol kg−1c μmol kg−1d
Brain 0.78 4.68 × 104 1.28 × 10−2 5.94 × 10−3 7.09 × 10−3
Lung 1.44 8.64 × 104 2.36 × 10−2 1.10 × 10−2 1.31 × 10−2
Spleen 0.86 5.16 × 104 1.41 × 10−2 6.54 × 10−3 7.82 × 10−3
Muscle 0.37 2.22 × 104 6.07 × 10−3 2.82 × 10−3 3.36 × 10−3
Diaphragm 0.44 2.64 × 104 7.21 × 10−3 3.35 × 10−3 4.00 × 10−3
Intestine 6.05 3.63 × 105 9.92 × 10−2 4.60 × 10−2 5.50 × 10−2
Kidney 0.17 1.02 × 104 2.79 × 10−3 1.29 × 10−3 1.55 × 10−3
Heart 4.81 2.89 × 105 7.89 × 10−2 3.66 × 10−2 4.37 × 10−2
Liver 0.5 3.00 × 104 8.20 × 10−3 3.81 × 10−3 4.55 × 10−3
Plasma 0.26 1.56 × 104 4.26 × 10−3 1.98 × 10−3 2.36 × 10−3
a
See Table 9 for calculation of enzyme activity and esterase binding sites based on turnover
rates.
b
Turnover: 3.66 × 106 hr−1; Main et al. (1972).
c
Turnover: 7.88 × 106 hr−1; Torpedo, Golicnik et al. (2002) .
d
Turnover: 6.60 × 106 hr−1; Kaplan et al. (2001).
Tissue μmol min−1 g−1 μmol hr−1 kg−1 μmol kg−1b μmol kg−1c
In all three PBPK/PD models [Gearhart et al. (1990, 1994), Knaak et al.
(2002), and Timchalk et al. (2002)], the active site data from the rat were
used in human models. The PD portion of these models is highly dependent
on these values. New estimates are needed to validate OP and carbamate
pesticide PBPK/PD models. Additional turnover numbers, kcat, (Radic
et al. 1992; Pyror et al. 1992; Selwood et al. 1993; Radic et al. 1993; Kaplan
et al. 2001) for the hydrolysis of thiocholinesters by AChE and BChE were
found and used to obtain new estimates of μmol active sites per kg tissue.
One kcat value was found for CaE (Stok et al. 2004). The results are shown
in Tables 9 and 10.
A 28.6% coefficient
fi of variation for AChE was determined for the
various tissues based on the new turnover numbers in Table 9. This varia-
tion suggests that the output (inhibition) from PBPK/PD models may vary
by at least this percentage. The source of enzymes and methods for deter-
mining turnover numbers was found to vary between studies.
In a study by Pryor et al. (1992), the active sites of electric eel (EE)
AChE were measured by titration with umbelliferyl diethyl phosphate
(UDP) (CAS no. 299-45-6). The release of umbelliferone (CAS no. 93-35-
6) from the reaction with EE-AChE was monitored by fluorescence
fl spec-
troscopy. The time course of fluorescence emission increased following the
addition of AChE to the titration solution. The data (fluorescence
fl vs. time
in sec) fifit the following first-order equation:
F = (F0 − Finf)e−kt + Finff (24)
where F, F0, and Finff are the emission intensities of time t, 0, and infi
finity,
respectively; k is the first-order rate constant (3.1 × 107 hr−1). The enzyme
concentration was determined from the value of Finff − Fb (Fb, background
fluorescence) using the calibration plot. Division of k by the concent-
fl
ration of UDP gave a second-order bimolecular rate constant of
2.77 × 1011 M−1 hr −1. This rate constant is similar to the rate constant
(1.71 × 1011 M−1 hr −1) determined by Kaplan et al. (2001) for human AChE
and ATCh in which the hydrolytic parameters (Km, kcat, and kcat/Km) of
human recombinant AChE and BChE against ATCh and BTCh (acetyl
and butyrylthiocholine) were assayed according to Ellman et al. (1961)
and monitored using a Thermomax microplate reader (Molecular
Devices, Sunnyvale, CA). Enzyme concentration was determined by
ELISA (enzyme-linked immunosorbent assay) (Shafferman et al. 1992)
108 J.B. Knaak et al.
and by active site titration (Velan et al. 1991) using the PsCs-soman
stereomer (CAS no. 24753-16-0). Human AChE displayed a 50-fold
difference in reactivity for ATCh over BTCh with kcat being 2.4 × 107 hr −1
and 4.8 × 105 hr −1, respectively. Human BChE was more reactive against
BTCh than AChE (kcat = 6.6 × 106 hr −1 and 4.8 × 105 hr −1, respectively).
Purification
fi of AChE, BChE, and CaE
Purified/recombinant
fi enzymes are needed for studying the kinetics of their
catalytic reactions. Rosenberry and Scoggin (1984) purifiedfi human eryth-
rocyte AChE on an acridinium resin affinityfi column. Five mg of enzyme
were obtained from 10 L of outdated erythrocytes. The purifi fied enzyme had
a specifific activity of 5000–5800 units mg−1 protein (unit = 1.0 μmol min−1;
5.0–5.8 mmol min−1 mg−1 protein) and was free of polypeptide contaminants
by gel electrophoresis. In detergents, the isolated enzyme corresponded to
a disulfide-linked
fi dimer (G2) that was converted to 75-kDa subunit mono-
mers (G1) by reduction with dithiothreitol. G1 contained 1.7 mol free sulf-
hydryl groups mol −1 subunit. This study provided strong evidence that
erythrocyte AChE is an amphipathic protein.
Affifinity chromatography, of mutant mouse AChE in serum free media,
with trimethyl (m-aminophenyl) ammonium linked through a long tether
arm to Sepharose CL-4B resin (Sigma, St. Louis, MO) permitted a one-step
purification
fi of AChE, both mutant and wild-type in amounts between 5
and 25 mg, as previously described. Purity was assessed by SDS-PAGE
(sodium dodecyl sulfate-polyarcylamide gel electrophoresis) and by com-
parisons of specific
fi activity with absorbance at 280 nm to measure protein
concentration (ε280 = 1.14 × 105 M−1 cm−1) (Boyd et al. 2004). The catalytic
activity of each unlabeled and labeled mutant was measured with the
Ellman assay. Km and the dissociation constant of a ternary complex result-
ing in substrate inhibition or activation, Kss, were kinetically evaluated.
Parameters for Carbamate Models 109
The x-intercept of a plot of the residual catalytic activity versus the con-
centration of the irreversible inhibitor 7-(methylethoxyphosphinyloxy)-1-
methylquinolinium iodide (MEPQ) (CAS no. 95230-44-7) yielded the
enzyme concentration, and, in turn, kcat. No data were supplied for kcat, Km,
and Kss.
Two types of CaE (esterase I and II) were purified fi from rat liver micro-
somes after 90% of the triacylglycerol lipase activity was released by heparin
treatment. Purifification of the residual fraction involved diethylaminoethyl
(DEAE)-cellulose chromatography, hydroxyapatite chromatography,
isoelectric focusing, and Sephadex G-200 chromatography. The final fi
preparation of esterases I and II, which were purified fi 70- and 140 fold,
respectively, gave single protein bands on polyacrylamide gel and sodium
dodecyl sulfate-gel electrophoresis. The molecular weights of esterases I
and II were calculated to be about 70,000 and 160,000 by gel fi filtration on
Sephadex G-200. Esterase I differed immunologically from esterase II, and
it was found to constitute about 30% of the total esterase activity in the
microsomal fraction; esterase II constituted 50%–60% (Ikeda et al. 1977).
Sanghani et al. (2004) purified
fi human isozymes hCE1 and hCE2 from
class 1 and 2 CaEs, respectively, using a modification
fi of the method of
Humerickhouse et al. (2000). Briefly,fl 85 g human liver was first homoge-
nized and centrifuged at 35,000 g for 40 min. The supernatant was added
to DE52 resin, the resin washed, and the CaEs eluted from the resin and
further purified
fi on a 50-mL concanavalin A column. Human isozymes
hCE1 and hCE2 were separated on a preparative nondenaturing gel elec-
trophoresis column in a Bio-Rad Prep Cell model 491 (Bio-Rad, Hercu-
les, CA). Purified
fi hCE1 and hCE2 exhibited specifi fic activities of about 7
and 140 units mg−1, respectively, using methylumbelliferyl acetate as sub-
strate. A unit is defi fined as 1.0 μmol substrate hydrolyzed min−1 mg−1
enzyme.
k −1
Vmax pmoles(substrate product)min 1 kg
k cat (min 1 ) = = (25)
[E]t μmolles(enzyme)kg −1
110 J.B. Knaak et al.
(31)
where S combines at two different sites on the enzyme, forming two binary
complexes, ES and SE, of which only ES results in substrate hydrolysis.
Values for Km, Kss, and b were calculated using nonlinear computer fi
fitting
according to the following equation:
1 + b[S] KSS ⎞ ⎛ Vmax ⎞
v=⎛ (32)
⎝ 1 + [S] KSS ⎠ ⎝ 1 + Km [S] ⎠
(33)
EH IB ki
→ EI BH
(34)
[EH t ] [EH ] exp( k*i [IB] t)
Table 12. Kinetic Constants for the Inhibition of AChE by Carbamate Pesticides
and for Their Reactivation.
(1975a), eDawson (1994), fYu et al. (1972b), gRotenberg and Almog (1995), hDawson (1995).
116 J.B. Knaak et al.
Table 13. Kinetic Constants for the Inhibition of BChE by Carbamate Pesticides.
VII. Discussion
Metcalf and March (1950), Gysin (1954), and Gubler et al. (1968) were
largely responsible for starting the development of carbamates as insect
control agents in the U.S. and Europe. Gysin (1954) concentrated on the
development of dimethylcarbamates (Isolan, Dimetan, and Dimetilan)
while Metcalf and March (1950) concentrated on the less stable but more
active methylcarbamates. The research activities in the laboratories of
Metcalf, March and Gysin, and others were ultimately responsible for the
development, registration, and marketing of the 10 carbamate insecticides
(i.e., aldicarb, carbaryl, carbofuran, formetanate, methiocarb, methomyl,
Parameters for Carbamate Models 119
specific
fi content of AChE, BChE, and CaE in tissues, skin permeation con-
stants (Kp), PCt:b, Vmax, and Km] including model development, e.g., with
ACSL and ERDEM, was carried out after the carbamates were registered
for use.
The pesticide registration requirements (Knaak et al. 1993) enforced by
EPA via FIFRA require the development of considerable toxicological and
metabolic data for assessing risks to the environment and to human and
animal health. Human health risk assessments are the most diffi ficult, involv-
ing the integration of toxicological, pathological, and metabolic data into a
well-connected seamless story. Pathological data are easily integrated into
toxicological reports involving the effects of chronic exposure to pesticides,
but no one knows exactly what to do with ADME. Consequently, the
development of metabolic data is still considered to be supplementary and
not very useful until it is placed in the framework of a predictive PBPK/PD
model. FIFRA does not require the development of the parameters (i.e.,
metabolic Vmax, Km values, tissue:blood partition coefficients,
fi oral, skin, and
inhalation parameters, plasma binding measurements, etc.) necessary for
modeling insecticides. The reason for not requiring these values in the past
was based on the belief that the science of PBPK modeling was immature,
the work too costly, and not enough scientists were available to develop
data or models or both. This is certainly not the case today, based on a
monograph by Reddy et al. (2005) in which the authors presented the
results of PBPK modeling in more than 1,000 publications.
Major problems in model development involve obtaining useful Vmax and
Km values for metabolic transformations and tissue:blood partition coeffi- fi
cients for parent materials and their metabolites. Methods currently exist
for obtaining Vmax and Km from studies involving human liver microsomal
P450 and the individual CYPs (Foxenberg et al. 2006, 2007). QSAR models
for predicting metabolic rates are currently being developed by Enslein et
al. (2007). The Poulin and Theil (2002a,b) mechanistic model provides
reasonable partition coeffi ficients for nonvolatile metabolites when using log
DpH 7.4 values (ACD, Toronto, Ontario) in place of log P values.
In this review on insecticidal carbamates, a decision was made to develop
preliminary PBPK/PD models for the 10 carbamates by using published
metabolic pathway data and the multipathway PBPK/PD model of isofen-
phos (Knaak et al. 2002) as a partial template for the carbamate models.
The aldicarb PBPK/PD model is given in Fig. 9 (see Appendix C). The
conceptual models were translated into ACSL-based mathematical models
incorporating the preliminary Vmax and Km values given in Tables 24–33
(see Appendix B), and the tissue : blood partition coefficientsfi listed in
Tables 14–23 (see Appendix A) in the model. The ACSL model was com-
piled using Compaq Visual Fortran, Version 6.6A (Compaq Computer
Corporation, Houston, TX) before running the model.
The output (i.e., time tissue concentration curves, etc.) from each model
was examined to make sure the model(s) performed as desired. The meta-
Parameters for Carbamate Models 121
bolic pathways in Tables 24–33 (Appendix B) were taken from the PBPK/
PD models and are suitable for direct entry into the front end of ERDEM
(exports command file fi to ERDEM202x) (Graphic Model). The molecular
weights for parent carbamates and their metabolites are required by
ERDEM along with PCt:b values, Vmax and Km values. The models used the
ki values for AChE and BChE in Tables 11 and 12. ki values for CaEs were
not found in the literature. ERDEM models were developed for carbofuran
(Zhang et al. 2006) and carbaryl (Okino et al. 2005a,b; Power et al. 2005)
using the metabolic pathways and preliminary Vmax and Km values pre-
sented in Tables 24–33 (Appendix B), along with the corresponding PCt:b
values and molecular weights given in Tables 14–23 (see Appendix A).
As of 2006, under the Food Quality Protection Act (FQPA) of 1996, the
EPA must consider available information concerning the cumulative effects
on human health resulting from exposure to multiple chemicals that have
a common mechanism of action, such as the N N-methyl carbamates. A cumu-
lative risk assessment also includes exposure data from multiple pathways.
EPA used the relative potency factor (RPF) method to determine the joint
risk associated with exposure to NN-methylcarbamates. Oxamyl was selected
as the index chemical for standardizing the toxic potencies and calculating
the relative potency factor for each carbamate. Brain ChE inhibition from
rats, measured at or near peak inhibition following a single oral exposure,
was used as the endpoint for measuring RPF.
In this review, preliminary PBPK/PD models were developed for the 10
N-methylcarbamates of interest. The hydrolysis of aryl N-methylcarba-
N N
mates (i.e., carbaryl, carbofuran, methiocarb, propoxur, etc.) by hydrolases
was considered to be the primary detoxification
fi pathway in humans as
opposed to the P450-catalyzed oxidative pathway leading to hydroxylated
derivatives in the rat. Hydrolytic enzymes catalyzing this pathway have not
been well characterized despite the fact that it has been more than 40 yr
since the carbamate insecticides were developed and registered. Rat and
human microsomal P450 and individual CYP studies designed to obtain
Vmax and Km data were carried out by Tang et al. (2002) and Usmani et al.
(2004a) involving carbaryl and carbofuran, respectively. Metabolic rates
were not determined for the hydrolysis of these two carbamates. The oxime
carbamates are predominantly hydrolysed to their respective oximes by
human or rat liver hydrolases. Metabolic rate constants for these enzymes
(e.g., first-order
fi or Michaelis–Menten) were not found in the literature.
Less metabolic data were found on oxamyl than on the other carbamoy-
loximes (i.e., aldicarb, methomyl, and thiodicarb). Oxamyl is metabolized
by hydrolysis to its oxime, des NN-methyl oxamyl, or by enzymatic conver-
sion via oxamyl nitrile to oxamyl acid. On the basis of the differences in
structure between the oxime and aryl carbamates, the metabolic enzymes
involved in their metabolism and their AChE ki values, it would seem
logical to use two index chemicals to represent the 10 carbamates. In
terms of oral toxicity, the oxime carbamates vary as follows: aldicarb >
122 J.B. Knaak et al.
oxamyl > methomyl > thiodicarb, with aldicarb being the most toxic and
thiodicarb the least toxic. Carbofuran is the most toxic of the aryl carba-
mates, followed by methiocarb > formetanate > propoxur > pirimicarb,
with carbaryl being the least toxic.
VIII. Recommendations
A research program is needed to develop liver microsomal metabolic rate
constants (Vmax, Km) for the hydroxylation of the aryl N-methylcarbamates
N
and the hydrolysis of the hydroxylated products and the oxime carbamates.
So far, data exist only on the formation of 3-hydroxycarbofuran from car-
bofuran and 4-hydroxycarbaryl from carbaryl. Studies involving the metab-
olism of the OP pesticides parathion and chlorpyrifos strongly suggest that
information on the activity of the individual CYPs against these insecti-
cides, and the content of these CYPs in HLMs by age, may be combined
to give the metabolic rate constants for HLMs.
A significant
fi amount of work has been carried out on the nature of the
active sites of AChE and BChE as well as the CaEs. Information regarding
the content of these enzymes in tissues needs to be improved. Current
estimates involve one study on tissue enzyme activity carried out by Maxwell
et al. (1987). A tabulation of ACh turnover numbers for AChE gives a
coefficient
fi of variation of 28.6%. The results [esterase binding site = (enzyme
activity)/turnover rate] suggest that there may be a 28% variation in the
inhibition estimates from PBPK/PD models.
Tissue:blood partition coeffi ficients estimated by mechanistic models need
to be validated based on experimental data using a high-throughput auto-
mated system based on the work of Jepson et al. (1994). To date, a system
of this nature does not exist.
Summary
A review of the scientifi fic literature was carried out for parameters [i.e.,
IC50, LD50, Kp (cm/hr) for percutaneous absorption, skin:water and tissue:
blood partition coefficients,
fi inhibition ki values, and metabolic parameters
such as Vmax and Km] suitable for building QSAR and PBPK/PD models
[using e.g., ACSL or ERDEM] for assessing human risk to 10 N-methyl-
N
carbamate insecticides: aldicarb, carbaryl, carbofuran, formetanate, methio-
carb, methomyl, oxamyl, pirimicarb, propoxur, and thiodicarb. While
searching for the parameters, PBPK/PD models were developed for these
carbamates based on published metabolic pathways. ACSL-based models
were written for each carbamate and were run using command fi files contain-
ing the parameters or parameter estimates. During this process, tissue:
blood partition coeffificients were developed for parent carbamates and
metabolites using published mechanistic models and logDpH 7.4 values. New
estimates of tissue AChE, BChE, and CaE were made using substrate
Parameters for Carbamate Models 123
Acknowledgments
Our thanks are extended to Prof. Herbert N. Nigg, University of Florida,
and Prof. James R. Olson, The State University of New York at Buffalo,
for reviewing the manuscript of this article and making helpful suggestions
that improve its quality. We also thank Peter Mueller and Dr. Robert W.
Gerlach, General Dynamics Information Technology, for their skilled work
in preparing this manuscript for publication. The work on this review was
funded by the U.S. EPA through General Services Administration contract
GS-09K-99-BHD-0001, tasks 9T3Z061TMA-C and EP06HO00393 with
General Dynamics Information Technology (GDIT), Henderson, NV.
Although this work was reviewed by EPA and approved for publication, it
may not necessarily reflect
fl offi
ficial Agency policy, nor does it represent the
official
fi views of GDIT. Mention of trade names or commercial products
does not constitute endorsement or recommendation for use.
References
Abd-Elroaf TK, Fahmy MAH, Fukuto TR, Elsebae AH (1977) Anticholinesterase
activity and toxicity of substituted phenyl methylcarbamates to honey bee.
J Econ Entomol 70:78–82.
Aeschlimann JA, Reinert M (1931) The pharmacological action of some analogues
of physostigmine. J Pharmacol Exp Ther 43:413.
Ahmad S, Knowles CO (1971) Formamidase involvement in the metabolism of
chlorphenamidine and formetanate acaricides. J Econ Entomol 64:792–795.
Aldridge WN, Reiner E (1972) Kinetics of reaction of B-esterases with carbamates.
In: Neuberger A, Tatum EL (eds) Frontiers in Biology. North Holland,
Amsterdam.
ACGIH (1991) Documentation of the Threshold Limit Values and Biological
Exposure Indices, 6th Ed, vols I, II, III. ACGIH, Cincinnati, OH.
Amidon GL, Lennernas H, Shah VP, Crison JR (1995) A theoretical basis for a
biopharmaceutics drug classification:
fi the correlation of in vitro drug product
dissolution and in vivo bioavailability. Pharm Res 12:413–420.
124 J.B. Knaak et al.
Carpenter CP, Weil CS, Palm PE, Woodside MW, Nair JH III, Smyth HF Jr (1961)
Mammalian toxicity of 1-naphthyl-N-methylcarbamate
N (Sevin insecticide).
J Agric Food Chem 9:30–39.
Casale GP, Vennerstrom JL, Bavari S, Wang TL (1993) Inhibition of interleukin 2
driven proliferation of mouse CTLL2 cells, by selected carbamate and organo-
phosphate insecticides and congeners of carbaryl. Immunopharmacol Immuno-
toxicol 15:199–215.
Chang JH, Benet LZ (2005) Glucuronidation and the transport of the glucuronide
metabolites in LLC-PK1 cells. Mol Pharmacol 2:428–434.
Chang K-M, Knowles CO (1979) Metabolism of oxamyl in mice and twospotted
spider mites. Arch Environ Contam Toxicol 8:499–508.
Chatonnet A, Lockridge O (1989) Comparison of butyrylcholinesterase and acetyl-
cholinesterase. Biochem J 260:625–634.
Chen KC, Dorough HW (1979) Glutathione and mercapturic acid conjugations in
the metabolism of naphthalene and 1-naphthyl N N-methylcarbamate (carbaryl).
Drug Chem Toxicol 2:331–354.
Cho TM, Rose RL, Hodgson E (2006) In vitro metabolism of naphthalene by
human liver microsomal cytochrome P450 enzymes. Drug Metab Dispos 34:
176–183.
Christian TS, Beasley JG (1968) Michaelis constants for isolated cholinesterase
systems. J Pharmacol Sci 6:1025–1027.
Clark DE, Pickett SD (2000) Computational methods for the prediction of “drug-
likeness.” Drug Discov Today 5:49–58.
Cobb GP, Harper FD, Weisskopf CP (2001) Nonlethal method of forensic eva-
luation of aldicarb exposure in wildlife. Arch Environ Contam Toxicol 40:
77–88.
Cohen JA, Oosterbann RA, Warringa MGPJ (1955) Turnover number of ali-ester-
ase, pseudo- and true cholinesterase and the combination of these enzymes with
diisopropyl fluorophosphates (DFP). Biochim Biophys Acta 18:228–235.
Convard T, Dubost JP, Le Solleu H, Kummer E (1994) SmilogP: a program for a
fast evaluation of theoretical log P from the SMILES code of a molecule. Quant
Struct-Act Relat 13:34–37.
Cool M, Jankowski CK (1985) A survey of the metabolism of carbamate insecti-
cides. In: Hutson DH, Roberts TR (eds) Progress in Pesticide Biochemistry and
Toxicology, vol 5 Wiley. Chichester, pp 87–142.
Crop Protection Handbook (2007) MeisterPRO Information Resources, Wil-
loughby, OH.
Cygler M, Schrag JD, Susman JL, Harel M, Silman I, Gentry MK, Doctor DP (1993)
Relationship between sequence conservation and three-dimensional structure in
a large family of esterases, lipases, and related proteins. Protein Sci 2:366–382.
Dawson RM (1994) Rate constants of carbamylation and decarbamylation of ace-
tylcholinesterase for physostigmine and carbaryl in the presence of an oxime.
Neurochem Int 24:173–182.
Dawson RM (1995) Oxime effects on the rate constants of carbamylation and
decarbamylation of acetylcholinesterase for pyridostigmine, physostigmine and
insecticidal carbamates. Neurochem Int 26:643–654.
Dawson RM, Poretski M (1985) Carbamylated acetylcholinesterase: acceleration
of decarbamylation by bispyridinium oximes. Biochem Pharmacol 34:4337–
4340.
126 J.B. Knaak et al.
Lewis RJ (1996) Sax’s Dangerous Properties of Industrial Materials, 9th Ed, vol 1–3.
Van Nostrand Reinhold, New York, pp 653–654.
Lewis DFV (2000) Structural characteristics of human P450s involved in drug
metabolism: QSARs and lipophilicity profi files. Toxicology 144:197–203.
Li Y, Barefoot AC, Reiser RW, Fogiel AJ, Sabourin PJ (1997) Identification fi of
thiocyanate as the principal metabolite of oxamyl in lactating goat. J Agric Food
Chem 45:962–966.
Lipinski CA (2000) Drug-like properties and the causes of poor solubility and poor
permeability. J Pharmacol Toxicol Methods 44:235–249.
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and com-
putational approaches to estimate solubility and permeability in drug discovery
and development settings. Adv Drug Delivery Rev 46:3–26.
Liu HX, Yao XJ, Zhang RS, Liu MC, Hu ZD, Fan BT (2005) Prediction of the
tissue/blood partition coefficients
fi of organic compounds based on the molecular
structure using least-squares support vector machines. J Comput-Aided Mol
Design 19:499–508.
Lockridge O (1990) Genetic variants of human serum cholinesterase influence fl
metabolism of the muscle relaxant succinylcholine. Pharmacol Ther 47:
35–60.
Lockridge O, La Du BN (1978) Comparison of atypical and usual human serum
cholinesterase. J Biol Chem 253:361–366.
Lockridge O, La Du BN (1991) Structure of human butylcholinesterase gene and
expression in mammalian cells. In: Massoulie J, Bacou F, Barnard E, Chatonnet
A, Doctor BP (eds) Cholinesterases: Structure, Function, Mechanism, Genetics,
and Cell Biology. Conference Proceedings Series, American Chemical Society,
Washington, DC.
Lockridge O, Bartel CF, Vaughan TA, Wong CK, Norton SE, Johnson LL (1987)
Complete amino acid sequence of human serum cholinesterase. J Biol Chem
262:549–557.
Lu AYH, West SB (1980) Multiplicity of mammalian microsomal cytochrome P450.
Pharmacol Rev 31:277–291.
MacPherson SE, Scott RC, Williams FM (1991) Fate of carbaryl in rat skin. Arch
Toxicol 65:594–598.
Main AR (1964) Affinity
fi and phosphorylation constants for the inhibition of ester-
ases by organophosphates. Science 144:992–993.
Main AR (1969a) Kinetics of cholinesterase inhibition by organophosphate and
carbamate insecticides. Can Med Assoc J 100:161–167.
Main AR (1969b) Kinetic evidence of multiple reversible cholinesterases based on
inhibition by organophosphates. J Biol Chem 244:829–840.
Main AR (1979) Mode of action of anticholinesterases. Pharmacol Ther 6:579–
629.
Main AR, Dauterman WC (1963) Determination of the bimolecular rate constant
for the reaction between organophosphorus inhibitors and esterases in the pres-
ence of substrate. Nature (Lond) 198:551–553.
Main AR, Tarkon E, Aull J, Soucie W (1972) Purification
fi of horse serum cholines-
terase by preparative polyacrylamide gel electrophoresis. J Biol Chem 247:
566–571.
Marshall TC, Dorough HW (1977) Bioavailability in rats of bound and conjugated
plant carbamate insecticide residues. J Agric Food Chem 25:1003–1009.
Parameters for Carbamate Models 133
Poulin P, Schoenlein K, Theil F-P (2001) Prediction of adipose tissue: plasma parti-
tion coeffificients for structurally unrelated drugs. J Pharm Sci 90:436–447.
Power FW, Knaak JB, Okino MS, Tornero-Velez R, Lowit A, Blancato JN, Dary
CC (2005) Use of exposure-related dose estimating model (ERDEM) for assess-
ment of aggregate exposure of infants and children to N-methyl carbamate
insecticides. Presented at 44th Annual Meeting of the Society of Toxicology,
New Orleans, LA (abstract 1298). March 6–10.
Pryor AN, Selwood T, Lee-Shan L, Andracki MA, Lee Bong Ho, Rao M,
Rosenberry T, Doctor BP, Silman I, Quinn DM (1992) Simple general acid-
base catalysis of physiological acetylcholinesterase reactions. J Am Chem Soc
114:3896–3900.
Radic Z, Gibney G, Kawamoto S, MacPhee-Quigley K, Bongiorno C, Taylor P
(1992) Expression of recombinant acetylcholinesterase in a Baculovirus system:
kinetic properties of glutamate 199 mutants. Biochemistry 31:9760–9767.
Radic Z, Pickering NA, Vellom DC, Camp S, Taylor P (1993) Three distinct
domains in the cholinesterase molecule confer selectivity for acetylcholinester-
ase and butylcholinesterase inhibitors. Biochemistry 32:12074–12084.
Raevsky OA (1997) Hydrogen bond strength estimation by means of HYBOT. In:
Waterbeemd H, van de Testa B, Folkers G (eds) Computer-Assisted Lead
Finding and Optimization. Helvetica Chimica Acta, Basel, pp 367–378.
Randall WR, Tsim KWK, Lai J, Barnard EA (1987) Monoclonal antibodies against
chicken brain acetylcholinesterase. Their use in immunopurification
fi and immu-
nochemistry to demonstrate allelic variants of the enzyme. Eur J Biochem 164:
95–102.
Reddy MB, Yang RS, Clewell HJ, Andersen ME (eds) (2005) Physiologically Based
Pharmacokinetic Modeling: Science and Applications. Wiley, New York.
Redinbo MR, Bencharit S, Potter PM (2003) Human carboxylesterase 1: from drug
metabolism to drug discovery. Biochem Soc Trans 31:620–624.
Reiser RW, Dietrich RF, Djanegara TK, Fogiel AJ, Payne WG (1997) Identification
fi
of a novel animal metabolite of methomyl insecticides. J Agric Food Chem
45:2309–2313.
Riddles PW, Richards LJ, Bowles MR, Pond SM (1991) Cloning and analysis of a
cDNA encoding a human liver carboxylesterase. Gene (Amst) 108:389–292.
Roberts TR, Hutson DH (1999) Carbamates. In: Jewess PJ, Lee PW, Nicholls PH,
Plimmer JR (eds) Metabolic Pathways of Agrochemicals, Part 2. Insecticides and
Fungicides. The Royal Society of Chemistry, Information Services, London.
Robertson A (1863) The calabar bean as a new agent in ophthalmic medicine. Edinb
Med J 8:815.
Rosenberry TL, Scoggin DM (1984) Structure of human erythrocyte acetylcholin-
esterase. Characterization of intersubunit bonding and detergent interaction.
J Biol Chem 259:5643–5652.
Ross MK, Borazjani A, Edwards CC, Potter PM (2006) Hydrolytic metabolism of
pyrethroids by human and other mammalian carboxylesterasess. Biochem Phar-
macol 71:657–669.
Rotenberg M, Almog S (1995) Evaluation of the decarbamylation process of cho-
linesterase during assay of enzyme activity. Clin Chim Acta 240:107–116.
Rotundo RL (1988) Biogenesis of acetylcholinesterase molecular forms in muscle.
Evidence for a rapidly turning over, catalytically inactive precursor pool. J Biol
Chem 263:19398–19406.
Parameters for Carbamate Models 137
Tomlin CDS (ed) (1994) The Pesticide Manual: World Compendium, 10th Ed.
British Crop Protection Council, Surrey, UK, pp. 680, 820, 983.
Tynes RE, Hodgson E (1985) Magnitude of involvement of the mammalian flavin- fl
containing monooxygenase in the microsomal oxidation of pesticides. J Agric
Food Chem 33:471–479.
USEPA (1988) Acceptable Daily Intake (ADI) Tracking Report. U.S. Envir-
onmental Protection Agency, Office fi of Pesticide Programs, Washington,
DC.
USEPA (1992) Dermal Exposure Assessment: Principles and Applications. Interim
Report. EPA 600/8–91/011B. U.S. Environmental Protection Agency, Office fi of
Research and Development, Washington, DC.
USEPA (1994) Reregistration Eligibility Decision (RED) Methiocarb. EPA 738-
R94-002. U.S. Environmental Protection Agency, Office fi of Prevention, Pesti-
cides and Toxic Substances, Washington, DC.
USEPA (2004) Exposure Related Dose Estimating Model (ERDEM) for Assess-
ing Human Exposure and Dose. EPA 600/X-04/060. U.S. Environmental Pro-
tection Agency, Office fi of Research and Development, Washington, DC.
ERDEM web site: http://www.epa.gov/heasdweb/erdem/erdem.htm (accessed
March 8, 2007).
USEPA (2005) Estimation of cumulative risk from N-methyl carbamate pesticides:
preliminary assessment. U.S. Environmental Protection Agency, Office fi of Pes-
ticide Programs, Washington, DC. Available at: http://www.epa.gov/scipoly/sap/
meetings/2005/august/preliminarynmc.pdf (accessed November 28, 2006).
Usmani KA, Hodgson E, Rose RL (2004a) In vitro metabolism of carbofuran by
human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos,
testosterone, and estradiol. Chem-Biol Interact 150:221–232.
Usmani KA, Karoly ED, Hodgson E, Rose RL (2004b) In vitro sulfoxidation of
thioether compounds by human cytochrome P450 and flavin-containing
fl mono-
oxygenase isoforms with particular reference to the CYP2C subfamily. Drug
Metab Dispos 32:333–339.
Van de Sandt JJ, Rutten AA, Van Ommen B (1993) Species-specific fi cutaneous
biotransformation of the pesticide propoxur during percutaneous absorption in
vitro. Toxicol Appl Pharmacol 123:144–150.
Van de Sandt JJ, Meuling WJ, Elliott GR, Cnubben NH, Hakkert BC (2000) Com-
parative in vitro-in vivo percutaneous absorption of the pesticide propoxur.
Toxicol Sci 58:15–22.
Van Hoof F, Heyndrickx A (1975) Excretion in urine of four insecticidal carbamates
and their phenolic metabolites after oral administration to rats. Arch Toxikol
34:81–88.
Velan B, Grosfeld H, Kronman C, Leitner M, Gozes Y, Lazar A, Marcus D, Sery
T, Papier Y, Grosfeld H, Cohen S, Shafferman A (1991) The effect of elimination
of intersubunit disulfi
fide bonds on the activity, assembly, and secretion of recom-
binant human acetylcholinesterase. Expression of acetylcholinesterase Cys-580–
Ala mutant. J Biol Chem 266:23977–23984.
Venkatapathy R, Moudgal CJ, Bruce RM (2004) Assessment of the oral rat chronic
lowest observed adverse effect level model in TOPKAT, a QSAR software
package for toxicity prediction. J Chem Inform Comput Sci 44:1623–1629.
Verschueren K (1983) Handbook of Environmental Data of Organic Chemicals,
2nd Ed. Van Nostrand Reinhold, New York, p 230.
140 J.B. Knaak et al.
Table 14. Chemical structure, physical and chemical properties, and tissue partition
coefficients
fi for aldicarb and the resulting metabolites.
1 Aldicarb
Propanal, 2-methyl-2-(methylthio)-, O-[(methylamino) carbonyl] oxime
CAS No. 116-06-3 fat 0.97 1.00
O MW, g mol−1 190.26 brain 1.81 1.98
S
N Exp Kow @ pH 7.0 NA rapid 1.18 1.14
O N
H LogD @ pH 7.4 1.13 kidney 1.24 1.31
LogP 1.13 liver 1.19 1.54
pKa, MA 13.80 slow 1.08 1.28
WS, g L−1 (3.07) 5.31 skin 1.22 1.32
Kp, cm hr−1 NA
Log Kp NA
2 Aldicarb sulfoxide
Propanal, 2-methyl-2-(methylsulfinyl)-,
fi O-[(methylamino) carbonyl] oxime
O CAS No. 1646-87-3 fat 0.15 0.23
S
MW, g mol−1 206.26 brain 0.99 1.00
Exp Kow @ pH 7.0 NA rapid 0.94 0.94
LogD @ pH 7.4 −1.12 kidney 0.94 0.97
N
LogP −1.12 liver 0.87 0.94
O O
pKa, MA 13.57 slow 0.91 0.93
−1
HN
WS, g L (77.5) 367.54 skin 0.79 0.89
3 Aldicarb sulfone
Propanal, 2-methyl-2-(methylsulfonyl)-, O-[(methylamino) carbonyl] oxime
O CAS No. 1646-88-4 fat 0.15 0.23
S
O MW, g mol−1 222.26 brain 1.00 1.01
Exp Kow @ pH 7.0 NA rapid 0.94 0.94
LogD @ pH 7.4 −0.57 kidney 0.95 0.97
N
LogP −0.57 liver 0.87 0.95
O
pKa, MA 13.44 slow 0.91 0.94
O
WS, g L−1 (7.09) 102.70 skin 0.80 0.89
HN
Parameters for Carbamate Models 143
4 Aldicarb oxime
Propanal, 2-methyl-2-(methylthio)-, oxime
OH CAS No. 1646-75-9 fat 1.15 1.18
N
MW, g mol−1 133.21 brain 1.97 2.16
Exp Kow @ pH 7.0 NA rapid 1.23 1.17
S LogD @ pH 7.4 1.21 kidney 1.30 1.37
LogP 1.21 liver 1.26 1.65
pKa, MA 11.52 slow 1.11 1.34
WS, g L−1 (12.6) 8.27 skin 1.31 1.40
7 Aldicarb nitrile
Propanenitrile, 2-methyl-2-(methylthio)-
S CAS No. 10074-86-9 fat 0.60 0.65
MW, g mol−1 115.19 brain 1.48 1.58
Exp Kow @ pH 7.0 NA rapid 1.08 1.08
LogD @ pH 7.4 0.90 kidney 1.12 1.17
N LogP 0.90 liver 1.06 1.30
pKa NA slow 1.00 1.14
WS, g L−1 (11.78) 17.79skin 1.05 1.15
144 J.B. Knaak et al.
10 Aldicarb aldehyde
Propanal, 2-methyl-2-(methylthio)-
S CAS No. 16042-21-0 fat 1.10 1.13
MW, g mol−1 118.20 brain 1.93 2.12
Exp Kow @ pH 7.0 NA rapid 1.22 1.16
O LogD @ pH 7.4 1.19 kidney 1.28 1.35
LogP 1.19 liver 1.24 1.62
pKa NA slow 1.10 1.33
WS, g L−1 (12.88) 9.82 skin 1.28 1.38
13 Aldicarb alcohol
1-Propanol, 2-methyl-2-(methylthio)-
S CAS No. 27874-69-7 fat 0.48 0.54
MW, g mol−1 120.21 brain 1.36 1.44
Exp Kow @ pH 7.0 NA rapid 1.05 1.03
OH LogD @ pH 7.4 0.78 kidney 1.07 1.12
LogP 0.78 liver 1.01 1.21
pKa MA 14.92 slow 0.98 1.10
WS, g L−1 (61.52) 21.61 skin 0.99 1.10
16 Aldicarb acid
Propanoic acid, 2-methyl-2-(methylthio)-
O OH CAS No. 27868-56-0 fat 0.14 0.22
MW, g mol−1 134.20 brain 0.98 0.99
Exp Kow @ pH 7.0 NA rapid 0.94 0.94
S LogD @ pH 7.4 −2.56 kidney 0.94 0.97
LogP 0.87 liver 0.86 0.97
pKa, MA 3.68 slow 0.91 0.93
WS, g L−1 (1000.0) 13584.03 skin 0.79 0.88
Table 15. Chemical Structure, Physical and Chemical Properties, and Tissue Parti-
tion Coeffi
ficients for Carbaryl and the Resulting Metabolites.
1 Carbaryl
1-Napthalenyl methylcarbamate
CAS No. 63-25-2 fat 20.65 18.77
HN O MW, g mol−1 201.20 brain 11.14 10.07
Exp Kow @ pH 7.0 2.36 rapid 3.94 2.76
O LogD @ pH 7.4 2.40 kidney 4.56 4.06
LogP 2.40 liver 4.91 6.42
pKa, MA 12.02 slow 2.99 4.10
WS, g L−1 (0.10) 0.38 skin 6.09 4.90
Kp, cm hr−1 0.04
Log Kp −1.41
2 4-OH carbaryl
1, 4-Napthalenediol, mono (methylcarbamate)
CAS No. 5266-97-7 fat 2.62 2.55
HN O MW, g mol−1 217.22 brain 3.01 3.42
Exp Kow @ pH 7.0 1.90 rapid 1.56 1.43
O LogD @ pH 7.4 1.56 kidney 1.70 1.80
LogP 1.57 liver 1.71 2.40
pKa, MA 9.20 slow 1.24 1.78
OH
WS, g L−1 (0.32) 1.73 skin 1.90 1.96
3 5-OH carbaryl
1,5-Naphthalenediol, mono (methylcarbamate)
CAS No. 5721-72-2 fat 3.25 3.15
HN O MW, g mol−1 217.22 brain 3.55 3.88
Exp Kow @ pH 7.0 1.94 rapid 1.70 1.52
O LogD @ pH 7.4 1.66 kidney 1.86 1.95
OH LogP 1.65 liver 1.89 2.68
pKa, MA 9.02 slow 1.44 1.94
WS, g L−1 L (0.30) 1.48 skin 2.13 2.16
4 3,4-Dihydrodihydroxy carbaryl
1,2,4-Naphthalenetriol, 1,2-dihydro-, 4-(methylcarbamate)
OH CAS No. 39647-39-7 fat 1.70 1.70
HO MW, g mol−1 235.24 brain 2.42 2.67
Exp Kow @ pH 7.0 NA rapid 1.36 1.28
LogD @ pH 7.4 1.38 kidney 1.46 1.54
LogP 1.38 liver 1.44 1.96
O O pKa, MA 12.62 slow 1.20 1.52
WS, g L−1 (0.66) 1.89 skin 1.54 1.63
NH
148 J.B. Knaak et al.
Table 15. Chemical Structure, Physical and Chemical Properties, and Tissue Parti-
tion Coeffi
ficients for Carbaryl and the Resulting Metabolites.
5 5,6-Dihydrodihydroxy carbaryl
1,2,5-Naphthalenetriol, 1,2-dihydro-, 5-(methylcarbamate)
CAS No. 5375-49-5 fat 0.18 0.25
HN O OH MW, g mol−1 235.24 brain 1.03 1.04
Exp Kow @ pH 7.0 NA rapid 0.95 0.95
O LogD @ pH 7.4 −0.14 kidney 0.96 0.99
OH
LogP −0.14 liver 0.89 0.97
pKa, MA 12.15 slow 0.92 0.95
WS, g L−1 (7.29) 37.54 skin 0.82 0.91
6 Hydroxymethyl carbaryl
Carbamic acid, (hydroxymethyl)-, 1-naphthalenyl ester
HO CAS No. 5266-96-6 fat 2.88 2.80
MW, g mol−1 217.22 brain 3.30 3.61
HN O Exp Kow @ pH 7.0 NA rapid 1.62 1.47
LogD @ pH 7.4 1.60 kidney 1.77 1.86
O LogP 1.60 liver 1.79 2.52
pKa, MA 10.27 slow 1.38 1.85
WS, g L−1 (0.57) 1.53 skin 2.00 2.04
7 Naphthol
1-Naphthalenol
CAS No. 90-15-3 fat 43.20 37.31
MW, g mol−1 144.17 brain 16.04 12.87
HO
Exp Kow @ pH 7.0 NA rapid 5.39 3.33
LogD @ pH 7.4 2.71 kidney 6.32 5.02
LogP 2.71 liver 6.87 8.12
pKa, MA 9.40 slow 4.01 5.08
WS, g L−1 (0.51) 0.39 skin 8.64 6.14
8 1-Hydroxy-2-naphthol
1,2-Naphthalenediol
CAS No. 547-00-5 fat 8.51 8.00
MW, g mol−1 160.17 brain 6.55 6.67
Exp Kow @ pH 7.0 NA rapid 2.58 2.08
LogD @ pH 7.4 2.04 kidney 2.93 2.91
HO LogP 2.11 liver 3.08 4.37
pKa, MA 8.42 slow 2.05 2.92
OH
WS, g L−1 L (0.95) 1.24 skin 3.69 3.40
Parameters for Carbamate Models 149
9 4-OH Naphthol
1,4-Naphthalenediol
CAS No. 571-60-8 fat 5.59 5.32
MW, g mol−1 160.17 brain 5.01 5.30
HO
Exp Kow @ pH 7.0 NA rapid 2.13 1.81
LogD @ pH 7.4 1.87 kidney 2.38 2.44
OH LogP 1.88 liver 2.47 3.54
pKa, MA 10.56 slow 1.74 2.44
WS, g L−1 L (1.05) 1.73 skin 2.89 2.79
10 5-OH naphthol
1,5-Naphthalenediol
CAS No. 83-56-7 fat 6.81 6.44
MW, g mol−1 160.17 brain 5.68 5.92
HO
Exp Kow @ pH 7.0 NA rapid 2.33 1.93
LogD @ pH 7.4 1.95 kidney 2.62 2.65
OH LogP 1.96 liver 2.74 3.92
pKa, MA 9.58 slow 1.87 2.65
WS, g L−1 (0.97) 1.48 skin 3.24 3.06
11 3, 4-Dihydrodihydroxy naphthol
1, 2, 4-Naphthalenetriol, 1, 2-dihydro-
OH CAS No. 73092-92-9 fat 1.32 1.33
−1
HO MW, g mol 178.18 brain 2.11 2.33
Exp Kow @ pH 7.0 NA rapid 1.27 1.21
LogD @ pH 7.4 1.27 kidney 1.34 1.42
LogP 1.27 liver 1.31 1.75
OH pKa, MA 9.92 slow 1.14 1.40
WS, g L−1 (22.41) 4.63 skin 1.38 1.48
12 5, 6-Dihydrodihydroxy naphthol
1, 2, 5-Naphthalenetriol, 1, 2-dihydro-
OH CAS No. 5536-39-0 fat 0.64 0.69
MW, g mol−1 178.18 brain 1.51 1.63
HO Exp Kow @ pH 7.0 NA rapid 1.09 1.07
OH
LogD @ pH 7.4 0.93 kidney 1.13 1.19
LogP 0.93 liver 1.07 1.32
pKa, MA 9.72 slow 1.02 1.15
WS, g L−1 (18.72) 9.03 skin 1.07 1.17
OH
OH
O OH
HN O
HN O
154 J.B. Knaak et al.
O O
NH
HN O OH
a
Parent chemical or metabolite number for cross-reference to Table 25 (Appendix B).
b–e
See footnotes in Table 14 (Appendix A).
156 J.B. Knaak et al.
Table 16. Chemical Structure, Physical and Chemical Properties, and Tissue Parti-
tion Coeffi
ficients for Carbofuran and the Resulting Metabolites.
e
Pesticide, pesticide Partition coefficient
fi
metabolite, and chemical Physical and chemical
No.a structureb propertiesc,d Tissue Rat Human
1 Carbofuran
7-Benzofuranol, 2,3-dihydro-2,2-dimethyl-, methylcarbamate
CAS No. 1563-66-2 fat 4.25 4.08
MW, g mol−1 221.25 brain 4.20 4.53
O Exp Kow @ pH 7.0 NA rapid 1.89 1.65
LogD @ pH 7.4 1.76 kidney 2.09 2.18
O O LogP 1.76 liver 2.15 3.08
pKa, MA 12.28 slow 1.57 2.17
NH WS, g L−1 (0.31) 1.06 skin 2.47 2.45
Kp, cm hr −1 NA
Log Kp NA
2 Carbofuran-7-phenol
7-Benzofuranol, 2,3-dihydro-2,2-dimethyl-
CAS No. 1563-38-8 fat 13.57 12.56
MW, g mol−1 164.20 brain 8.74 8.41
O Exp Kow @ pH 7.0 NA rapid 3.23 2.43
LogD @ pH 7.4 2.23 kidney 3.71 3.50
OH
LogP 2.23 liver 3.96 5.42
pKa, MA 10.09 slow 2.50 3.52
WS, g L−1 L (1.23) 0.82 skin 4.84 4.16
3 3-OH carbofuran
3,7-Benzofurandiol, 2,3-dihydro-2,2-dimethyl-, 7-(methylcarbamate)
OH CAS No. 16655-82-6 fat 0.22 0.29
MW, g mol−1 237.25 brain 1.08 1.11
Exp Kow @ pH 7.0 NA rapid 0.97 0.96
O
LogD @ pH 7.4 0.21 kidney 0.98 1.01
LogP 0.21 liver 0.90 1.01
O O pKa, MA 12.28 slow 0.93 0.98
WS, g L−1 (3.87) 18.38 skin 0.84 0.94
NH
4 Hydroxymethyl carbofuran
Carbamic acid, (hydroxymethyl)-, 2,3-dihydro-2,2-dimethyl-7-benzofuranyl ester
CAS No. 18999-70-7 fat 0.68 0.73
MW, g mol−1 237.25 brain 1.55 1.68
O Exp Kow @ pH 7.0 NA rapid 1.11 1.08
LogD @ pH 7.4 0.96 kidney 1.14 1.20
O O LogP 0.96 liver 1.09 1.35
pKa, MA 10.53 slow 1.02 1.17
NH WS, g L−1 (1.83) 4.21 skin 1.09 1.19
OH
Parameters for Carbamate Models 157
5 Carbofuran-3,7-diol
3,7-Dihydroxy-2,2-dimethyl-2,3-dihydrobenzofuran
OH CAS No. 17781-15-6 fat 0.40 0.47
MW, g mol−1 180.20 brain 1.28 1.35
Exp Kow @ pH 7.0 NA rapid 1.02 1.01
O
LogD @ pH 7.4 0.68 kidney 1.05 1.09
LogP 0.68 liver 0.98 1.16
OH pKa, MA 9.90 slow 0.97 1.06
WS, g L−1 (15.74) 14.43 skin 0.94 1.04
6 3-Keto carbofuran
3(2H)-Benzofuranone,
H 2,2-dimethyl-7-[[(methylamino) carbonyl] oxy]-
O CAS No. 16709-30-1 fat 1.96 1.94
MW, g mol−1 235.24 brain 2.62 2.90
Exp Kow @ pH 7.0 NA rapid 1.42 1.32
O
LogD @ pH 7.4 1.44 kidney 1.53 1.62
LogP 1.44 liver 1.52 2.09
O O pKa, MA 11.92 slow 1.24 1.60
WS, g L−1 (0.19) 1.68 skin 1.65 1.73
NH
7 3-Keto-7-phenol
7-Hydroxy-2,2-dimethylbenzofuran-3-one
O CAS No. 17781-16-7 fat 7.90 7.44
MW, g mol−1 178.18 brain 6.25 6.41
Exp Kow @ pH 7.0 NA rapid 2.49 2.03
O
LogD @ pH 7.4 2.01 kidney 2.82 2.82
LogP 2.05 liver 2.96 4.22
OH pKa, MA 8.44 slow 1.99 2.83
WS, g L−1 (0.73) 1.08 skin 3.54 3.28
OH
O O
NH
Parameters for Carbamate Models 159
O
OH
HO O
HO OH
OH
HO OH
OH
a
Parent chemical or metabolite number for cross-reference to Table 26 (Appendix B).
b–e
See footnotes in Table 14 (Appendix A).
Table 17. Chemical Structure, Physical and Chemical Properties, and Tissue Parti-
tion Coeffi
ficients for Formetanate and the Resulting Metabolites.
e
Pesticide, pesticide Partition coefficient
fi
metabolite, and chemical Physical and chemical
No.a structureb propertiesc,d Tissue Rat Human
1 Formetanate
Methanimidamide, N,N-dimethyl-
N N -[3-[[(methylamino) carbonyl] oxy]phenyl]-
N′
CAS No. 22259-30-9 fat 0.48 0.54
N MW, g mol−1 221.26 brain 1.36 1.44
Exp Kow @ pH 7.0 NA rapid 1.05 1.03
N LogD @ pH 7.4 0.78 kidney 1.07 1.12
LogP 0.86 liver 1.01 1.21
pKa, MA 12.36 slow 0.98 1.09
WS, g L−1 (1.55) 7.31 skin 0.99 1.09
O O Kp, cm hr−1 NA
Log Kp NA
HN
2 Demethylformetanate
Methanimidamide, N-methyl-
N N -[3-[[(methylamino) carbonyl] oxy] phenyl]-
N′
CAS No. 25636-15-1 fat 0.17 0.24
HN MW, g mol−1 207.23 brain 1.01 1.03
Exp Kow @ pH 7.0 NA rapid 0.95 0.95
N LogD @ pH 7.4 −0.29 kidney 0.95 0.98
LogP 0.58 liver 0.88 0.96
pKa, MA 12.38 slow 0.91 0.95
WS, g L−1 (35.16) 71.03 skin 0.81 0.90
O O
HN
3 3-Formaminophenyl N-methylcarbamate
Formamide, N
N-[3-[[(methylamino) carbonyl] oxy] phenyl]-
O CAS No. 24891-34-7 fat 0.28 0.35
MW, g mol−1 194.19 brain 1.15 1.20
HN Exp Kow @ pH 7.0 NA rapid 0.99 0.98
LogD @ pH 7.4 0.44 kidney 1.00 1.04
LogP 0.44 liver 0.93 1.06
pKa, MA 12.11 slow 0.94 1.01
WS, g L−1 (3.65) 19.71 skin 0.88 0.98
O O
HN
4 3-Formaminophenol
Formamide, N-(3-hydroxyphenyl)-
N
O CAS No. 24891-35-8 fat 0.49 0.55
MW, g mol−1 137.14 brain 1.37 1.45
HN Exp Kow @ pH 7.0 NA rapid 1.05 1.03
LogD @ pH 7.4 0.79 kidney 1.08 1.13
LogP 0.80 liver 1.02 1.22
pKa, MA 9.41 slow 0.99 1.10
OH WS, g L−1 (5.68) 18.20 skin 0.99 1.09
161
162 J.B. Knaak et al.
5 3-Aminophenol
Phenol, 3-amino-
H2N CAS No. 591-27-5 fat 0.25 0.32
MW, g mol−1 109.13 brain 1.12 1.15
Exp Kow @ pH 7.0 NA rapid 0.98 0.97
LogD @ pH 7.4 0.34 kidney 0.99 1.02
OH LogP 0.34 liver 0.92 1.04
pKa, MA 10.01 slow 0.93 0.99
WS, g L−1 (21.55) 56.12 skin 0.86 0.96
6 3-Acetamidophenol
Acetamide, N-(3-hydroxyphenyl)-
N
O CAS No. 621-42-1 fat 0.44 0.50
MW, g mol−1 151.16 brain 1.32 1.40
HN Exp Kow @ pH 7.0 NA rapid 1.04 1.02
LogD @ pH 7.4 0.73 kidney 1.06 1.11
LogP 0.73 liver 1.00 1.18
pKa, MA 9.50 slow 0.98 1.07
OH WS, g L−1 (12.92) 17.84 skin 0.97 1.06
HO O
HO O
HO O
a
Parent chemical or metabolite number for cross-reference to Table 27 (Appendix B).
b–e
See footnotes in Table 14 (Appendix A).
164 J.B. Knaak et al.
Table 18. Chemical Structure, Physical and Chemical Properties, and Tissue Parti-
tion Coeffi
ficients for Methiocarb and the Resulting Metabolites.
e
Pesticide, pesticide Partition coefficient
fi
metabolite, and chemical Physical and chemical
No.a structureb propertiesc,d Tissue Rat Human
1 Methiocarb
Phenol, 3,5-dimethyl-4-(methylthio)-, methylcarbamate
CAS No. 2032-65-7 fat 64.84 53.51
HN O MW, g mol−1 225.31 brain 18.85 14.20
Exp Kow @ pH 7.0 NA rapid 6.22 3.60
O LogD @ pH 7.4 2.89 kidney 7.32 5.47
LogP 2.89 liver 7.99 8.92
pKa, MA 12.16 slow 4.58 5.55
S WS, g L−1 (0.12) 0.11 skin 10.11 6.72
Kp, cm hr−1 NA
Log Kp NA
2 Methiocarb sulfoxide
Phenol, 3,5-dimethyl-4-(methylsulfinyl)-,
fi methylcarbamate
CAS No. 2635-10-1 fat 0.37 0.43
HN O MW, g mol−1 241.31 brain 1.24 1.31
Exp Kow @ pH 7.0 NA rapid 1.01 1.00
O LogD @ pH 7.4 0.62 kidney 1.03 1.08
LogP 0.62 liver 0.97 1.13
O pKa, MA 12.03 slow 0.96 1.04
S WS, g L−1 (1.79) 7.81 skin 0.93 1.02
3 Methiocarb sulfone
Phenol, 3,5-dimethyl-4-(methylsulfonyl)-, methylcarbamate
CAS No. 2179-25-1 fat 1.29 1.31
HN O MW, g mol−1 257.31 brain 2.09 2.30
Exp Kow @ pH 7.0 NA rapid 1.26 1.20
O LogD @ pH 7.4 1.26 kidney 1.34 1.41
LogP 1.26 liver 1.31 1.73
O pKa, MA 11.96 slow 1.13 1.39
S WS, g L−1 (0.46) 1.81 skin 1.37 1.46
O
4 Hydroxymethyl methiocarb
3,5-Dimethyl-4-(methylthio) phenyl hydroxymethyl) carbamate
HO CAS No. NA fat 9.63 9.02
MW, g mol−1 241.31 brain 7.08 7.11
HN O Exp Kow @ pH 7.0 NA rapid 2.74 2.17
LogD @ pH 7.4 2.09 kidney 3.12 3.06
O LogP 2.09 liver 3.30 4.64
pKa, MA 10.42 slow 2.16 3.07
WS, g L−1 (0.74) 0.43 skin 3.97 3.59
S
Parameters for Carbamate Models 165
5 Methiocarb phenol
Phenol, 3,5-dimethyl-4-(methylthio)-
HO CAS No. 7379-51-3 fat 45.24 38.89
MW, g mol−1 168.26 brain 16.36 13.03
Exp Kow @ pH 7.0 NA rapid 5.48 3.36
S LogD @ pH 7.4 2.73 kidney 6.43 5.07
LogP 2.73 liver 6.99 8.22
pKa, MA 10.03 slow 4.07 5.14
WS, g L−1 (0.84) 0.29 skin 8.81 6.21
O
S
a
Parent chemical or metabolite number for cross-reference to Table 28 (Appendix B).
b–e
See footnotes in Table 14 (Appendix A).
168 J.B. Knaak et al.
Table 19. Chemical Structure, Physical and Chemical Properties, and Tissue Parti-
tion Coeffi
ficients for Methomyl and the Resulting Metabolites.
1 syn-(Z)-methomyl
Ethanimidothioic acid, N
N-[[(methylamino)carbonyl]oxy]-methyl ester, (Z)-
O CAS No. 19928-37-1 fat 0.36 0.42
MW, g mol−1 162.21 brain 1.23 1.29
O N Exp Kow @ pH 7.0 NA rapid 1.01 1.00
H
S N LogD @ pH 7.4 0.60 kidney 1.03 1.07
LogP 0.60 liver 0.96 1.12
pKa, MA 13.27 slow 0.96 1.04
WS, g L−1 (11.38) 20.55 skin 0.92 1.02
Kp, cm hr−1 NA
Log Kp NA
2 anti-(E)-methomyl
Ethanimidothioic acid, N
N-[[(methylamino) carbonyl] oxy]-methyl ester, (E)-
HN CAS No. 19928-35-9 fat 0.36 0.42
MW, g mol−1 162.21 brain 1.23 1.29
S N
O O Exp Kow @ pH 7.0 NA rapid 1.01 1.00
LogD @ pH 7.4 0.60 kidney 1.03 1.07
LogP 0.60 liver 0.96 1.12
pKa, MA 13.27 slow 0.96 1.04
WS, g L−1 (11.38) 20.55 skin 0.92 1.02
3 syn-(Z)-methomyl oxime
Ethanimidothioic acid, N
N-hydroxy-, methyl ester, (Z)-
S CAS No. 19125-12-3 fat 0.95 0.98
MW, g mol−1 105.16 brain 1.79 1.96
OH
N Exp Kow @ pH 7.0 NA rapid 1.18 1.13
LogD @ pH 7.4 1.12 kidney 1.23 1.30
LogP 1.12 liver 1.19 1.52
pKa, MA 11.26 slow 1.07 1.27
WS, g L−1 (16.69) 12.47 skin 1.21 1.31
4 anti-(E)-methomyl oxime
Ethanimidothioic acid, N
N-hydroxy-, methyl ester, (E)-
S CAS No. 19145-16-5 fat 0.95 0.98
MW, g mol−1 105.16 brain 1.79 1.96
N Exp Kow @ pH 7.0 NA rapid 1.18 1.13
LogD @ pH 7.4 1.12 kidney 1.23 1.30
OH
LogP 1.12 liver 1.19 1.52
pKa, MA 11.26 slow 1.07 1.27
WS, g L−1 (16.69) 12.47 skin 1.21 1.31
Parameters for Carbamate Models 169
5 S-Methyl, N
N-methyl carbamic acid
Carbamothioic acid, methyl-, S-methyl ester
O CAS No. 22013-97-4 fat 0.24 0.31
MW, g mol−1 105.16 brain 1.11 1.14
S N Exp Kow @ pH 7.0 NA rapid 0.97 0.97
H LogD @ pH 7.4 0.30 kidney 0.99 1.02
LogP 0.30 liver 0.91 1.03
pKa, MA 12.77 slow 0.93 0.99
WS, g L−1 (41.17) 62.53 skin 0.85 0.95
6 Ethylium
Ethylium, 1-[(methylthio) imino]-
S CAS No. 61599-22-2 fat 1.13 1.15
N
MW, g mol−1 89.16 brain 1.95 2.14
Exp Kow @ pH 7.0 NA rapid 1.22 1.17
LogD @ pH 7.4 1.20 kidney 1.29 1.36
LogP 1.20 liver 1.25 1.63
pKa, MB 4.01 slow 1.11 1.33
WS, g L−1 (9.58) 11.81 skin 1.29 1.39
7 Carbon dioxide
O CAS No. 124-38-9 fat 0.53 0.58
MW, g mol−1 44.01 brain 1.40 1.50
O
Exp Kow @ pH 7.0 NA rapid 1.06 1.04
LogD @ pH 7.4 0.83 kidney 1.09 1.14
LogP 0.83 liver 1.03 1.25
pKa NA slow 0.99 1.11
WS, g L−1 (358.82) 25.72 skin 1.01 1.11
8 Acetonitrile
N CAS No. 75-05-8 fat 0.16 0.23
MW, g mol−1 41.05 brain 1.00 1.01
Exp Kow @ pH 7.0 NA rapid 0.94 0.94
LogD @ pH 7.4 −0.45 kidney 0.95 0.98
LogP −0.45 liver 0.87 0.95
pKa NA slow 0.91 0.94
WS, g L−1 (122.06) 312.45 skin 0.80 0.90
170 J.B. Knaak et al.
9 Hydrogen cyanide
N CAS No. 74-90-8 fat 0.15 0.23
MW, g mol−1 27.03 brain 1.02 1.03
Exp Kow @ pH 7.0 NA rapid 0.95 0.95
LogD @ pH 7.4 −0.25 kidney 0.95 0.98
LogP −0.25 liver 0.88 0.96
pKa NA slow 0.91 0.95
WS, g L−1 (89.68) 175.60 skin 0.81 0.90
O
Parameters for Carbamate Models 171
a
Parent chemical or metabolite number for cross-reference to Table 29 (Appendix B).
b–e
See footnotes in Table 14 (Appendix A).
172 J.B. Knaak et al.
Table 20. Chemical Structure, Physical and Chemical Properties, and Tissue Parti-
tion Coeffi
ficients for Oxamyl and the Resulting Metabolites.
1 Oxamyl
Ethanimidothioic acid, 2-(dimethylamino)-N-[[(methylamino)]
N oxy]-oxo-, methyl
ester; CAS No. for Z isomer, 32817-80-4, is shown; CAS No. for E isomer,
32817-79-1.
O CAS No. 23135-22-0 fat 0.16 0.23
MW, g mol−1 219.26 brain 1.00 1.01
O N Exp Kow @ pH 7.0 NA rapid 0.94 0.94
H
S N LogD @ pH 7.4 −0.47 kidney 0.95 0.98
LogP −0.47 liver 0.87 0.95
pKa, MA 10.48 slow 0.91 0.94
O N WS, g L−1 (14.15) 87.52 skin 0.80 0.90
Kp, cm hr−1 NA
Log Kp NA
2 des-N-Oxamyl
N
Ethanimidothioic acid, 2-(methylamino)-N[[(methylamino) carbonyl] oxy]-2-oxo-,
methyl ester, (Z
Z isomer shown, no CAS No. for isomer)
S CAS No. 50917-40-3 fat 0.27 0.34
MW, g mol−1 205.24 brain 1.14 1.18
O O O
N Exp Kow @ pH 7.0 NA rapid 0.98 0.98
LogD @ pH 7.4 0.40 kidney 0.99 1.03
HN HN
LogP 0.40 liver 0.93 1.05
pKa, MA 9.28 slow 0.94 1.00
WS, g L−1 (5.18) 19.10 skin 0.87 0.97
3 Oxamyl oxime
Ethanimidothioic acid, 2-(dimethylamino)-N-hydroxy-2-oxo-,
N methyl ester; CAS No.
for Z isomer, 66344-33-0 is shown; CAS No. for E isomer, 66344-32-9.
S CAS No. 66344-33-0 fat 0.22 0.30
MW, g mol−1 162.21 brain 1.09 1.11
O OH
N Exp Kow @ pH 7.0 NA rapid 0.97 0.96
LogD @ pH 7.4 0.22 kidney 0.98 1.01
N
LogP 0.34 liver 0.91 1.01
pKa, MA 8.47 slow 0.93 0.98
WS, g/L (23.97) 43.38 skin 0.84 0.94
5 des-N-Oxamyl
N oxime
Ethanimidothioic acid, N
N-hydroxy-2-(methylamino)-2-oxo-, methyl ester
O CAS No. 66157-67-3 fat 0.26 0.33
S MW, g mol−1 148.18 brain 1.12 1.16
HN Exp Kow @ pH 7.0 NA rapid 0.98 0.97
N LogD @ pH 7.4 0.35 kidney 0.99 1.03
OH LogP 0.38 liver 0.92 1.04
pKa, MA 9.63 slow 0.94 0.99
WS, g L−1 (15.42) 38.83 skin 0.86 0.96
8 des-N-Oxamyl
N oxime glucuronic acid
3,4,5-Trihydroxy-6-({[(1Z)-2-(methylamino)-1-(methylthio)-2-oxoethylidene]
amino}oxy)tetrahydro-2H-pyran-2-carboxylic
H acid
O OH CAS No. NA fat 0.14 0.22
MW, g mol−1 324.31 brain 0.98 0.99
HO Exp Kow @ pH 7.0 NA rapid 0.94 0.94
O HN
LogD @ pH 7.4 −2.99 kidney 0.94 0.97
N LogP 0.73 liver 0.86 0.94
HO O O
pKa, MA 2.68 slow 0.91 0.93
OH S WS, g L−1 (1000.0) 3096.82 skin 0.79 0.88
174 J.B. Knaak et al.
9 Glucuronide of N,N-dimethyloxamic
N acid
6-[2-(Dimethylamino)(oxo)acetoxy]-3,4,5-trihydroxytetrahydro-2H-pyran-2-
H
carboxylic acid
O CAS No. NA fat 0.14 0.22
MW, g mol−1 293.23 brain 0.98 0.99
O
OH N Exp Kow @ pH 7.0 NA rapid 0.94 0.94
LogD @ pH 7.4 −4.65 kidney 0.94 0.97
O O
O LogP −0.93 liver 0.86 0.94
pKa, MA 2.64 slow 0.91 0.93
HO OH WS, g L−1 (1000.0) 125778.30 skin 0.79 0.88
OH
10 des-N-Oxamyl
N acid (N
N-methyloxamic acid)
Acetic acid, (methylamino) oxo-
O CAS No. 29262-58-6 fat 0.14 0.22
MW, g mol−1 103.08 brain 0.98 0.99
O
OH Exp Kow @ pH 7.0 NA rapid 0.94 0.94
LogD @ pH 7.4 −4.99 kidney 0.94 0.97
HN
LogP −1.24 liver 0.86 0.94
pKa, MA 2.37 slow 0.91 0.93
WS, g L−1 (1000.0) 2090361.00 skin 0.79 0.88
HN O
a
Parent chemical or metabolite number for cross-reference to Table 30 (Appendix B).
b–e
See footnotes in Table 14 (Appendix A).
Parameters for Carbamate Models 175
Table 21. Chemical Structure, Physical and Chemical Properties, and Tissue Parti-
tion Coeffi
ficients for Pirimicarb and the Resulting Metabolites.
1 Pirimicarb
Carbamic acid, dimethyl-, 2-(dimethylamino)-5,6-dimethyl-4-pyrimidinyl ester
N CAS No. 23103-98-2 fat 3.68 3.54
MW, g mol−1 238.29 brain 3.83 4.17
Exp Kow @ pH 7.0 NA rapid 1.78 1.58
O N N
LogD @ pH 7.4 1.70 kidney 1.96 2.05
LogP 1.70 liver 2.00 2.86
N O
pKa, MB 4.45 slow 1.49 2.04
WS, g L−1 (11.24) 0.96 skin 2.28 2.29
Kp, cm hr−1 NA
Log Kp NA
2 Hydroxymethyl pirimicarb
2-(Dimethylamino)-5,6-dimethylpyrimidin-4-yl (hydroxymethyl)methylcarbamate
N
CAS No. NA fat 0.61 0.66
MW, g mol−1 254.29 brain 1.48 1.60
Exp Kow @ pH 7.0 NA rapid 1.09 1.06
O N N
LogD @ pH 7.4 0.91 kidney 1.12 1.18
LogP 0.91 liver 1.07 1.31
N O 13.17 slow 1.01 1.15
pKa, MA
WS, g L−1 (65.65) 3.74 skin 1.05 1.15
HO
3 Pirimicarb phenol
4(1H)-Pyrimidinone,
H 2-(dimethylamino), 5,6-dimethyl-
N CAS No. 40778-16-3 fat 0.15 0.22
MW, g mol−1 167.21 brain 0.98 0.99
Exp Kow @ pH 7.0 NA rapid 0.94 0.94
N N
LogD @ pH 7.4 −0.99 kidney 0.94 0.97
LogP 1.20 liver 0.87 0.94
HO
pKa, MA 7.58 slow 0.91 0.93
WS, g L−1 (2.8) 444.05 skin 0.79 0.89
HO O
a
Parent chemical or metabolite number for cross-reference to Table 31 (Appendix B).
b–e
See footnotes in Table 14 (Appendix A).
Parameters for Carbamate Models 177
Table 22. Chemical Structure, Physical and Chemical Properties, and Tissue Parti-
tion Coeffi
ficients for Propoxur and the Resulting Metabolites.
1 Propoxur
Phenol, 2-(1-methylethoxy)-, methylcarbamate
CAS No. 114-26-1 fat 2.88 2.80
HN O MW, g mol−1 209.24 brain 3.29 3.61
Exp Kow @ pH 7.0 NA rapid 1.60 1.47
O LogD @ pH 7.4 1.60 kidney 1.77 1.86
LogP 1.60 liver 1.79 2.52
pKa, MA 12.28 slow 1.38 1.85
O
WS, g L−1 (0.71) 1.69 skin 2.00 2.04
Kp, cm hr−1 NA
Log Kp NA
2 2-Isopropoxy phenol
Phenol, 2-(1-methylethoxy)-
CAS No. 4812-20-8 fat 9.17 8.60
MW, g mol−1 152.19 brain 6.87 6.94
O
Exp Kow @ pH 7.0 NA rapid 2.08 2.13
HO LogD @ pH 7.4 2.06 kidney 3.04 3.00
LogP 2.07 liver 3.21 4.53
pKa, MA 9.99 slow 2.12 3.01
WS, g L−1 (2.77) 1.29 skin 3.86 3.51
4 5-OH Propoxur
1,3-Benzenediol, 4-(1-methylethoxy)-, 3-(methylcarbamate)
CAS No. 13200-88-9 fat 0.66 0.71
HN O MW, g mol−1 225.24 brain 1.54 1.65
Exp Kow @ pH 7.0 NA rapid 1.10 1.07
O OH LogD @ pH 7.4 0.95 kidney 1.14 1.20
LogP 0.95 liver 1.09 1.34
pKa, MA 9.93 slow 1.02 1.17
O
WS, g L−1 (2.02) 4.99 skin 1.08 1.18
178 J.B. Knaak et al.
6 4-OH Propoxur
Carbamic acid, methyl-, 4-hydroxy-2-isopropoxyphenyl ester
CAS No. 17595-59-4 fat 0.59 0.64
HN O MW, g mol−1 225.24 brain 1.46 1.57
Exp Kow @ pH 7.0 NA rapid 1.08 1.05
O LogD @ pH 7.4 0.89 kidney 1.11 1.17
LogP 0.89 liver 1.06 1.29
pKa, MA 9.40 slow 1.01 1.14
O OH
WS, g L−1 (2.14) 5.61 skin 1.04 1.14
8 N-Hydroxymethyl propoxur
Carbamic acid, (hydroxymethyl)-, 2-(1-methylethoxy) phenyl ester
HO CAS No. 10310-16-4 fat 0.50 0.56
MW, g mol−1 225.24 brain 1.38 1.46
HN O Exp Kow @ pH 7.0 NA rapid 1.05 1.03
O
LogD @ pH 7.4 0.80 kidney 1.08 1.13
O LogP 0.80 liver 1.02 1.23
pKa, A 13.59 slow 0.99 1.10
WS, g L−1 (4.22) 6.70 skin 0.99 1.10
Parameters for Carbamate Models 179
OH
Parameters for Carbamate Models 181
OH
a
Parent chemical or metabolite number for cross-reference to Table 32 (Appendix B).
b–e
See footnotes in Table 14 (Appendix A).
Parameters for Carbamate Models 183
Table 23. Chemical Structure, Physical and Chemical Properties, and Tissue Parti-
tion Coeffi
ficients for Thiodicarb and the Resulting Metabolites.
1 Thiodicarb
Ethanimidothioic acid, N-
N N’-[thiobis[(methylimino) carbonyloxy]] bis-, dimethyl
ester
CAS No. 59669-26-0 fat 2.38 2.33
MW, g mol−1 354.47 brain 2.93 3.23
N S
Exp Kow @ pH 7.0 NA rapid 1.51 1.39
O O LogD @ pH 7.4 1.52 kidney 1.64 1.73
LogP 1.52 liver 1.64 2.29
N pKa, MB −2.09 slow 1.31 1.72
S N S
WS, g L−1 (0.19) 0.29 skin 1.81 1.88
N O Kp, cm hr−1 NA
Log Kp NA
O
2 syn-(Z)-Methomyl
Ethanimidothioic acid, N
N-[[(methylamino)carbonyl]oxy]- methyl ester, (Z)-
O CAS No. 19928-37-1 fat 0.36 0.42
MW, g mol−1 162.21 brain 1.23 1.29
O N Exp Kow @ pH 7.0 NA rapid 1.01 1.00
H
S N LogD @ pH 7.4 0.60 kidney 1.03 1.07
LogP 0.60 liver 0.96 1.12
pKa, MA 13.27 slow 0.96 1.04
WS, g L−1 (11.38) 20.55 skin 0.92 1.02
3 anti-(E)-Methomyl
Ethanimidothioic acid, N
N-[[(methylamino)carbonyl]oxy]- methyl ester, (E)-
HN CAS No. 19928-35-9 fat 0.36 0.42
MW, g mol−1 162.21 brain 1.23 1.29
S N
O O Exp Kow @ pH 7.0 NA rapid 1.01 1.00
LogD @ pH 7.4 0.60 kidney 1.03 1.07
LogP 0.60 liver 0.96 1.12
pKa, MA 13.27 slow 0.96 1.04
WS, g L−1 (11.38) 20.55 skin 0.92 1.02
4 ssyn-(Z)-Methomyl oxime
Ethanimidothioic acid, N
N-hydroxy-, methyl ester, (Z)-
S CAS No. 19125-12-3 fat 0.95 0.98
MW, g mol−1 105.16 brain 1.79 1.96
OH
N Exp Kow @ pH 7.0 NA rapid 1.18 1.13
LogD @ pH 7.4 1.12 kidney 1.23 1.30
LogP 1.12 liver 1.19 1.52
pKa, MA 11.26 slow 1.07 1.27
WS, g L−1 (16.69) 12.47 skin 1.21 1.31
184 J.B. Knaak et al.
5 anti-(E)-Methomyl oxime
Ethanimidothioic acid, N-hydroxy-, methyl ester, (E)-
S CAS No. 19145-16-5 fat 0.95 0.98
MW, g mol−1 105.16 brain 1.79 1.96
N Exp Kow @ pH 7.0 NA rapid 1.18 1.13
LogD @ pH 7.4 1.12 kidney 1.23 1.30
OH
LogP 1.12 liver 1.19 1.52
pKa, MA 11.26 slow 1.07 1.27
WS, g L−1 (16.69) 12.47 skin 1.21 1.31
6 S-Methyl, N
N-methyl carbamic acid
Carbamothioic acid, methyl-, S-methyl ester
O CAS No. 22013-97-4 fat 0.24 0.31
MW, g mol−1 105.16 brain 1.11 1.14
S N Exp Kow @ pH 7.0 NA rapid 0.97 0.97
H LogD @ pH 7.4 0.30 kidney 0.99 1.02
LogP 0.30 liver 0.91 1.03
pKa, MA 12.77 slow 0.93 0.99
WS, g L−1 (41.17) 62.53 skin 0.85 0.95
7 Ethylium
Ethylium, 1-[(methylthio) imino]-
S CAS No. 61599-22-2 fat 1.13 1.15
N
MW, g mol−1 89.16 brain 1.95 2.14
Exp Kow @ pH 7.0 NA rapid 1.22 1.17
LogD @ pH 7.4 1.20 kidney 1.29 1.36
LogP 1.20 liver 1.25 1.63
pKa, MB 4.01 slow 1.11 1.33
WS, g L−1 (9.58) 11.81 skin 1.29 1.39
8 Carbon dioxide
O CAS No. 124-38-9 fat 0.53 0.58
MW, g mol−1 44.01 brain 1.40 1.50
O
Exp Kow @ pH 7.0 NA rapid 1.06 1.04
LogD @ pH 7.4 0.83 kidney 1.09 1.14
LogP 0.83 liver 1.03 1.25
pKa NA slow 0.99 1.11
WS, g L−1 (358.82) 25.72 skin 1.01 1.11
Parameters for Carbamate Models 185
9 Acetonitrile
N CAS No. 75-05-8 fat 0.16 0.23
MW, g mol−1 41.05 brain 1.00 1.01
Exp Kow @ pH 7.0 NA rapid 0.94 0.94
LogD @ pH 7.4 −0.45 kidney 0.95 0.98
LogP −0.45 liver 0.87 0.95
pKa NA slow 0.91 0.94
WS, g L−1 (122.06) 312.45 skin 0.80 0.90
10 Hydrogen cyanide
N CAS No. 74-90-8 fat 0.15 0.23
MW, g mol−1 27.03 brain 1.02 1.03
Exp Kow @ pH 7.0 NA rapid 0.95 0.95
LogD @ pH 7.4 −0.25 kidney 0.95 0.98
LogP −0.25 liver 0.88 0.96
pKa NA slow 0.91 0.95
WS, g L−1 (89.68) 175.60 skin 0.81 0.90
O
186 J.B. Knaak et al.
a
Parent chemical or metabolite number for cross-reference to Table 33 (Appendix B).
b–e
See footnotes in Table 14 (Appendix A).
Parameters for Carbamate Models 187
Table 24. Biotransformation and Elimination Paths of Aldicarb and the Resulting
Metabolites and Preliminary Liver Vmax and Km Values.a
1 Aldicarb
Aldicarb oxime
Aldicarb sulfoxide
Aldicarb nitrile
Aldicarb eliminated
2 Aldicarb sulfoxide
Aldicarb oxime sulfoxide
Aldicarb sulfone
Aldicarb nitrile sulfoxide
Aldicarb sulfoxide eliminated
3 Aldicarb sulfone
Aldicarb oxime sulfone
Aldicarb nitrile sulfone
Aldicarb sulfone eliminated
4 Aldicarb oxime
Aldicarb aldehyde
Aldicarb oxime eliminated
7 Aldicarb nitrile
Aldicarb nitrile eliminated
10 Aldicarb aldehyde
Aldicarb alcohol
Aldicarb acid
13 Aldicarb alcohol
Aldicarb alcohol eliminated
16 Aldicarb acid
Aldicarb acid eliminated
Table 25. Biotransformation and Elimination Paths of Carbaryl and the Resulting
Metabolites and Preliminary Liver Vmax and Km Valuesa.
1 Carbaryl
Naphthol
4-OH Carbaryl
5-OH Carbaryl
3,4-Dihydrodihydroxy carbaryl
5,6-Dihydro-dihydroxy carbaryl
Hydroxymethyl carbaryl
2 4-OH carbaryl
4-OH Naphthol
4-OH Carbaryl sulfuric acid
4-OH Carbaryl glucuronic acid
4-OH Carbaryl eliminated
3 5-OH carbaryl
5-OH Naphthol
5-OH Carbaryl sulfuric acid
5-OH Carbaryl glucuronic acid
5-OH Carbaryl eliminated
4 3,4-Dihydrodihydroxy carbaryl
3,4-Dihydrodihydroxy naphthol
3,4-Dihydrodihydroxy carbaryl
sulfuric acid
3,4-Dihydrodihydroxy carbaryl
glucuronic acid
3,4-Dihydrodihydroxy carbaryl
eliminated
5 5,6-Dihydrodihydroxy carbaryl
5,6-Dihydrodihydroxy naphthol
5,6-Dihydrodihydroxy carbaryl
sulfuric acid
5,6-Dihydrodihydroxy carbaryl
glucuronic acid
5,6-Dihydrodihydroxy carbaryl
eliminated
6 Hydroxymethyl carbaryl
1-Naphthol
Hydroxymethyl carbaryl sulfuric acid
Hydroxymethyl carbaryl glucuronic
acid
Hydroxymethyl carbaryl eliminated
190 J.B. Knaak et al.
8 1-Hydroxy-2-naphthol
2-OH Naphthyl sulfuric acid
2-OH Naphthyl glucuronic acid
2-OH Naphthol eliminated
9 4-OH naphthol
4-OH Naphthyl sulfuric acid
4-OH Naphthyl glucuronic acid
4-OH Naphthol eliminated
10 5-OH naphthol
5-OH Naphthyl sulfuric acid
5-OH Naphthyl glucuronic acid
5-OH Naphthol eliminated
11 3,4-Dihydrodihydroxy naphthol
3,4-Dihydrodihydroxy naphthyl
sulfuric acid
3,4-Dihydrodihydroxy naphthyl
glucuronic acid
3,4-Dihydrodihydroxy naphthol
eliminated
12 5,6-Dihydrodihydroxy naphthol
5,6-Dihydrodihydroxy naphthyl
sulfuric acid
5,6-Dihydrodihydroxy naphthyl
glucuronic acid
5,6-Dihydrodihydroxy naphthol
eliminated
Table 26. Biotransformation and Elimination Paths of Carbofuran and the Result-
ing Metabolites and Preliminary Liver Vmax and Km Valuesa.
1 Carbofuran
Carbofuran-7-phenol
3-OH carbofuran
Hydroxymethyl carbofuran
Carbofuran eliminated
2 Carbofuran 7-phenol
3,7-Diol
7-Phenyl sulfuric acid
7-Phenyl glucuronic acid
7-Phenol eliminated
3 3-OH carbofuran
3,7-Diol
3-Keto carbofuran
3-OH carbofuran sulfuric acid
3-OH carbofuran glucuronic acid
3-OH carbofuran eliminated
4 Hydroxymethyl carbofuran
Hydroxymethyl carbofuran sulfuric acid
Hydroxymethyl carbofuran glucuronic
acid
Hydroxymethyl carbofuran eliminated
5 Carbofuran 3,7-diol
3-Keto-7-phenol
3,7-Diol sulfuric acid
3,7-Diol glucuronic acid
3,7-Diol eliminated
6 3-Keto carbofuran
3-Keto-7-phenol
3-Keto carbofuran eliminated
7 3-Keto-7-phenol
3-Keto-7-phenyl sulfuric acid
3-Keto-7-phenyl glucuronic acid
3-Keto-7-phenol eliminated
1 Formetanate
Demethylformetanate
3-Formaminophenyl
N
N-methylcarbamate
2 Demethylformetanate
3-Formaminophenol
Demethylformetanate eliminated
3 3-Formaminophenyl N-methylcarbamate
3-Formaminophenol
4 3-Formaminophenol
3-Aminophenol
3-Formaminophenyl glucuronic acid
3-Formaminophenyl sulfuric acid
5 3-Aminophenol
3-Acetamidophenol
3-Aminophenyl glucuronic acid
3-Aminophenyl sulfuric acid
6 3-Acetamidophenol
3-Acetamidophenyl glucuronic acid
3-Acetamidophenyl sulfuric acid
195
196 J.B. Knaak et al.
Table 28. Biotransformation and Elimination Paths of Methiocarb and the Result-
ing Metabolites and Preliminary Liver Vmax and Km Valuesa.
1 Methiocarb
Methiocarb sulfoxide
Methiocarb phenol
Hydroxymethyl methiocarb
2 Methiocarb sulfoxide
Methiocarb sulfone
Methiocarb sulfoxide phenol
3 Methiocarb sulfone
Methiocarb sulfone phenol
4 Hydroxymethyl methiocarb
Hydroxymethyl methiocarb glucuronic
acid
Hydroxymethyl methiocarb sulfuric acid
Hydroxymethyl methiocarb eliminated
5 Methiocarb phenol
Methiocarb phenyl glucuronic acid
Methiocarb phenyl sulfuric acid
6 Methiocarb phenol sulfoxide
Methiocarb sulfoxide phenyl glucuronic
acid
Methiocarb sulfoxide phenyl sulfuric acid
Table 29. Biotransformation and Elimination Paths of Methomyl and the Resulting
Metabolites and Preliminary Liver Vmax and Km Valuesa.
1 syn-(Z)-methomyl
anti-(E)-methomyl
syn-(Z)-methomyl oxime
2 anti-(E)-methomyl
anti-(E)-methomyl oxime
3 syn-(Z)-methomyl oxime
S-Methyl, N
N-methyl carbamic acid
4 anti-(E)-methomyl oxime
Ethylium
198 J.B. Knaak et al.
5 S-Methyl, N
N-methyl carbamic acid
Carbon dioxide
6 Ethylium
Acetonitrile
7 Carbon dioxide
Carbon dioxide eliminated
8 Acetonitrile
Hydrogen cyanide
Glutathione conjugate of acetonitrile
Acetonitrile eliminated
9 Hydrogen cyanide
Hydrogen cyanide eliminated
Table 30. Biotransformation and Elimination Paths of Oxamyl and the Resulting
Metabolites and Preliminary Liver Vmax and Km Valuesa.
1 Oxamyl
des N oxamyl
Oxamyl oxime
Oxamyl nitrile
2 des N oxamyl
des N Oxamyl oxime
3 Oxamyl oxime
Oxamyl oxime glucuronic acid
des N oxamyl oxime
9 Glucuronide of N,N-dimethyloxamic
N acid
Glucuronide of N,N-dimethyloxamic
N acid
eliminated
10 des N
N-oxamyl acid (N
N-methyloxamic acid)
Glucuronide of N
N-methyloxamic acid
11 Glucuronide of N
N-methyloxamic acid
Glucuronide of N
N-methyloxamic acid
eliminated
a
Preliminary estimates of liver Vmax (μmol hr−1kg−1 bw, unscaled) and Km (μM) are equal
to 10.0.
b
Parent chemical or metabolite number for cross-reference in Table 20 (Appendix A).
c
Refer to Table 20 for structure based on No.
200 J.B. Knaak et al.
Table 31. Biotransformation and Elimination Paths of Pirimicarb and the Resulting
Metabolites and Preliminary Liver Vmax and Km Valuesa.
1 Pirimicarb
Pirimicarb phenol
Hydroxymethyl pirimicarb
2 Hydroxymethyl pirimicarb
Pirimicarb phenol
Demethyl pirimicarb phenol
Amino pirimicarb phenol
3 Pirimicarb phenol
Demethyl pirimicarb phenol
Hydroxymethyl pirimicarb phenol
Pirimicarb phenyl glucuronic acid
Pirimicarb phenol eliminated
1 Propoxur
2-Isopropoxy phenol
5-OH propoxur
4-OH propoxur
Hydroxymethyl propoxur
Propoxur eliminated
2 2-Isopropoxy phenol
2-Isopropoxy phenyl sulfuric acid
2-Isopropoxy phenyl glucuronic acid
2-Isopropoxy phenol eliminated
4 5-OH propoxur
2-Isopropoxy 5-OH phenol
5-OH propoxur sulfuric acid
5-OH propoxur glucuronic acid
5-OH propoxur eliminated
6 4-OH propoxur
2-Isopropoxy 4-OH phenol
4-OH propoxur sulfuric acid
4-OH propoxur glucuronic acid
4-OH propoxur eliminated
8 N-Hydroxymethyl propoxur
Hydroxymethyl propoxur sulfuric acid
Hydroxymethyl propoxur glucuronic acid
Hydroxymethyl propoxur eliminated
201
202 J.B. Knaak et al.
Table 33. Biotransformation and Elimination Paths of Thiodicarb and the Result-
ing Metabolites and Preliminary Liver Vmax and Km Valuesa.
1 Thiodicarb
syn-(Z)-methomyl
anti-(E)-methomyl
2 syn-(Z)-methomyl
ani-(E)-methomyl
syn-(Z)-methomyl oxime
3 anti-(E)-methomyl
anti-(E)-methomyl oxime
4 syn-(Z)-methomyl oxime
S-Methyl, N
N-methyl carbamic acid
5 anti-(E)-methomyl oxime
Ethylium
6 S-Methyl, N
N-methyl carbamic acid
Carbon dioxide
7 Ethylium
Acetonitrile
204 J.B. Knaak et al.
8 Carbon dioxide
Carbon dioxide eliminated
9 Acetonitrile
Hydrogen cyanide
Glutathione conjugate of acetonitrile
Acetonitrile eliminated
10 Hydrogen cyanide
Hydrogen cyanide eliminated
Carbaryl Carbaryl, HLMc 4-OH Carbaryl 0.87 349 Tang et al. 2002
Carbaryl, HLM 5-OH Carbaryl 0.04 349 Tang et al. 2002
Carbaryl, HLM Hydroxymethyl carbaryl 0.57 81.0 Tang et al. 2002
Carbofuran Carbofuran (rat output)d Carbofuran-7-phenol 0.012 25.0 Zhang et al. 2006
Carbofuran (rat output)d 3-OH carbofuran 0.024 12.5 Zhang et al. 2006
Carbofuran, HLM 3-OH carbofuran 3.30 1974 Usmani et al. 2004
Carbofuran, RLMc 3-OH carbofuran 5.50 207 Usmani et al. 2004
a
From metabolism pathways in Tables 25 and 26.
b
Parameters for Carbamate Models
HLM Vmax values (nmol min−1 mg−1 protein) and may be expressed as in vivo values (μmol hr−1 kg−1 bw); this is accomplished by multiplying the in vitro
values by 60 min hr−1; 30 mg microsomal protein/g liver; and by 27 g liver/kg bw to give the in vivo value in nmol hr−1kg−1 bw and dividing the resultant by
1000.
c
HLM, human liver microsomes; RLM, rat liver microsomes.
d
ERDEM Vmax (mmol/L/H) was converted to nmol min−1 mg−1 protein by using 30 mg protein/g liver.
205
206
Table 35. Published CYP Vmax and Km Values for Carbaryl and Carbofuran.
Fig. 9. Physiologically based pharmacokinetic/pharmacodynamic model for oral and dermal exposure to
aldicarb. The model includes the inhibition and recovery of blood AChE and BChE, brain AChE, BChE,
and CaE, and liver BChE and CaE.
208 J.B. Knaak et al.
Appendix D. Nomenclature.
Term Description
Term Description
HB hydrogen bonding
hCE-1, hCE-2 human liver isozymes
HLM human liver microsome
HPLC high performance liquid chromatography
HuAChE human AChE
IP intraperitoneally
IPP 2-isopropoxyphenol (CAS no. 4812-20-8)
iso-OMPA tetraisopropylpyrophosphoramide (CAS no. 513-00-8)
LD50 lethal dose for 50% of the population
LOAEL lowest observed adverse effect level
MDHP 2-methylamino-5,6-dimethyl-4-hydroxypyrimidine
(CAS no. 78195-33-2)
MEPQ 7-(methylethoxyphosphinyloxy)-1-methylquinolinium iodide
(CAS no. 95230-44-7)
MLM mouse liver microsome
MR molar refractivity
MRP2 multidrug-resistant protein
NADPH nicotinomide adenine dinucleotide phosphate
NCEA National Center for Environmental Assessment
NOAEL no observable adverse effect level
OATP organic anion-transporting peptides
OP organophosphorus
ORMUCS ordered multicategorical classifi
fication method using the simplex
technique
PAPS 3′-phosphoadenosinne-5′-phosphosulfate
PAS peripheral anionic binding site or sites
PBPK/PD physiologically based pharmacokinetic/pharmacodynamic
PCB polychlorinated biphenyl
QSAR quantitative structure–analysis relationship
RBC red blood cells
RfD reference dose
RLM rat liver microsome
RPF relative potency factor
SDS-PAGE sodium dodecyl sulfate-polyacrylamide gel electrophoresis
TCh thiocholine
TLC thin-layer chromatography
UDP umbelliferyl diethyl phosphate (CAS no. 299-49-6)
UDPGA uridine diphosphate glucuronic acid
UGT UDP-glucuronosyltransferases
WHO World Health Organization
210 J.B. Knaak et al.
Expression Description
α molecular polarizability
[E] enzyme concentration
[E]t; [E]T total enzyme
[EH], EH concentration of the active enzyme
[ES] enzyme–substrate complex
[IB], IB concentration of carbamate in the incubation mixture
[S] substrate concentration
ACt total AChE
AiACHEB amount of inhibited blood AChE
Arsal amount of chemical in reference saline
Assal amount of chemical in the sample saline after fifiltration
b coeffificient from nonlinear equation fitting Eq. 32; reflflects
effi
ficiency of hydrolysis of ternary complex SES relative to ES
BH leaving group
CB carbamic acid concentration or concentration of pesticide in skin
CACHEB concentration of free AChE in blood
Camax maximum H-bond acceptor descriptor in a molecule
CB carbamate inhibitor
CCarbamate concentration of carbamate in blood
Cfil
fi concentration of the chemical in the ultrafi
filtrate from reference
saline
CHG indicator variable for charged substituents
Cj concentration of chemical in tissue j
Csal concentration of the chemical in the reference saline before
ultrafifiltration
Css concentration of chemical in the sample saline after fifiltration
D*vo:w vegetable oil:buffer, nonionized and ionized species at pH 7.4; or
distribution between vegetable oil and buffer at pH 7.4 (Eq. 15)
Dvo:w distribution between vegetable oil:buffer, neutral compound
Dvo:w, pH7.4 distribution between n-octanol and buffer at pH 7.4 (ACD values)
E enzyme
E0 initial enzyme
EA acylated enzyme
EC carbamylated enzyme
EHAB enzyme inhibitor or Michaelis–Menten complex
EHCB enzyme–carbamate complex
EHt EH at time t
EI enzyme inhibitor complex
Es Taft steric parameter
fub binding to protein in blood
fut binding to protein in tissue
HB leaving group
ᑣ inductive parameter
I0 initial inhibitor
I50 molar concentrations resulting in 50% inhibition
Parameters for Carbamate Models 211
Expression Description
Expression Description
Contents
I. Introduction ...................................................................................................... 213
II. Production and Use ......................................................................................... 215
III. Contamination Status ...................................................................................... 216
A. Air, Water, Sediments, and Soils ............................................................ 216
B. Biological Samples .................................................................................... 230
C. Foodstuffs ................................................................................................... 242
D. Human Exposure ....................................................................................... 243
E. Dioxin Contamination .............................................................................. 244
IV. Environmental Behavior and Bioaccumulation .......................................... 269
A. Transport Behavior in Tropical Environments ..................................... 269
B. Bioaccumulation in Biota ......................................................................... 272
V. Temporal Trends ............................................................................................. 273
VI. Environmental and Human Health Implications ........................................ 277
VII. Conclusions and Recommendations ............................................................. 282
Summary ........................................................................................................... 284
Acknowledgments ........................................................................................... 284
References ........................................................................................................ 285
I. Introduction
Global contamination and toxic effects of persistent organic pollutants
(POPs) have been an emerging environmental issue and have received
considerable attention during the past four decades. Although the extent
of contamination by POPs has been dominant in industrialized nations, an
213
214 T.B. Minh et al.
China
India
South
China Philippines
Sea
Malaysia
a
sia
a
Indonesia
Mekong
River Delta
Fig. 1. Map of Vietnam. Vietnam is located at the center of the Southeast Asian
region: it has two the largest deltas, Red River Delta and Mekong River Delta.
Organic Pollutants in Vietnam 215
source of dioxins in Vietnam in the past was Agent Orange and other
herbicides sprayed in South Vietnam during the American war. Recently,
Stellman and coworkers (Stellman et al. 2003) provided revised estimates
of the amounts of herbicides used in Vietnam. During 1961–1971, at least
about 45 million L Agent Orange was sprayed (Stellman et al. 2003). 2,4,5-
T, a constituent of Agent Orange, is known to be contaminated with 2,3,7,8-
tetrachlorodibenzo-p- -dioxin (TCDD). However, the combustion-derived
sources of dioxins in Vietnam are unknown. Various kinds of combustion
processes may facilitate the widespread contamination of dioxins and
related compounds in Vietnam.
Red River, Hanoi River water 1990 1 0.68 3.2 0.045 0.84 lwata et al. 1994 DDTs: sum of p,p′-DDE, p,p′-DDD
Phu Loc Lake, Hue Lake water 1990 1 0.29 18 0.21 1.2 lwata et al. 1994 and p,p′-DDT
Huong River, Hue River water 1900 1 1.1 1.9 0.07 1.6 lwata et al. 1994 HCHs: sum of α-, β-, and γ-HCH
γ
Nha Be River, Hochiminh Estuarine 1990 1 4.7 31 0.55 2.7 lwata et al. 1994 CHLs: sum of cis-chlordane, trans-
City water chlordane, cis-nonachlor, trans-
Gua canal, Cu Chi River water 1990 1 0.6 9.5 0.16 1.9 lwata et al. 1994 nonachlor and oxychlordane
Long Tau River, Estuarine 1990 1 0.55 5.2 0.13 0.57 lwata et al. 1994 PCBs: quantifified by an equivalent
Hochiminh City water mixture of Kanechlor preparations
Thi Nghe canal, Hochiminh Estuarine 1990 1 25 19 1 8 lwata et al. 1994 (KC-300, KC-400, KC-500 and
City water KC-600)
Red River and Duong River, River water 1998/99 Hung and DDTs: sum of p,p′-DDE, p,p′-DDD,
northern Vietnam Thiemann 2002 p,p′-DDT, o,p′-DDE, o,p′-DDD,
a
Dry season 18 44 (0.55–320) 17 (1.6–83) 21 (0.81–110) — o,p′-DDT
Rainy season 18 56 (8.4–230) 29 (3.1–97) 27 (1.6–130) — HCHs: sum of α-, β-, γ-
γ , and δ-HCH
CHLs: sum of heptachlor and
heptachlorepoxide
Lakes in Hanoi: West Lake, Lake water 1998/99 Hung and
Thuyen Quang Lak Thiemann 2002
Bay Mau Lake and Ba Mau
Lake
Organic Pollutants in Vietnam
a
217
Mean (range).
218 T.B. Minh et al.
Sample/sampling site
Location characteristic Year n DDTs
Song Long Tau, Duyen Hai, Sediment, paddy field 1990 6 17 (2.1–47)
Hochiminh City
Thi Nghe Canal, Hochiminh Sediment, municipal 1990 3 530 (360–790)
City sewage
Thinh Liet, Thanh Tri, Hanoi Soil, paddy fi
field 1990 1 330
Table 2. (cont.)
Sample/sampling site
Location characteristic Year n DDTs
Ba Diep, Hooc Mon Soil, upland 1990 1 280
DS/RSa
Hanoi Sediment, irrigation 1995/96 1 6.9/13
canal, northwest
Hanoi
Organic Pollutants in Vietnam 221
Table 2. (cont.)
Sample/sampling site
Location characteristic Year n DDTs
Hanoi Sediment, paddy 1995/96 1 7.5/14
field, southwest
fi
Hanoi
Ba Lat estuary, Red River, Sediment 1995/96 1 7.1/3
northern Vietnam
Cua Lan estuary, Thai Binh Sediment, intertidal 1995/96 1 5.8/4.9
coast lines, northern mudflat
fl areas
Vietnam
Tra Ly estuary, Thai Binh Sediment, intertidal 1995/96 1 7.3/5.1
coast lines, northern mudflat
fl areas
Vietnam
Diem Dien estuary, Thai Sediment, intertidal 1995/96 1 6.2/4.6
Binh coast lines, northern mudflat
fl areas
Vietnam
Tra Co beach, Mong Cai, Marine sediment, 1997 1 (pooled) 10
northern coast of Vietnam intertidal mudflat
fl
areas
Mong Duong, northern coast Marine sediment, 1997 1 (pooled) 8.1
of Vietnam intertidal mudflat
fl
areas
Ha Long, northern coast of Marine sediment, 1997 1 (pooled) 7.2
Vietnam intertidal mudflat
fl
areas
Hai Phong, northern coast of Marine sediment, 1997 1 (pooled) 6.7
Vietnam intertidal mudflat
fl
areas
Ba Lat estuary, northern Marine sediment, 1997 1 (pooled) 6.3
coast of Vietnam intertidal mudflat
fl
areas
Cau Dien, Nhue River, Sediment, canal, 1997 2 43 (15–71)
suburb Hanoi densely populated
industrial area
Nhue River, suburb Hanoi Sediment, canal, rural 1997 1 8.3
area
Nhue River, suburb Hanoi Sediment, canal 1997 1 21
Table 2. (cont.)
Sample/sampling site
Location characteristic Year n DDTs
Gia Lam, suburb Hanoi Sediment, canal, rural 1997 1 17
area, eastern Hanoi
city
Dong Anh, suburb Hanoi Sediment, canal, rural 1997 1 23
area, northern
Hanoi city
Ha Long Bay, northern estuary sediment 1998 — 28
Vietnam
Viet Tri, northern Vietnam Industrial areas 1998 — 5.2
Hanoi Soils, municipal 1999–01 7 19 (1.9–52)b
dumping sites
Hanoi Soils, reference areas 1999–01 3 3.2 (2.2–4.3)
relative to the
municipal dumping
sites
Hochiminh City Soils, municipal 1999–01 6 23 (1.1–83)
dumping sites
Hochiminh City Soils, reference areas 1999–01 3 3.8 (0.41–10)
relative to the
municipal dumping
sites
Canal, Can Tho, Mekong Sediment, canals in 2003–04 4 2.8 (1.8–4.3)
River, southern Vietnam Cantho city
a
Dry season/rainy season.
b
Mean (range).
Organic Pollutants in Vietnam 225
Fig. 3. Distribution of DDTs and PCBs in sediments from Sai Gon–Dong Nai River
region, southern Vietnam (Minh TB et al. 2005; Minh NH et al. 2007a).
Fig. 5. Distribution of DDTs and PCBs in sediments from Hau River, the largest
branch of the Mekong River, southern Vietnam (Minh NH et al. 2004b, 2007b).
Organic Pollutants in Vietnam 229
during our survey in the early 1990s could be derived from electrical
equipment imported from industrialized nations, e.g., the former Soviet
Union and Australia, and from leakage from army weapons extensively
used in the Vietnam War during 1961–1971 (Thao et al. 1993a,b).
Available data on the worldwide comparison of PCBs and OC insecticide
levels in open dumpsites are rather scarce. A comparison of PCBs and
DDTs levels in dumping sites from Vietnam with those in soils from other
countries is given in Fig. 8. In general, the levels of PCBs in dumping sites
were higher than those in background soils from various countries, includ-
ing industrialized nations, e.g., the U.S., Russia, and Italy, where heavy
contamination of PCBs has been common (Meijer et al. 2003). Our survey
indicated that DDT levels in dumping site soils were comparable to those
found in agricultural soils collected in the early 1990s from various coun-
tries such as Russia (Iwata et al. 1995), Ireland (McGrath 1995), and
Slovakia (Marta et al. 1997), and higher than in most of the urban soils
collected in many countries such as Egypt (Ahmed et al. 1998), Korea (Kim
and Smith 2001), and the rural areas of Vietnam (Minh NH et al. 2006a)
(see Fig. 8). This observation highlights the role of open dumping sites in
developing Asian countries as significant
fi pollution sources of PCBs and
DDTs.
B. Biological Samples
The suitability of using a wide range of biological samples as bioindicators
for monitoring POPs contamination was extensively discussed by Tanabe
and Subramanian (2006). Surveys examined POP residue levels in various
Organic Pollutants in Vietnam 231
biological samples such as fish,fi bivalves, and birds from the Asia-Pacifific
region, including Vietnam, have made clear the status of contamination,
distribution, and source allocation. An extensive study on OC contamination
in fi
fish from Asia and Oceania including Vietnam was carried out by Kannan
et al. (1995). Similar to sediment samples, a relatively uniform distribution
of OCs was observed in fish fi in various countries in the Asia-Pacifific region.
In Vietnam, residues of DDTs were relatively high in the surveys conducted
in 1990 and 1997 (Table 3). Mussels collected from coastal areas in north
and middle Vietnam contained elevated DDT concentrations (Table 3;
Monirith et al. 2003). Subsequent surveys conducted by Nhan et al. (1998,
1999) examined OC distribution in clams from different sites along the
northern coast, showing a very similar distribution in sediment samples. In
particular, residue concentrations of DDTs, HCHs, and PCBs were rela-
tively high in the sites near the border of China, and a decreasing trend was
noticed toward the southern coastlines (Table 4). At the two estuary areas,
Hai Phong harbor with extensive human and industrial activities, and Thai
Binh province, one of the high rice production areas in Vietnam, higher
concentrations were again observed. In general, the distribution and
magnitude of contamination in sediment and biota (fish fi and bivalves) was
very similar at both the local and regional scale, which can be attributed to
the enhanced volatilization of semivolatile organic compounds because of
the high temperatures prevailing in tropical ecosystems.
Polybrominated diphenyl ethers (PBDEs) are emerging contaminants
that have received considerable attention in recent years. We conducted a
232 T.B. Minh et al.
Con Lu island, Red Fish (mugil sp. and 1997 10 3.2 4,200 (330–
River estuary, chlorophthalmus 8,500)
northern sp.)
Vietnam
Con Lu island, Red Shrimp 1997 20 (pooled as 2.8 160
River estuary 1 sample)
Cat Ba island, Cai Green Mussel, 1997 38 (pooled as 1.1 530
Hai province floating habitat 1 sample)
Cat Hai province Green Mussel, 1997 34 (pooled as 0.9 300
floating 1 sample)
habitat
Cat Hai province Green Mussel, 1997 8 (pooled as 1 0.7 2,500
floating sample)
habitat
Cat Hai province Green Mussel, 1997 12 (pooled as 2 420
floating 1 sample)
habitat
Lach Truong, Green Mussel, 1997 33 (pooled as 1.2 610
Thanh Hoa aquaculture 1 sample)
Ron River estuary, Green Mussel, 1997 50 (pooled as 0.6 470
Ky Anh fishing 1 sample)
village
Lang Co, Hue Green Mussel 1997 143 (pooled as 0.9 34,000
1 sample)
Thi Nai, Binh Dinh Green Mussel, 1997 54 (pooled as 1.1 220
urban, shipping 1 sample)
traffi
fic,
aquaculture
Phan Ri estuary, Green Mussel, 1997 30 (pooled as 1.1 240
Phan Ri urban, fifishing 1 sample)
village
Organic Pollutants in Vietnam 233
120 (47–210) 7.9 (<0.5–17) 580 (270–950) Kannan et DDTs: sum of p,p′-DDE,
al. 1995 p,p′-DDD and
48 (32–74) 8.9 (>0.5–12) 630 (160–1,300) Kannan et p,p′-DDT
al. 1995 HCHs: sum of α-, β-, and
110 (33–200) 3.2 (<0.5–18) 950 (190–3,100) Kannan et γ
γ-HCH
al. 1995 CHLs: sum of cis-
chlordane, trans-
chlordane,
cis-nonachlor, trans-
nonachlor and
oxychlordane
350 (27–210) 110 (29–210) 110 (81–140) Minh et al. PCBs: quantifified by an
2002 equivalent mixture of
Kanechlor perparations
(KC-300, KC-400, KC-
150 3.9 100 Minh et al. 500 and KC-600)
2002
3.6 14 86 Monirith et DDTs: sum of p,p′-DDE,
al. 2003 p,p′-DDD and
12 12 20 Monirith et p,p′-DDT
al. 2003 HCHs: sum of α-, β-, and
γ
γ-HCH
5.7 24 450 Monirith et CHLs: sum of cis-
al. 2003 chlordane, trans-
chlordane,
3 5 110 Monirith et cis-nonachlor, trans-
al. 2003 nonachlor and
oxychlordane
3.3 13 65 Monirith et PCBs: quantifified by an
al. 2003 equivalent mixture of
5.5 20 190 Monirith et Kanechlor perparations
al. 2003 (KC-300, KC-400, KC-
500 and KC-600)
10 — 380 Monirith et
al. 2003
6.3 36 26 Monirith et
al. 2003
2.9 11 80 Monirith et
al. 2003
234 T.B. Minh et al.
Table 3. (cont.)
Table 3. (cont.)
a
Mean (range).
b
Average concentrations of 7 resident and 17 migratory species.
Organic Pollutants in Vietnam 237
0.47 (<0.03–1.5) 0.62 (<0.01–2.6) 7.2 (0.91–27) Minh et al. DDTs: sum of p,p′-DDE,
2005, p,p′-DDD and
2006 p,p′-DDT
HCHs: sum of α-, β-, and
γ
γ-HCH
2.2 (0.86–5.1) 5.7 (4.2–8.2) 50 (37–77) Minh et al.
2005,
2006
150 (23–310) 100 (5–550) 780 (250–2,400) Minh et al. CHLs: sum of cis-
2002 chlordane, trans-
chlordane,
cis-nonachlor, trans-
330 (20–1,700) 22 (5.3–130) 530 (82–1,600) Minh et al. nonachlor and
2002 oxychlordane
PCBs: quantifified by an
equivalent mixture of
Kanechlor preparations
(KC-300, KC-400, KC-
500 and KC-600)
238 T.B. Minh et al.
Samples/sampling site
Locations Year despcription Unit n DDTs
Me Tri and Tu Liem, 2000 Breast milk, overall ng g−1 lipid 42 2,100 (480 –
Hanoi near municipal 6,900)a
dumping sites
Vinh Loc and Dong 2001 Breast milk, ng g−1 lipid 3,020
Thanh, Hochiminh primiparous women
City near municipal
dumping sites
Vinh Loc and Dong 2001 Breast milk, ng g−1 lipid 1,500
Thanh, Hochiminh multiparous women
City near municipal
dumping sites
Vinh Loc and Dong 2001 Breast milk, overall ng g−1 lipid 44 2,300 (440 –
Thanh, Hochiminh near municipal 17,000)
City dumping sites
Tan Than village, 1985–87 Breast milk, rural area ng g−1 lipid 2 10,500
suburb Hochiminh
City
Song Be province, 1985–87 Breast milk, rural area ng g−1 lipid 3 12,000
southern Vietnam
a
Mean (range).
Organic Pollutants in Vietnam 239
DDTs
Common catfish
HCHs
Dumping site catfish
PCBs
Mean Max
PBDEs
Fig. 11. Comparison of DDTs residues in fi fish, mussels, and birds in Asia-Pacifi fic
countries. [From: fifish: Kannan et al. (1995), Nakata et al. (1995), Guruge et al.
(1997), Monirith et al. (2000), Minh TB et al. (2002); mussels: Monirith et al. (2003);
birds: Hoshi et al. (1998), Choi et al. 2001, Kunisue et al. (2002, 2003), Minh TB
et al. (2002), Tanabe et al. (1998)].
C. Foodstuffs
The first examination of OC contamination in foodstuffs from Vietnam was
conducted by Schecter et al. (1990a). Pork and chicken fat were analyzed,
and relatively high levels of DDTs were found (190–5100 ng/g lipid).
However, residues levels of other contaminants such as HCHs, CHLs,
HCB, and PCBs were relatively low.
A subsequent investigation done by Kannan et al. (1992) in the samples
collected during January 1990 and May 1991 examined various kinds of
foodstuffs including rice, pulses, oil, butter, animal fat, meat, fish,
fi and
seafood from Hanoi, northern Vietnam, and Tay Ninh and Hochiminh City,
southern Vietnam. The results demonstrated significant
fi concentrations of
PCBs in foods from both the northern and southern parts, which is consistent
Organic Pollutants in Vietnam 243
with the data reported for soils collected at the same locations (Thao et al.
1993a,b). DDT concentrations were prominent in all kinds of foodstuffs,
particularly in oil and animal fat. The ongoing application of DDT at the
time of this investigation was also evident. In particular, composition of
DDT compounds showed that p,p′-DDT was the predominant isomer in
rice, pulses, and oils, accounting for approximately 50% of the total DDT
concentrations (Kannan et al. 1992). Very recently, Schecter et al. (2003)
reported some alarmingly elevated concentrations of PCDD/Fs in foodstuffs
from Bien Hoa City, southern Vietnam, where Agent Orange was sprayed
during the Vietnam War. Several samples of duck, toad, chicken, and
snakehead fish collected from the former U.S. Army base site contained
elevated concentrations of DDTs. The high levels of DDTs found in meat
of livestock and fish from these studies indicate the application of technical
DDT to prevent malaria near cattle sheds, stagnant water bodies, and
drainage channels, which are common breeding sites for mosquitoes
(Kannan et al. 1992).
D. Human Exposure
Available data on human exposure to organochlorine insecticides and
PCBs in Vietnamese residents are limited. A preliminary survey by Schecter
et al. (1989a) reported very high concentrations of DDTs and HCHs in
human breast milk from some locations in and around Hochiminh. DDT
levels were higher in both rural and urban areas, ranging from 10,500 to
12,000 ng/g lipid. PCB levels, however, were relatively low compared to
other countries. A subsequent study conducted in 2000–2001 provided
more extensive data on human exposure and insights into the accumulation
kinetics of PCBs and OC insecticides such as DDTs, HCHs, CHLs, HCB,
and tris(4-chlorophenyl)methane (TCPMe), a newly detected environmental
contaminant that exhibits weak endocrine-disrupting properties. Breast
milk from 96 nursing women living near the dumping sites of municipal
wastes in Hanoi and Hochiminh, the two largest metropolitan cities in
Vietnam, was analyzed for these contaminants (see Table 4). In general,
similar degrees of exposure to DDTs, CHLs, HCB, and PCBs were observed
among samples from Hanoi and Hochiminh. Interestingly, HCH residues
in breast milk of women from Hanoi were signifi ficantly higher than those
in Hochiminh, suggesting recent high background levels of HCHs in the
northern compared to the southern region. Consistent results where also
observed in the survey on sediment and bivalves from various locations
along the northern coast of Vietnam, which demonstrated relatively higher
residues in sites near the China border (Nhan et al. 1998, 1999). Earlier
reports also pointed out similar spatial distribution in different kinds of
environmental samples, showing higher levels of HCHs in Hanoi compared
to Hochiminh (Thao et al. 1993a; Iwata et al. 1994; Kannan et al. 1995). In
addition to the influence
fl of the possible transport from China, the world
244 T.B. Minh et al.
E. Dioxin Contamination
Southern Vietnam has long been considered as a well-known region where
Agent Orange was extensively sprayed during 1961–1971 in the Vietnam
War, resulting in severe dioxin contamination of various environmental
media and the food chain, including humans. During the past three decades,
Schecter and coworkers have been conducting investigations on dioxin
contamination in southern Vietnam, including sediments, foodstuffs, and,
particularly, samples from humans living near the “hot spot” of dioxin
contamination (Table 5). In general, dioxin contamination as a result of
Agent Orange can be characterized by the predominant of 2,3,7,8-
Sample/sampling
Location Year site description Unit n PCDDs
Soil, sediment
Saigon River 1984/85 Sediment, pg g−1 dry wt 1 5,800
industrial area
Dong Nai River 1984/85 Sediment, near pg g−1 dry wt 5 1,200 (830–
Orange Agent 1,400)
spraying during
Vietnam War
Red River 1984/85 Sediment, river pg g−1 dry wt 2 240 (220–
250)
Bien Hoa 2000 Soil, near the Air ng g−1 dry wy 4 590 (0.039–
Base, former 1,645)
Agen Orange
Storage
Organic Pollutants in Vietnam 245
Table 5. (cont.)
Sample/sampling
Location Year site description Unit n PCDDs
Bien Hung Lake, 2000 Sediment, former pg g−1 dry wt 3 340 (199–
Bien Hoa Air Base 532)
Bien Hung Lake, 2000 Sediment, close pg g−1 dry wt 3 1,640 (1,410–
Bien Hoa to the former 1,970)
Air Base,
Agent Orange
Storage
Bien Hung Lake, 2000 Sediment, pg g−1 dry wt 2 600 (500–
Bien Hoa downstream 700)
and upstream
Dong Nai River, 2000 Sediment, pg g−1 dry wt 2 630 (540–
southern reservoir of 715)
Vietnam Bien Hung
Lake
Hanoi 2000 Sediment, control pg g−1 dry wt 1 400
samples for
samples near
former Air
Base
Aso, Aluoi valey, 1996 Soil, former US pg g−1 dry wt 1 650
Hue Army Force
Base
Aso, Aluoi valey, 1996 Sediment, pond, pg g−1 dry wt 1 500
Hue former US
Army Force
base
Aso, Aluoi valey, 1997 Soil, former US pg g−1 dry wt 1 1,600
Hue Army Force
Base
Aso, Aluoi valey, 1997 Soil, former US pg g−1 dry wt 1 880
Hue airstrip
Aso, Aluoi valey, 1997 Soil, manioc pg g−1 dry wt 1 170
Hue fi
fields
Aso, Aluoi valey, 1997 Sediment, pond, pg g−1 dry wt 4 150 (32–250)
Hue former US
Army Force
base
Aso, Aluoi valey, 1999 Soil, former US pg g−1 dry wt 10 360 (98–730)
Hue Army Force
Base
Tabat, Aluoi 1999 Soil, former US pg g−1 dry wt 9 740 (430–
valey, Hue Army Force 1,100)
Base
Aluoi, Aluoi 1999 Soil, former US pg g−1 dry wt 9 270 (110–
valey, Hue Army Force 430)
Base
Adot, Aluoi 1999 Soil, areas pg g−1 dry wt 3 350 (48–550)
valey, Hue sprayed with
Agent Orange
Organic Pollutants in Vietnam 247
92 740 — Dwernychuk et
al. 2002
98 1,700 — Dwernychuk et
al. 2002
80 960 — Dwernychuk et
al. 2002
7.1 180 — Dwernychuk et
al. 2002
2.7 (1.1–3.7) 150 (33–250) — Dwernychuk et
al. 2002
Table 5. (cont.)
Sample/sampling
Location Year site description Unit n PCDDs
6 94 — Dwernychuk et
al. 2002
3.3 49 — Dwernychuk et
al. 2002
14 840 — Dwernychuk et
al. 2002
2.1 89 — Dwernychuk et
al. 2002
Table 5. (cont.)
Sample/sampling
Location Year site description Unit n PCDDs
— 32 — Schecter et al.
1989c, 1989d
Table 5. (cont.)
Sample/sampling
Location Year site description Unit n PCDDs
Table 5. (cont.)
Sample/sampling
Location Year site description Unit n PCDDs
26 32 34 Schecter et al.
2003
Table 5. (cont.)
Sample/sampling
Location Year site description Unit n PCDDs
Table 5. (cont.)
Sample/sampling
Location Year site description Unit n PCDDs
Table 5. (cont.)
Sample/sampling
Location Year site description Unit n PCDDs
Table 5. (cont.)
Sample/sampling
Location Year site description Unit n PCDDs
Table 5. (cont.)
Sample/sampling
Location Year site description Unit n PCDDs
31 135 — Dwernychuk et
al. 2002
33 127 — Dwernychuk et
al. 2002
84 304 — Dwernychuk et
al. 2002
83 260 — Dwernychuk et
al. 2002
266 T.B. Minh et al.
Table 5. (cont.)
Sample/sampling
Location Year site description Unit n PCDDs
48 136 — Dwernychuk et
al. 2002
22 130 — Dwernychuk et
al. 2002
Fig. 12. Concentrations and TEQs of PCDD/Fs in soils from open dumping sites
for municipal wastes in developing Asian countries (Minh NH et al. 2003).
Organic Pollutants in Vietnam 269
Philippines
Cambodia
India
Vietnam,, Hanoi
Vietnam,, Hochiminh
Hong Kong
Australia
USA, Indiana
USA, Michigan
Canada, British Columbia
Canada, Yukon
United Kingdom
Spain
Germany
1 10 100 1000 10000 100000
Flux of PCDD/Fs to soils (ng m–2 yr –1)
Fig. 13. Comparison of fluxes to soils from open dumping sites in Asian countries
with those from other locations in the world (Minh NH et al. 2003; Wagrowski and
Hites 2000).
Fig. 14. Comparison of the load of PCDD/Fs to dumping sites in Asian countries
with those in Kanto region, an extensive industrial area in Japan (Minh NH et al.
2003).
B. Bioaccumulation in Biota
V. Temporal Trends
Well-designed studies on temporal trends of POPs contamination in
developing countries are generally limited. This is a common issue in
underdeveloped nations, where advanced knowledge and state-of-the-art
analytical equipment are still substantially lacking. Therefore, reliable and
reproducible data for long-term trends of POP contamination, a key
requirement in monitoring programs, are limited in these countries,
including Vietnam. Nevertheless, studies on temporal trends of contamination
are very important, particularly in tropical developing countries. Few
reports have suggested the role of the southern Asian region as a possible
emission source of toxic contaminants for pristine areas such as the Arctic
274 T.B. Minh et al.
and the Antarctic (Iwata et al. 1993, 1994; Kannan et al. 1995; Kunisue et
al. 2002). Despite the ban on OC usage in most of the developed nations,
high consumption of OC insecticides to enhance food production and
eradicate vector-borne diseases has been a fact in developing countries.
Thus, despite the rapid decrease of OC residues in developed nations, the
status of contamination in the developing world seems different, with slower
rates of decline. Although well-designed studies on the temporal trends of
contamination in POPs from Vietnam have been limited, trends of OC
residues in river water and sediments from the Red River estuary and from
Hochiminh City, and human breast milk from women living in suburb areas
of Hanoi and Hochiminh, were investigated.
Viet (2002) examined concentrations of DDTs and γγ-HCH (lindane), the
two most common insecticides used extensively in Vietnam, in water and
sediments from the Red River delta. River water and sediments were
collected at the same locations annually in both dry and wet seasons
and examined for contamination trends during 1995–2001 (Fig. 16).
DDT residues in water have declined relatively rapidly during 1995–1998
and remained constant until recent years at levels below 10 ng/L.
Concentrations in sediments also exhibited a reducing trend but to a lesser
extent. DDT residues in sediments dropped by a factor of 2 during 1997
and 2000. DDT was officially
fi banned in Vietnam in 1995 (Sinh et al. 1999).
The reduction of DDT concentrations in both water and sediments from
Red River, northern Vietnam, indicate the effect of legislative action to
reduce the degree of pollution. An interesting result was observed on
trends of lindane in sediment, showing peak concentrations in 1997 and
lower levels during 1995–1996 and 1999–2001. Recent studies examined
HCH residues in sediments from different sites in the Red River delta and
max
DDTs
mean
Lindane min
40
80 20
Rainy season
40 10
0 0
1995 96 97 98 99 00 01 RS DS RS DS RS DS RS DS RS DS
Year 1995 96 97 99 00 01
Year
Fig. 16. Temporal trends of DDTs and lindane in surface water and sediment from
Red River Delta, northern Vietnam during 1995–2001 (Viet et al. 2002).
Organic Pollutants in Vietnam 275
estuary and found that HCH concentrations in the 1997 survey were higher
than those analyzed in the 1995 sampling survey (Nhan et al. 1998, 1999).
Such a fluctuating trend of HCH contamination suggests sporadic input of
this insecticide into the Red River watershed. In general, results in water
and sediments in recent years indicated a rapid decline of DDTs and HCHs
in surface water, but a slow reduction in sediment levels.
In southern Vietnam, several studies reported levels of DDTs and PCBs
in urban sediments from Hochiminh metropolitan area (Iwata et al. 1994;
Phuong et al. 1998; Minh NH et al. 2007a). Results of these investigations
in similar sampling areas were compiled to evaluate contamination trends.
PCBs levels decreased from 310 ng/g dry wt in 1990 (Iwata et al. 1994) to
220 ng/g in 1996 (Phuong et al. 1998) and to 82 ng/g in 2004 (Minh et al.
2007a). In the same period, DDTs decreased from 240 ng/g dry wt to 80 and
37 ng/g, respectively.
It is well known that decrease of POP residues in environmental matrices
often follows fi first-order kinetics, and thus their residue level data can be
fitted in simple log-linear regression for examination of temporal trends
fi
(Bignert et al. 1998; Noren and Meironyte 2000). Using this approach, data
from the above studies (Iwata et al. 1994; Phuong et al. 1998; Minh et al.
2007b) were combined to estimate half-life (definedfi as the time needed for
a compound to decrease to one-half of its original concentration) of DDTs
and PCBs in sediments from canals in the metropolitan area of Hochiminh
(Fig. 17). The estimated half-lives were approximately 5 yr for DDTs and
7 yr for PCBs.
The half-life of DDTs in this study is in agreement with those observed
in various environmental matrices from northern Europe (Bignert et al.
1998) as well as those reported for human breast milk in Hochiminh (Minh
et al. 2004a). The estimated half-life for PCBs in sediments from Hochiminh
350
Concentration (ng/g dry wt)
300 PCBs
250 DDTs
200
150
100
50
0
‘89 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05
Year of sampling
Fig. 17. Temporal trends of DDTs and PCBs in sediments collected from Hochiminh
City during the last 14 years (Minh NH et al. 2007a).
276 T.B. Minh et al.
8000
7000
p,p’-DDT
Conc. (ng g–1 lipid)
6000
5000
4000
- 0.248x
y = 6250 e
3000
2000
1000
0
1989 1995 2000 2005 2011
8000
7000
p,p’-DDE
Conc. (ng g–1 lipid)
6000
5000
-0.105x
4000 y = 7570 e
3000
2000
1000
0
1989 1995 2000 2005 2011
Year
Fig. 18. Estimation of time-trend curve of p,p′-DDT and p,p′-DDE residues in
human breast milk in Vietnam (Minh NH et al. 2004a).
sewage canal contained elevated levels of DDTs, far exceeding the probable
effect levels (PELs). PCB concentrations in Vietnamese sediments in these
locations were also above the PEL level. Likewise, concentrations of DDTs
in soils collected from some locations from north, middle, and south
Vietnam (Thao et al. 1993a,b) approached or exceeded the guideline
level (700 ng/g dry wt) proposed by Environment Canada and the level of
1000 ng/g dry wt recommended by the Japanese government.
Results of a 2004 survey indicated that concentrations of DDTs in all
sediment samples from Hochiminh canals are higher than the ISQG, and
those in more than half of the samples still exceeded the PEL (Minh TB et
al. 2005; Minh NH et al. 2007a). Nearly half of sediment samples from the
Sai Gon-Dong Nai River had concentrations above the ISQG and 20% of
the samples were above the PEL; only 10% of the estuarine and coastal
samples showed values over the ISQG and no samples over the PEL
(Fig. 19). On the other hand, PCBs levels in all sediments were lower than
the PEL (277 ng/g dry wt; data not shown) and only sediments from Hochim-
inh City canals contained PCBs higher than the ISQG (34 ng/g). The results
demonstrate high toxic potential of sediment in the city canals and there-
fore suggest a need for appropriate management. In this context, it is
important to note that despite the decrease in POPs pollution, present
levels in many sediment samples still exceed the PELs. Input of OCs to the
30
10
Concentration (ng/g dry wt)
9
(A)
8
7
(A)
6
5 (A)
4
(B)
3
2
(B) (B)
1
0
Fig. 19. Concentrations of DDT compounds in sediments from Sai Gon–Dong Nai
River, southern Vietnam in comparison with the Canadian Environmental Quality
Guideline for Sediment (Minh NH et al. 2007a).
Organic Pollutants in Vietnam 279
than in the Philippines and India. In addition, intakes estimated for children
living near the hot spot of dioxin contamination from Agent Orange in
southern Vietnam are still very high, even after spraying ended almost
three decades ago (see Fig. 21; Dwernychuk et al. 2002). Thus, Vietnam
could serve as a suitable location for future research on possible toxic
effects of dioxins on wildlife and humans as this is a place where a unique
situation of both current and historical dioxin contamination exists.
• Several studies have been conducted to understand the levels and impacts
of dioxins in specifific hot spots from southern Vietnam as a result of Agent
Orange spraying during the war. Surveys conducted during the late 1980s/
early 1990s indicate elevated levels of dioxins from these sites. In addition,
our recent studies have raised a concern regarding dioxin contamination
in open dumping sites in developing Asian countries, suggesting their
role as a potential source of dioxins and related compounds. Although
dioxin residues in soils and human milk collected from dumping sites in
Vietnam were generally lower than those in other Asian countries, the
status of dioxin pollution in these dumping sites was much greater than
those in control sites. The role of dumping sites as a source of dioxins,
therefore, is an important environmental issue for future research.
• For temporal trends of POPs pollution, available data demonstrate a
relatively rapid decline in OC insecticide residues such as DDTs and
HCHs in the Vietnamese environment, while PCBs show slower
decreasing trends. In this context, it is important to note that despite the
fact that DDT residues have declined over the last decade, the present
levels are still high and well exceed the environmental quality guideline
values.
• Open dumping sites for municipal wastes in developing Asian countries
are potential sources of many chemical contaminants. Long-term health
impacts of POPs on humans living in and around these dumping sites are
probably a major concern for future research in Vietnam.
• With rapid growth of industrial activities, the use of modern chemicals
such as PBDEs as flame retardants is another issue that needs particular
attention. In this context, the role of “e-waste,” the specifi
fic dumping sites
of used electronic devices and appliances and computers, as a significantfi
source of modern and toxic chemicals such as polybrominated com-
pounds, should be elucidated in developing Asian countries including
Vietnam.
• Considering these critical issues of POPs pollution, it is clear that con-
tinued and constant efforts should be made to deal with environmental
problems. Despite the possible decrease in global contamination by POPs
in the future, developing countries in the Asia-Pacific
fi region may continue
to be a potential sources for certain contaminants such as DDTs and
PCDD/Fs. Comprehensive and long-term monitoring programs are still
urgently needed. In this context, well-designed monitoring of temporal
trends of POP residues in developing countries, including Vietnam, over
an extended period is crucial for tracing the unrevealed sources and
predicting future prospects of their pollution. In addition, the issue of
toxic chemicals exposure to humans, particularly those currently residing
in extremely poor living conditions, such as near open dumping sites for
municipal wastes in developing countries, should be the major strategy
for future research.
284 T.B. Minh et al.
Summary
This review provides a comprehensive overview of the contamination by
persistent organic pollutants (POPs) in Vietnam based on the results of
extensive monitoring studies conducted during the last two decades.
Available data on POP levels in various environmental media and humans
are compiled and discussed to help provide in-depth insights into their
distributions and sources, transport behavior and fate, bioaccumulation
features, temporal trends, and the potential impacts on ecosystems and
human health. Surveys conducted in the framework of the Asia-Pacific fi
Mussel Watch Program during early 1990s indicated widespread
contamination by PCBs and organochlorine insecticides, particularly DDT
and HCH in various environmental compartments such as air, water, soils,
sediments, and fish collected from different parts of Vietnam. Recent
studies continued to reveal elevated contamination by DDTs in fi fish, mussels,
and birds from Vietnam. DDT concentrations in fish and birds from Vietnam
are among the highest reported for countries in the Asia-Pacifi fic region,
suggesting the role of Vietnamese environment as a potential emission
source of DDTs in this region. Although residues of this insecticide in
Vietnam have declined relatively rapidly during the past decade, recent
levels still exceed the proposed guideline values proposed by Canada and
the U.S. Open dumping sites for municipal wastes in some major cities
such as Hanoi and Hochiminh are a matter of concern with regard to
environmental pollution, particularly contamination by DDTs and PCDD/
Fs. Daily intakes of DDTs via seafood estimated for the Vietnamese general
population were among the highest reported for East Asian countries. In
the open dumping sites, intakes of dioxins by residents were signifi ficantly
greater than those living far from dumping sites. Particularly, the estimated
intakes of dioxins via soil ingestion and dermal exposure for children were
higher than those for adults, suggesting greater risk of dioxin exposure for
children near dumping sites. Future studies should be focused on the tem-
poral trends of POPs in biota in Vietnam to predict the future trends of
contamination and to understand possible toxic impacts on organisms. In
addition, human exposure and possible toxic effects, particularly on chil-
dren, should be considered as priority research, because they are the most
susceptible group and have greater exposure to POPs.
Acknowledgments
We thank Annamalai Subramanian, CMES, Ehime University, Japan for
his critical reading of this manuscript. This study was supported by grants
from the Environmental Science and Technology in the Core University
Program between Japan Society for the Promotion of Science (JSPS) and
National Center for Natural Science and Technology, Vietnam (NCST),
Research Revolution 2002 (RR2002) of Project for Sustainable Coexistence
Organic Pollutants in Vietnam 285
of Human, Nature and the Earth (FY2002) and “21st Century Center of
Excellence (COE) Program” from the Ministry of Education, Culture,
Sports, Science and Technology, Japan.
References
Agency for Toxic Substances and Disease Registry (ATSDR) (1997) Interim policy
guideline: dioxins and dioxin-like compounds in soil. U.S. Department of Health
and Human Services, Public Health Services, Atlanta, GA.
Agency for Toxic Substances and Disease Registry (ATSDR) (1998) Toxicological
Profifile for Chlorinated Dibenzo--p-dioxins (CDDs). Department of Health and
Human Services, Public Health Services, Atlanta, GA.
Ahmed MT, Ismail SMM, Mabrouk SS (1998) Residues of some chlorinated hydro-
carbon pesticides in rain water, soil and ground water and their influence
fl on
some soil microorganisms. Environ Int 24:665–670.
Bignert A, Olsson M, Persson W, Jensen S, Zakrisson S, Litzén K, Eriksson U,
Häggberg L, Alsberg T (1998) Temporal trends of organochlorines in Northern
Europe, 1967–1995. Relation to global fractionation, leakage from sediments
and international measures. Environ Pollut 99:177–198.
Canadian Council of the Ministers of the Environment (2002) Canadian Envir-
onmental Quality Guidelines 1999, updated 2001, 2002. Canadian sediment
quality guideline for the protection of aquatic life. Summary table updated 2002.
Winnipeg, MB, Canada.
Choi JW, Matsuda M, Kawano M, Min BY, Wakimoto T (2001) Accumulation
profifiles of persistent organochlorines in waterbirds from an estuary in Korea.
Arch Environ Contam Toxicol 41:353–363.
Dwernychuk LW, Cau HD, Hatfield fi CT, Boivin, TG, Hung TM, Dung PT, Thai
ND (2002) Dioxin reservoirs in southern Viet Nam: a legacy of Agent Orange.
Chemosphere 47:117–137.
Food and Agriculture Organization of the United Nations (FAO). FAO Statistics
Division (FAOSTAT), FAOSTAT Core Consumption Data, http://faostat.fao.
org/site/346/default.aspx, accessed June 2006.
Guruge KS, Tanabe S, Fukuda M, Yamagishi S, Tatsukawa R (1997) Accumulation
pattern of persistent organochlorine residues in common cormorants
(Phalacrocorax carbo) from Japan. Mar Pollut Bull 34:186–193.
Hoshi H, Minamoto N, Iwata H, Shiraki K, Tatsukawa R, Tanabe S, Fujita S, Hirai
K, Kinjo T (1998) Organochlorine pesticides and polychlorinated biphenyls
congeners in wild terrestrial mammals and birds from Chubu region, Japan:
interspecies comparison of the residue levels and composition. Chemosphere
36:3211–3221.
Hung DQ, Thiemann W (2002) Contamination by selected chlorinated pesticides
in surface waters in Hanoi, Vietnam. Chemosphere 47:357–367.
Iwata H, Tanabe S, Sakai N, Tatsukawa R (1993) Distribution of persistent organo-
chlorines in the oceanic air and surface seawater and the role of the ocean on
their global transport and fate. Environ Sci Technol 27:1080–1098.
Iwata H, Tanabe S, Sakai N, Nishimura A, Tatsukawa R (1994) Geographical dis-
tribution of persistent organochlorines in air, water and sediments from Asia and
Oceania, and their implication for global redistribution from lower latitudes.
Environ Pollut 85:15–33.
286 T.B. Minh et al.
Nhan DD, Carvalho FP, Am NM, Tuan QT, Yen NTH, Villeneuve JP, Cattini C
(2001) Chlorinated pesticides and PCBs in sediments and mollusks from fresh-
water canals in the Hanoi region. Environ Pollut 112:311–320.
Noren K, Meironyte D (2000) Certain organochlorine and organobromine contami-
nants in Swedish human milk in perspective of 20–30 years. Chemosphere
40:1111–1123.
Ogura I, Masunaga S, Nakanishi J (2001) Atmospheric deposition of polychlorinated
dibenzo-p- -dioxins, polychlorinated dibenzofurans, and dioxin-like polychlori-
nated biphenyls in the Kanto Region, Japan. Chemosphere 44:1473–1487.
Phiet PH, Anh TK, Vu DQ, Schecter A (1989) Preliminary observations of the
clinical histories, polychlorinated dibenzodioxin and dibenzofuran tissue levels
and 2,3,7,8-TCDD toxic equivalents of potentially dioxin exposed patients living
in the south of Vietnam. Chemosphere 19:937–940.
Phuong NTG, Hung BS, Vu DQ, Schecter A (1989) Dioxin levels in adipose tissues
of hospitalized women living in the south of Vietnam in 1984–85 with a brief
review of their clinical histories. Chemosphere 19:933–936.
Phuong PK, Son CPN, Sauvain J, Tarradellas J (1998) Contamination by PCBs,
DDTs, and heavy metals in sediments of Ho Chi Minh City’s canals, Viet Nam.
Bull Environ Contam Toxicol 60:347–354.
Schecter A, Ryan JJ, Constable JD (1986) Chlorinated dibenzo-p-dioxin and
dibenzofuran levels in human adipose tissue and milk samples from the north
and south of Vietnam. Chemosphere 15:1613–1620.
Schecter A, Ryan JJ, Constable JD (1987) Polychlorinated dibenzo-p - -dioxin and
polychlorinated dibenzofuran levels in human breast milk from Vietnam
compared with cow’s milk and human breast milk from the North American
continent. Chemosphere 16:2003–2016.
Schecter A, Fuerst P, Fuerst C, Meemken HA, Groebel W, Constable JD (1989a)
Levels of polychlorinated dibenzofurans, dibenzodioxins, PCBs, DDT, DDE,
hexachlorobenzene, dieldrin, hexachlorocyclohexanes, and oxychlordane in
human breast milk from the United States, Thailand, Vietnam and Germany.
Chemosphere 18:445–454.
Schecter A, Eitzer BD, Hites RA (1989b) Chlorinated dioxin and dibenzofuran
levels in sediments collected from rivers in Vietnam. Chemosphere 18:831–834.
Shecter A, Kooke R, Serne P, Olie K, Huy DQ, Hue ND, Constable J (1989c)
Chlorinated dioxin and dibenzofuran levels in food samples collected between
1985–87 in the north and south of Vietnam. Chemosphere 18:627–634.
Schecter A, Kooke R, Serne P, Olie K, Huy DQ, Hue ND, Constable J (1989d)
Chlorinated dioxin and dibenzofuran levels in food samples collected between
1985–87 in the north and south of Vietnam. Chemosphere 18:627–634.
Schecter A, Tong HY, Monson SJ, Gross ML, Constable J (1989e) Adipose tissue
levels of 2,3,7,8-TCDD in Vietnamese adults living in Vietnam, 1984–87. Che-
mosphere 18:1057–1062.
Schecter A, Furst P, Ryan JJ, Furst C, Meemken H, Groebel W, Constable J, Vu
D (1989f) Polychlorinated dioxin and dibenzofuran levels from human milk from
several locations in the United States, Germany and Vietnam. Chemosphere
19:979–984.
Schecter A, Vu D, Tong HY, Monson SJ, Gross ML, Constable JD (1989g) Levels
of 2,3,7,8-TCDD and 2,3,7,8-TCDF in human adipose tissue from hospitalized
persons in the north and south of Vietnam 1984–88. Chemosphere 19:
1001–1004.
Organic Pollutants in Vietnam 289
291
292 Index